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Abstract 
 
Low birth weight offspring are at increased risk for developing metabolic syndrome in later 
life, specifically its precursor, insulin resistance (IR).  Reduced mitochondrial lipid 
metabolism is implicated in IR pathogenesis, promoting accumulation of acylcarnitines, and 
potentiating alterations in phosphorylation status of insulin signaling intermediates.  While 
high-energy Western diets are classically implicated in IR progression, the in utero 
environment was recently highlighted as a major programming mechanism of later life IR.  
Using a guinea pig model of placental insufficiency, we investigated how an adverse in utero 
environment impacts later life mitochondrial lipid metabolism and IR progression, as well as 
its interaction with a postnatal Western diet. Markers of mitochondrial dysfunction and 
reduced lipid metabolism, including acylcarnitine accumulation, were observed in 
conjunction with disrupted phosphorylation of insulin signaling intermediates in skeletal 
muscle of low birth weight offspring.  Additionally, a postnatal Western diet unmasked low 
birth weight-induced mitochondrial dysfunctions, promoting further acylcarnitine 
accumulation. 
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Excerpts of this chapter have been previously published: Dunlop K, Cedrone M, Staples 
JF, Regnault TR. Altered Fetal Skeletal Muscle Nutrient Metabolism Following an 
Adverse In Utero Environment and the Modulation of Later Life Insulin Sensitivity. 
Nutrients. 2015 Feb 12;7(2):1202-16. doi: 10.3390/nu7021202. 
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1.1 Metabolic Syndrome 
 Throughout the world, non-communicable diseases now represent one of the 
greatest strains on the global community.  Furthermore, as our population ages, the 
burden of treating these non-communicable diseases on the health care system continues 
to increase, placing strain on the economy as well.  Non-communicable diseases, 
including heart disease, stroke and diabetes are among the top six leading causes of death 
in Canada, according to a 2014 survey conducted by Statistics Canada.1  Diabetes has 
been shown to lead to cardiovascular diseases, including heart disease and stroke, 
highlighting diabetes as a likely contributor to the development of these non-
communicable diseases.2  Of particular interest, other chronic diseases with a high 
prevalence in Canada include hypertension, dyslipidemia, impaired glucose tolerance and 
obesity, which together describe hallmarks of the metabolic syndrome (MetS).3  In 
Canada, it was estimated that 1 in 5 individuals aged 18-79 displayed observable 
manifestations of MetS between 2009 and 2011,4 a number that is only expected to 
continue to increase as our population ages. Clinically, MetS is defined as a cluster of 
risk factors including central obesity, hyperglycemia, dyslipidemia and hypertension, 
which predispose the patient to developing cardiovascular disease, type 2 diabetes, non-
alcoholic fatty liver disease, and other age-related metabolic diseases.3,5,6 The clinical 
presentation of MetS remains highly contested, with various international organizations 
providing different diagnostic criteria.  The World Health Organization (WHO) 
guidelines for the diagnosis of MetS include the following parameters: waist 
circumference greater than 102cm in men and greater than 88cm in women; fasting 
glucose levels greater than 110 mg/dL; blood pressure of 140/90 mmHg or greater; 
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triglyceride levels of 150 mg/dL; HDL cholesterol levels less than 35 mg/dL in men and 
less than 39 mg/dL.7  However, before these overt features of MetS present, peripheral 
insulin resistance often manifests, representing a key early feature of disease 
progression.8,9 
 Of growing concern is the rapidly increasing incidence of not only MetS, but also 
insulin resistance and type 2 diabetes. As of 2008/2009 approximately 1 in 11 Canadians 
were living with insulin resistance or diabetes.2  The emergence of insulin resistance has 
recently been highlighted as a critical pathophysiological event underlying the 
development of components of MetS, disrupting the metabolic capacity of the patient and 
perpetuating the development of further metabolic disease.8  Additionally, a particularly 
concerning trend is the growing incidence of insulin resistance and type 2 diabetes in the 
adolescent population.  In the past two decades alone, the incidence of type 2 diabetes in 
the adolescent population has increased worldwide,10 highlighting that research needs to 
be conducted not only to determine effective treatments for management of insulin 
resistance and MetS, but also for early, more effective prevention strategies targeting 
youth. 
 
1.2 Low Birth Weight (LBW) and Intrauterine Growth Restriction (IUGR) 
 As part of our investigation into the pathogenesis of MetS, we will be focusing on 
the LBW population, as epidemiological studies have highlighted an association between 
LBW secondary to IUGR and increased risk of MetS development in later life.11-13  LBW 
is classically defined as an infant born with a weight less than 2500g or below the 10th 
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percentile for gestational age.14 However, these arbitrary cutoffs do not account for the 
fact that some babies outside these cutoffs may have been exposed to an adverse in utero 
environment and grown inappropriately for their genetic potential.15-19 While these 
infants are not usually classified as LBW according to the clinical definitions, they may 
still have experienced metabolic adaptions to a suboptimal in utero environment that 
increases their risk of later life metabolic disease, highlighting that a continuum of risk 
exists among a range of birth weights.20,21  
 The prevalence of LBW in Canada has been holding steady at approximately 6% 
between 2000 and 2007.22  However, worldwide a modest increase in the percentage of 
births classified LBW has been observed over the past decade.22 LBW infants are often 
considered to be “small for gestational age” (SGA), a clinical definition applied when the 
infant is born with a weight below the 10th percentile for gestational age.23  However, 
current growth charts often used to classify these SGA infants do not take important 
factors such as race and ethnicity into account, highlighting the need for personalized 
growth curves depending on sex, ethnicity and other factors that may impact growth 
potential of the fetus in order to accurately represent the LBW population.24-26 The LBW 
population is particularly important, since recent evidence suggests these infants are at 
greater risk for perinatal mortality and morbidity, as well as long-term metabolic 
disease.13,27,28 
 A particular cause of LBW is the suitability of the in utero environment.  An 
adverse in utero environment, often characterized by suboptimal nutrient transfer to the 
fetus, culminates in IUGR. IUGR is a major obstetrical concern, and is the endpoint of a 
continuum of conditions that result in the failure of the fetus to attain its inherent growth 
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potential, leading to a low weight at birth.29  The etiology of IUGR is multifactorial, with 
adverse environmental or genetic and epigenetic factors likely playing a role in the 
abnormal growth and development of the fetus. One of the most important environmental 
factors regulating fetal growth is nutrient delivery to the fetus which occurs via placental 
diffusion and transport.30 In developed countries, a main cause of IUGR is placental 
insufficiency, ultimately affecting 5-10% of all pregnancies.23  Placental insufficiency is 
characterized by a reduced functional capacity of the placenta, and is typically associated 
with poor placental vascular development, which prevents adequate nutrition and oxygen 
from reaching the developing fetus, resulting in a hypoxic, nutrient deprived in utero 
environment.31,32 Placental insufficiency may develop due to maternal vascular disease, 
pre-eclampsia, placenta praevia or other placental anomalies that prevent proper 
development and/or vascularization of the placenta.30  Interestingly, it should be noted 
that independent of reductions in nutrient supply, hypoxia alone has been shown to have 
a significant impact on fetal growth, emphasizing hypoxia as a key contributor to 
impaired fetal growth and potentially IUGR.32 
 With exposure to a hypoxic in utero environment, the fetus undergoes key 
adaptations to ensure survival. A critical component of this adaptation in the acute setting 
has been considered a redistribution of fetal cardiac output towards essential organs such 
as the brain, heart and adrenal glands, at the expense of other organ systems, including 
the lungs, kidney, liver and skeletal muscle.33-35 With prolonged hypoxia, animal and 
human studies have highlighted a redistribution of blood flow toward the brain, as well as 
increased blood flow towards adrenal glands,36-39 and it is inferred from this 
redistribution that the brain continues to receive sufficient perfusion and nutrient supply 
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to maintain relative growth. This brain sparing effect is visible at birth, with the size of 
the fetal head being larger than that of the abdomen, giving rise to an observable 
asymmetrical growth restriction. Concurrent with the overall reduction in body weight 
and brain sparing effect, fetuses exposed to hypoxic in utero environments also display a 
reduced muscle mass compared with normal birth weight offspring,40,41 and are 
predisposed to altered insulin sensitivity.8,12,13,42 Furthermore, rodent models of low birth 
weight have also demonstrated a decrease in skeletal muscle mass at birth and throughout 
life,43 similar to the altered muscle to fat ratio observed in older men who were LBW at 
birth.44 With this altered body composition there are also metabolic changes to the 
offspring, resulting in what has been proposed as a “thrifty phenotype”.12,13 This “thrifty 
phenotype” encompasses a collection of metabolic adaptations initiated to aid in fetal 
survival when challenged with nutrient deprivation in utero.45 
 
1.3 The “Thrifty Phenotype” Hypothesis and The Developmental Origins of Health 
and Disease 
 The “thrifty phenotype” hypothesis was first put forth by Forshdahl, Barker and 
Colleagues in order to explain the risks associated with metabolic adaptations in utero. 
Over time, this hypothesis came to be known as the “Forsdahl-Barker hypothesis”, then 
later as the Developmental Origins of Health and Disease hypothesis, as further evidence 
strengthening the association between growth in utero and later life disease risk was 
discovered.  
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 The first associations between growth in utero and later life disease presentation 
were observed by conducting geographical studies of lifestyle factors and cardiovascular 
disease risk in Norway and England.  In the 1970s, Forsdahl used official statistical data 
in Norway to report a greater risk of coronary heart disease in adulthood when 
adolescents were exposed to poor living conditions in early life.46,47 In the 1980s, Barker 
and colleagues highlighted the emergence of paradoxical patterns whereby cardiovascular 
disease rates were twice as high in poorer socioeconomic areas of Britain, highlighting 
that adult lifestyle had a limited ability to predict cardiovascular disease risk.48 Further 
investigation into these paradoxical patterns revealed a parallel between coronary heart 
disease prevalence and death rate among newborns, providing the first clue that 
cardiovascular disease risk may be linked to fetal growth.49 These geographical studies 
provided the evidence required for Barker and colleagues to develop the hypothesis that 
poor nutrition in utero and during early infancy had the ability to induce coronary heart 
disease and an increased risk of stroke in adult life.48-51 While no biological mechanisms 
were put forth by Forsdahl or Barker at this time, Forsdahl’s observation that poverty 
during adolescence followed by a period of prosperity allowed for speculation that a form 
of permanent damage could be caused by early nutritional deficits that is maladaptive 
when exposed to later-life nutrient excess.47 
 Over time, further epidemiological studies have been conducted, highlighting 
associations between growth in utero and later life insulin resistance and obesity,12,52 both 
of which are important risk factors for development of MetS.  Examination of the birth 
records compiled by midwives in Hertfordshire from 1911 onwards allowed for 
associations to be made within this population who still resided in the area 50-70 years 
8 
 
later.  Studies conducted in this population highlighted impaired glucose tolerance in 
LBW men at an average age of 64, as well as presence of dyslipidemia and other 
components of MetS.12  Epidemiological studies conducted in Helsinki, Finland also 
highlighted a striking association between thinness at birth as a marker of suboptimal 
growth in utero and body weight in adolescence.  Children who were light and thin at 
birth, but who were caught-up in weight by adolescence so they had an average or above 
average body mass index had the highest incidence of cardiovascular disease, 
highlighting rapid postnatal growth as another important contributor to later life disease 
risk.53,54  
 Once this striking epidemiological data was presented to the scientific 
community, research has continued with animal models in order to better understand the 
molecular mechanisms associated with these observations.  With the expansion of this 
field of research, the “thrifty phenotype” hypothesis was expanded into the 
Developmental Origins of Health and Disease Hypothesis in order to encompass the vast 
importance of early life environment and its implications for later life disease risk (Figure 
1.1).55  
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Figure 1.1: Factors That May Contribute to Low Birth Weight and The 
Developmental Origins of Health and Disease. An in utero insult, or collection of 
insults, generally results in intrauterine growth restriction, impaired fetal growth and 
development, and a low birth weight outcome.  This predisposes the infant to a higher 
risk of developing metabolic diseases as they age and interact with their postnatal 
environment, experiencing rapid postnatal catch-up growth that may exacerbate the 
effects of programmed metabolic disease. 
 
 
10 
 
 While the “thrifty phenotype” continues to represent the observable phenotype 
associated with IUGR, theories of an accompanying altered metabolic phenotype are now 
emerging.  Fetal programming and developmental plasticity theories have developed, 
postulating that altered oxygen and nutrient transfer during critical windows of 
development, when the fetus is most sensitive to its environment, are associated with 
permanent alterations in structure and metabolism, and a fixed functional capacity of vital 
organs in postnatal life.13 In humans, organogenesis occurs predominantly in utero, and is 
associated with a high degree of organ plasticity in order to promote metabolic 
development.56 However, plasticity of the organs is decreased in postnatal life; therefore, 
adaptations to these metabolic organs initiated in utero in order to aid in fetal survival 
may persist into adulthood, increasing the propensity for these offspring to develop 
metabolic disease as they interact with their postnatal environment.13,57  
 Markers of altered fetal growth, including low weight at birth and asymmetric 
growth, are most widely used as indicators of IUGR or a hypoxic in utero environment. 
However, more subtle adaptations at the physiological level may be the drivers 
underlying the observable later life phenotypes, such as changes in skeletal muscle 
metabolic function. Once the organs have fully developed in utero, the IUGR fetus faced 
with a postnatal environment characterized by nutrient excess may develop long-term 
adverse metabolic consequences.8,12,13 Unfortunately, the mechanisms underlying these 
alterations in the metabolic capacity of the IUGR fetus and their propensity towards the 
development of later life insulin resistance and MetS remain poorly defined. 
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1.4 Skeletal Muscle Insulin Resistance 
 Skeletal muscle is the primary location for insulin-stimulated glucose uptake, 
accounting for up to 70% of whole body glucose disposal,58 and is a key regulator of 
whole body energy metabolism,59 with other metabolic organs, including liver, adipose 
tissue and pancreas also involved in the insulin response and pathogenesis of insulin 
resistance. The primary metabolic objective in the skeletal muscle is production of 
adenosine triphosphate (ATP) for contractile purposes; however, skeletal muscle is also 
responsible for the production and storage of glycogen, an insulin dependent process that 
provides the cells with glucose for ATP production when circulating levels are low. β-
oxidation, a process whereby free fatty acids are broken down to provide muscle with 
carbon chain substrates, is also important for skeletal muscle ATP production. Since the 
skeletal muscle is a critical producer of ATP and an important location for glucose and 
fat metabolism, determining the propensity of skeletal muscle towards developing insulin 
resistance is a key determinant in the pathophysiological progression towards metabolic 
syndrome. 
 Depressed insulin sensitivity, or insulin resistance, is a metabolic state in which 
peripheral tissues, such as skeletal muscle, are no longer responsive to the anabolic 
effects of insulin, thereby displaying reduced insulin-stimulated glucose uptake and 
perpetuating a state of hyperglycemia.60 Insulin resistance at the level of the skeletal 
muscle has been associated with a modulation of the serine/threonine phosphorylation 
status of insulin receptor substrates (IRS).61-63 A relative increase in the serine 
phosphorylation of IRS-1, the predominant isoform in skeletal muscle,64 at Ser307 reduces 
its ability to activate or complex with phosphatidylinositol 3-kinase (PI3-kinase). This 
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activation failure impairs downstream phosphorylation of protein kinase B (Akt) at Ser473 
and Thr308, and Akt Substrate of 160 kDa (AS160) at Thr642, ultimately leading to a 
reduction in glucose uptake into skeletal muscle cells through glucose transporter 4 
(GLUT4) transporters (Figure 1.2).61,63,65  
 
 
 
  
Figure 1.2: Molecular Manifestations of Insulin Resistance. Modulations of the 
phosphorylation status, including increased inhibitory phosphorylation or decreased 
activating phosphorylation, impair the ability of GLUT4 to translocate to the plasma 
membrane, preventing adequate glucose uptake and perpetuating hyperglycemia. 
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1.4.1 Skeletal Muscle Insulin Resistance in IUGR Offspring 
 A hypoxic in utero environment, commonly associated with IUGR, is known to 
negatively influence the fetus during critical periods of development.8,12,13 Interestingly, 
IUGR offspring in animal models display improved insulin sensitivity in very early 
postnatal life, as assessed by intravenous glucose tolerance challenge; however, a shift 
towards impaired glucose clearance and decreased insulin sensitivity is evident as these 
offspring age.66-68 The timing of this shift in insulin sensitivity appears to be sex-specific, 
with insulin action being impaired earlier in males and later in females.66 These animal 
studies highlight that sexually dimorphic effects occur with adverse in utero 
environments, and in the case of insulin resistance, studies suggest males appear to be 
more susceptible to a programmed later life insulin resistance.66,69 
 Interestingly however, this sex-specific programming of insulin resistance may 
not exist in humans. In a mixed cohort of offspring aged 25 who were growth restricted 
in utero, a significantly lower insulin-stimulated glucose uptake was observed compared 
to controls, as well as a higher plasma insulin concentration, suggesting the development 
of insulin resistance irrespective of sex. Of note, these observations were in conjunction 
with a normal glucose tolerance challenge, thus representing an early phase in the 
pathogenesis to insulin resistance and MetS.70 However, by age 64, men who were born 
small exhibited a strong link with impaired glucose tolerance and type 2 diabetes,52 while 
data concerning women born small is not widely available. Therefore, understanding the 
early steps in the progression towards insulin resistance in the LBW population, and any 
sex-specific effects, is of critical importance for mitigating the risk of these offspring to 
the development of later life type 2 diabetes. 
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 Animal models of IUGR, as well as human studies, have been used in order to 
identify the molecular changes occurring at the level of the insulin-signaling cascade that 
may be underlying the reduced insulin sensitivity in this population.65,71 In early postnatal 
life, expression of the insulin receptor is increased in LBW sheep, as a compensatory 
mechanism for the low insulin and glucose levels experienced in utero.72 However, by 
young adulthood skeletal muscle expression levels of the insulin receptor in LBW 
offspring are no different to normal birth weight controls, highlighting that the later life 
alterations in insulin sensitivity are likely due to a defect down-stream of the receptor that 
affects the ability of GLUT4 to translocate to the membrane and take glucose into the 
cell.71 Analysis of key intermediates in the insulin signaling cascade has demonstrated 
sex-specific alterations in animal models of IUGR that may be responsible for altered 
GLUT4 expression and reduced glucose uptake that is associated with states of insulin 
resistance.41,65,71,73 
 In rodent models of placental insufficiency, young adolescent male offspring 
show altered GLUT4 transport in conjunction with an increased phosphorylation of IRS-
1,65 which is known to blunt the physiological response to insulin63 by reducing the 
coupling efficiency of the insulin receptor and IRS-1.74 IRS-1 is also known to complex 
with PI3-kinase, and in young male LBW offspring, reduced expression of the p85 
regulatory subunit and p110β catalytic subunit of PI3K has also been observed in rodent, 
as well as larger animal (e.g., sheep) models of placental insufficiency.67,71,72 
Downstream of IRS-1, the total Akt levels were not altered by insulin infusion in growth 
restricted males;65,71 however, phosphorylation of this intermediate was increased by 
insulin, suggesting a compensatory mechanism may be at play to maintain this 
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physiological response to exogenous insulin.65 Although Akt’s involvement in the insulin 
cascade appears to be unaffected, downstream AS160 shows reduced phosphorylation in 
response to insulin,65 suggesting a functional impairment that impacts GLUT4 
translocation to the plasma membrane.75 
 Human data has suggested similar molecular alterations are present in young 
LBW males, including reduced expression of the p85 and p110β subunits of PI3-kinase 
and reduced skeletal muscle GLUT4 content.40,71 These alterations occur in conjunction 
with a blunted phosphorylation of Akt in response to insulin infusion, but with 
maintenance of glucose tolerance and whole body insulin sensitivity.40,71 Taken together, 
changes in the molecular expression of key insulin signaling intermediates in skeletal 
muscle of LBW offspring may precede development of whole body insulin resistance and 
glucose intolerance, representing an early defect in metabolism, or pre-diabetic state, that 
could be indicative of future metabolic disease.71 However, the mechanisms by which the 
in utero environment may be modulating these changes in insulin sensitivity remain ill 
defined. 
 
1.5 Origins of Skeletal Muscle Insulin Resistance 
 Traditional factors identified in the development of insulin resistance have been 
poor diet and sedentary lifestyle.   The increasing prevalence of a “Western”, or energy-
dense, high-fat/high-sugar diet, has been implicated as a key factor contributing to the 
pathogenesis of insulin resistance, promoting accumulation of fat within the skeletal 
muscle associated with a state of lipid overload and impacting mitochondrial function,76-
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78 leading to a diminished capacity for mitochondrial fatty acid oxidation associated with 
mitochondrial dysfunction.79 
 
1.5.1 Lipid Overload 
 Consumption of this energy-dense diet generates a surplus of free fatty acids, 
ultimately leading to ectopic lipid accumulation in non-adipose tissues such as skeletal 
muscle.80 Once in the skeletal muscle, excess fatty acids are activated to form their acyl-
CoA derivatives, which can be esterified into diacylglycerol (DAG), metabolized into 
ceramide, or conjugated to acylcarnitine for entry into the mitochondria to undergo β-
oxidation.81 Excess lipids may also be stored in lipid droplets as triacylglycerols, 
generating a pool of substrates termed intramyocellular triglycerides (IMTG).77 IMTG 
content is known to increase with percentage body fat, and to be elevated in obese or type 
2 diabetic individuals.82 IMTGs are broken down by lipases to undergo oxidation; 
however, disturbances in the rate of breakdown or oxidation may lead to accumulation of 
toxic lipid intermediates and subsequent insulin resistance.77,83 The type of triglyceride 
(saturated vs. unsaturated) that make up the skeletal muscle lipid pool is also important, 
since unsaturated triglycerides may be destined to accumulate as IMTG, whereas 
saturated triglycerides may be broken down into DAGs.84 Additionally, a higher 
proportion of saturated fatty acids within this lipid pool has recently been associated with 
insulin resistance.84  
 In rodent lipid infusion studies, insulin resistance develops secondary to increased 
concentrations of long-chain acyl-CoAs in the skeletal muscle.61 This increased lipid 
availability has been associated with reduced levels of skeletal muscle β-oxidation,85,86 
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leading to accumulation of toxic lipid metabolites including DAG61 and ceramide.87 
While specific changes in long-chain acyl-CoA levels have not been reported in IUGR or 
LBW offspring, reductions in enzymes involved in β-oxidation have been reported,88 
suggesting that accumulation of long-chain acyl-CoAs secondary to a reduction in 
oxidative capacity may be involved in the pathogenesis of insulin resistance.  
 Accumulation of these lipid metabolites in the skeletal muscle has been associated 
with increases in stress-induced kinases, such as protein kinase C (PKC)-θ or ε, isoforms 
known to act upstream of c-Jun N-terminal kinase (JNK) and IκB (inhibitor of NFκB) 
kinase (IKKβ). Notably, JNK and IKKβ are two central serine/threonine kinases 
mediating phosphorylation of IRS-1 at Ser307.  Increased inhibitory serine phosphorylation 
of IRS-1 induces a subsequent reduction in Ser473 phosphorylation of Akt, and reduced 
insulin-stimulated glucose uptake,61,81,87,89 similar to the molecular alterations that have 
been observed in the insulin signaling pathway in skeletal muscle of the LBW 
population.65,71 PKC-θ activation itself (translocation from the cytosol to the plasma 
membrane) has also been reported to occur during a state of lipid overload in skeletal 
muscle, and may represent an alternative pathway mediating alterations in the 
serine/threonine phosphorylation status of key insulin signaling intermediates.61,83 Direct 
evidence that these changes may be happening in LBW, IUGR offspring as they age is 
still lacking, but if occurring, presents a potential pathway where in utero induced 
changes in skeletal muscle metabolic capacity may play a contributing role to later life 
insulin resistance when challenged with a postnatal high fat diet. 
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1.5.2 Mitochondrial Dysfunction 
 Recently, reports implicating mitochondrial lipid metabolism in the pathogenesis 
of insulin resistance have emerged in addition to the traditional lipid overload theories 
described above.  Skeletal muscle relies heavily on fatty acid β-oxidation to generate 
energy, using this method to provide up to 90% of its total energy demand.79 Therefore, 
any alterations in fatty acid oxidation may impair skeletal muscle oxidative capacity. 
Certainly in rodent IUGR studies, muscle oxidative capacity is adversely affected in 
growth-restricted animals, preventing ATP generation,43,90 and as such could set the stage 
for impaired mitochondrial function when challenged with a postnatal Western diet. 
 Mitochondrial metabolism represents a complex series of enzymatic events 
initiated to oxidize lipids to carbon dioxide, with the ultimate goal of producing energy in 
the form of ATP.  A definition of mitochondrial dysfunction has recently been proposed 
that implicates decreased mitochondrial oxidation of substrates resulting from a global 
reduction in oxidative phosphorylation.91 This decreased oxidation characteristic of 
mitochondrial dysfunction may be induced due to decreased protein content or activity of 
oxidative proteins and/or reduced mitochondrial biogenesis or content.91 Mitochondrial 
dysfunction has also been associated with accumulation of toxic lipid intermediates as 
described above, as well as accumulation of acylcarnitine intermediates, in association 
with alterations in insulin signaling.92  However, the exact mechanisms linking 
mitochondrial dysfunction and insulin signaling remain complex and poorly understood. 
 In order to fully comprehend the scope of mitochondrial dysfunction and its role 
in the pathogenesis of insulin resistance, knowledge of normal mitochondrial lipid 
metabolism is essential.   The process begins with long-chain fatty acid generation from 
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lipolysis in adipose tissue, or breakdown of triglycerides in very low-density lipoproteins 
or chylomicrons.93  Once these long-chain fatty acids are formed they are taken up into 
skeletal muscle either through passive diffusion, or the coordinated actions of fatty acid 
translocase/cluster of differentiation 36 (FAT/CD36) and the family of fatty acid 
transport proteins (namely FATP1 and 4).93  While the majority of fatty acid chains will 
be oxidized in the mitochondria, a subset of very-long chain fatty acids may be 
preferentially diverted towards the peroxisomes to undergo β-oxidation in this location, 
generating the reactive oxygen species hydrogen peroxide as a signaling intermediate.94   
 To initiate the oxidative process in the mitochondria, fatty acyl-CoAs must enter 
the mitochondrial matrix through the carnitine palmitoyltransferase (CPT) system.95  This 
system consists of subcellular CPT1, which exchanges the Co-A moiety of the fatty acid 
for carnitine, forming an acylcarnitine.  Once the acylcarnitine has crossed into the 
mitochondria through acylcarnitine translocase, it is converted once again to its acyl-CoA 
form by CPT2, in order to continue through the oxidative process.95  It is important to 
note that CPT1 is allosterically regulated by malonyl-CoA, an intermediate derived from 
glucose metabolism and the first step of lipogenesis, thus providing an important control 
mechanism for regulating oxidative rate, making CPT1 the control point, or rate-limiting 
enzyme of mitochondrial oxidation.93   
 Now that the fatty acyl-CoAs have been transported into the mitochondria, they 
undergo a series of enzymatic reactions collectively termed β-oxidation.  This process 
begins when acyl-CoA dehydrogenase enzymes selectively oxidize the acyl group of the 
fatty acid depending on the length of the chain.  For example, very-long chain acyl-CoA 
dehydrogenase (VLCAD) acts on fatty acid chains greater than 22 carbons long, whereas 
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medium chain acyl-CoA dehydrogenase acts on fatty acids with a chain length between 6 
and 12 carbons.96  Following dehydrogenation, the carbon chain then undergoes 
hydration and another oxidation step, followed by thiolysis catalyzed by 3-ketoacyl CoA 
thiolase (KT), ultimately releasing acetyl-CoA.96  This 4-step cycle continues, generating 
2 carbon acetyl-CoA molecules at each iteration, until the entire long-chain has been 
reduced to an acetyl-CoA intermediate. These acetyl-CoA intermediates generated from 
β-oxidation are then fed into the tricarboxylic acid (TCA) cycle, a series of enzymatically 
driven reactions that generate carbon dioxide and the electron carriers, nicotinamide 
adenine dinucleotide (NADH) and flavin adenine dinucleotide (FADH2).97  NADH and 
FADH2 then enter the electron transport chain, where the energy from the electrons 
carried on these intermediates is harnessed to pump protons across the mitochondrial 
membrane to generate the electrochemical gradient required for ATP synthesis through 
the process of oxidative phosphorylation (Figure 1.3).95,97  
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Figure 1.3: Mitochondrial Lipid Oxidation Pathway. Fatty acids enter the cell via fatty 
acid transporters, and are then transported into the mitochondria through the co-ordinated 
actions of CPT1 and CPT2. Once in the mitochondria, the fatty acyl-CoA undergoes β-
oxidation, successively reducing the fatty acid chain by 2 carbons and generating acetyl-
CoA intermediates for use in the TCA Cycle.  The TCA cycle then generates CO2 and the 
reducing co-factors NADH and FADH2, which are fed through the complexes of the 
electron transport chain, with the ultimate goal of generating energy in the form of ATP. 
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 Defects along this oxidative pathway have the potential to allow for accumulation 
of acylcarnitine metabolites, which have recently emerged as strong indicators of 
mitochondrial dysfunction and increased nutrient load.62,98 Acylcarnitine accumulation in 
tissue is indicative of impairment in the utilization of the substrates generated through β-
oxidation for downstream energy production, and the presence of fatty acids that are 
incompletely oxidized.99 The recent interest in the field of metabolomics, which uses 
mass spectrometry techniques to determine how metabolic intermediates are altered in 
disease states, has allowed for profiling of these acylcarnitine intermediates.  The surge in 
metabolomics research has highlighted a method well suited to further investigation of 
the relationship between mitochondrial dysfunction, incomplete β-oxidation and the 
pathogenesis of insulin resistance. For example, high-fat feeding in rodents has been 
shown to induce a lipid profile high in even-chain acylcarnitines. Accumulation of these 
even-chain acylcarnitine species ranging in length from 6 carbon chains (C6) to 22 
carbon chains (C22) indicates that a large proportion of the fatty acids entering the 
mitochondria are only partially degraded for use as metabolic substrates.62,100 Of interest, 
recent evidence has suggested that one even-chain acylcarnitine in particular, C14 
carnitine, which can accumulate in situations of incomplete β-oxidation, has the ability to 
activate pro-inflammatory pathways, as well as an induction of JNK which may modulate 
the serine/threonine phosphorylation status of insulin signaling intermediates, 
perpetuating a state of insulin resistance.89,101 Mitochondrial dysfunction has also been 
observed in rodent models of diabetes, including the Zucker Diabetic Fatty rat, further 
supporting the idea that incomplete fatty acid oxidation and accumulation of acylcarnitine 
intermediates may be implicated in the pathogenesis of insulin resistance.62,102 Currently, 
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the impact of high fat feeding in LBW, IUGR offspring upon acylcarnitine production 
and mitochondrial dysfunction has not been reported. However, short-term high fat 
feeding trials in human LBW offspring show that LBW is associated with a reduced 
degree of metabolic plasticity,103 suggesting that in utero-induced changes to 
mitochondrial oxidation may be unique in LBW offspring.  Given the impact of diet 
alone upon acylcarnitine accumulation, a LBW situation in conjunction with poor 
postnatal diet may potentially exacerbate acylcarnitine accumulation and mitochondrial 
dysfunction. 
 
1.5.3 Regulation of Mitochondrial Function and Biogenesis 
 The regulation of mitochondrial biogenesis and respiration is an important 
element determining oxidative capacity and the subsequent propensity for development 
of insulin resistance.  The genes and enzymes involved in the oxidative process must be 
tightly regulated in order to adequately oxidize incoming fatty acids, generating co-
factors and TCA substrates to generate ATP for cellular demand.  This is accomplished 
by a tight co-ordination and interactions between a number of transcription factors 
regulating the enzymes involved in mitochondrial β-oxidation, including peroxisome 
proliferator-activated receptors, their co-activators, sirtuins, and the forkhead/winged 
helix transcription factors that each mediate an important aspect of mitochondrial 
biogenesis and oxidative function. 
 One such regulator of lipid oxidation is peroxisome proliferator-activated receptor 
alpha (PPARα), which is mainly expressed in tissues with a high oxidative capacity such 
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as the liver, heart, and skeletal muscle.79  PPARα is activated upon binding of neutral 
lipids, promoting fatty acid uptake, and is involved in the induction of oxidative target 
genes with a PPARα response element, including CD36, CPT1b, VLCAD, MCAD and 
KT.100,102,104,105 As such, increased activity of PPARα promotes mitochondrial β-
oxidation.  However, in order for full activation of PPARα and induction of its gene 
targets, co-ordination with peroxisome proliferator-activated receptor-gamma co-
activator 1-alpha (PGC-1α) is required as a critical component of the PPARα-activated 
transcriptional machinery.100 High levels of PGC-1α activity not only activate genes 
related to β-oxidation through the actions of PPARα, but also activate genes involved in 
the TCA cycle, including α-ketoglutarate dehydrogenase and succinate 
dehydrogenase.105,106 Additionally, PGC-1α in complex with nuclear respiratory factor-1 
(NRF-1) has the ability to induce transcription of components of oxidative 
phosphorylation, including subunits of complexes I through V.106  Furthermore, this 
highlights PGC-1α as a key regulator of optimal mitochondrial function that promotes the 
complete oxidation of fatty acids.105  Loss of PGC-1α has been implicated in the 
pathogenesis of insulin resistance in the context of high-fat diets, such that consumption 
of a high-fat diet decreases muscle PGC-1α expression, leading to a reduction in the 
coupling efficiency between β-oxidation and the TCA cycle, and coinciding with a shift 
from complete to incomplete β-oxidation, accumulation of acylcarnitines and altered 
insulin sensitivity.100,105 Recent studies have also reported reduced levels of PGC-1α 
mRNA107,108 and protein in the soleus108 and gastrocnemius109 muscles of young 
adolescent LBW offspring, as well as alterations in the methylation status of the PGC-1α 
promoter of both rodent109 and human110 models of IUGR. However, expression levels of 
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mitochondrial regulators of β-oxidation following consumption of a high-fat diet, 
combined with a LBW situation remain to be fully elucidated. 
 Another important family of transcription factors involved in the regulation of 
mitochondrial biogenesis as it relates to oxidative capacity is the sirtuins (SIRTs).  SIRTs 
are responsible for cellular energy sensing, as they are modulated by the availability of 
metabolic cofactors, including NAD+ and NADH, therefore acting as a regulatory 
mechanism for the mitochondrial oxidative process in response to nutrient availability.111 
Seven SIRT isoforms have been identified in mammals; however, in terms of the 
regulation of overall mitochondrial function, the most notable isoforms are SIRT1 and 
SIRT3.112  SIRT1 is predominantly localized to the nucleus, as well as the cytosol and 
mitochondria,113 where it deacetylates target proteins involved in lipid metabolism and 
energy balance.111  SIRT1 is activated during situations in which cellular energy is low 
(high NAD+/NADH ratio) in order to induce fatty acid oxidation by deacetylating PGC-
1α and PPARα, allowing a global induction of oxidative genes with the ultimate goal of 
increasing ATP production.105,111,113 On the other hand, SIRT3 is localized exclusively to 
the mitochondria and may have the potential to deacetylate proteins involved in the 
electron transport chain, highlighting SIRT3 as an important regulator of ATP synthesis 
and mitochondrial energy metabolism.114,115  Recent reports suggest SIRT3 may also 
regulate metabolism at the oxidative level by initiating deacetylation of long-chain acyl-
CoA dehydrogenase (LCAD) in order to promote β-oxidation.116  Therefore, 
dysregulation of mitochondrial biogenesis or oxidative function due to decreased 
availability or activity of the above-mentioned factors, including PPARα, PGC-1α, 
26 
 
SIRT1 and/or SIRT3, has the potential to promote mitochondrial dysfunction and reduced 
lipid oxidation (Figure 1.4).  
 
 
Figure 1.4: Regulation of Mitochondrial Lipid Oxidation. In order for lipids to be 
completely oxidized, tight co-ordination between a number of transcription factors is 
required.  In resting states, PGC-1α and PPARα are acetylated, preventing their co-
ordination.  To induce the gene targets involved in β-oxidation and increase the oxidation 
rate, deacetylation by SIRT1 is required to allow PGC-1α and PPARα to complex 
together.  PGC-1α on its own, in its deacetylated state, is also able to induce genes 
involved in the TCA cycle and electron transport chain, promoting complete lipid 
oxidation.  SIRT3, which resides exclusively in the mitochondria, is responsible for 
deacetylating protein targets in the electron transport chain, in order to maintain its 
activity and promote ATP generation. 
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 Unfortunately, the link between mitochondrial dysfunction and insulin resistance 
remains unclear.  Is mitochondrial dysfunction the insult that induces insulin resistance, 
or does a primary insult of insulin resistance promote mitochondrial dysfunction?  While 
this relationship remains complex and elusive, important insight into how insulin 
signaling and mitochondrial metabolic pathways intersect has been brought forth in 
recent years.  One important transcription factor in this relationship between insulin 
signaling and mitochondrial metabolism has been identified, namely the forkhead/winged 
helix transcription factor FOXO1.92  FOXO1 is important in regulating cell proliferation, 
as well as mediating the expression of hundreds of genes involved in gluconeogenesis, 
lipid metabolism and oxidative stress.117  Recently, FOXO1 has been identified as a 
substrate of Akt, containing three phosphorylation sites for Akt-mediated 
phosphorylation (Thr24, Ser256, Ser319).118  Phosphorylation of these residues, secondary to 
Akt activation through the insulin signaling cascade, promotes FOXO1 nuclear exclusion 
and translocation to the cytosol, inhibiting FOXO1-mediated gene expression and 
regulating rates of gluconeogenesis and lipid metabolism in response to nutrient 
availability.119  In situations of insulin resistance, impairment of IRS and reduced 
activation of Akt allows for hyperactivation of FOXO1, which has the ability to disrupt 
the electron transport chain by inducing expression of heme oxygenase 1 (HMOX1) 
which depletes heme availability, an essential cofactor facilitating electron transport.92 By 
disrupting mitochondrial oxidative phosphorylation, the NAD+/NADH ratio decreases, 
blunting the activation of SIRT1 and PGC-1α-mediated mitochondrial biogenesis and 
impairing fatty acid oxidation, promoting a state of mitochondrial dysfunction.92  
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However, whether insulin resistance is the result of accumulation of intermediates 
associated with mitochondrial dysfunction remains unclear. 
 
1.6 Rationale, Hypothesis, Objectives 
1.6.1 Rationale and Hypothesis 
 Recent evidence has suggested that infants of an adverse in utero environment 
represent a unique population who appear to be at greater risk for development of insulin 
resistance and other components of MetS.12,13,49-52 Adaptive, programmed changes in 
metabolic development and function initiated to aid in fetal survival are thought to lead to 
structural and metabolic deficits in later life.8  However, the molecular alterations 
associated with these programmed changes and their role in promoting later life 
metabolic disease remain unclear.  While defects in the skeletal muscle metabolism of 
LBW offspring have been highlighted in both human and animal studies, including 
alterations in insulin sensitivity and oxidative phosphorylation,40,43,71,120 the in utero 
contributors to the origins of insulin resistance and the relative contribution of in utero-
induced alterations to skeletal muscle fatty acid metabolism and mitochondrial function 
on the progression of insulin resistance remain ill defined. 
 Further, and more concerning, are recent studies suggesting that these LBW 
offspring are unable to lose weight as efficiently as normal birth weight offspring when 
maintained on a 40%-calorie restricted diet,43 and that PGC-1α deficiencies associated 
with IUGR appear resistant to exercise intervention.121  These studies highlight that these 
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offspring, while being at a higher risk of developing aspects of metabolic disease, may be 
resistant to current intervention practices.  Additionally, when these infants with 
programmed alterations in skeletal muscle development are faced with a postnatal 
environment of nutrient excess, they appear to be at greater risk for aberrant skeletal 
muscle function.8,13 Therefore, understanding the unique relationships and subtle 
metabolic differences between low and normal birth weight infants and how they interact 
with their postnatal nutritional environment is an important step in determining methods 
to improve skeletal muscle insulin sensitivity in order to mitigate the risk of these LBW 
offspring developing MetS in later life. As such, we postulate that IUGR is associated 
with in utero-induced alterations in skeletal muscle lipid oxidation, which impair 
insulin sensitivity, independent of postnatal diet.  Early exposure to a poor postnatal 
diet may have the potential to exacerbate the already dysfunctional system, further 
increasing the risk of developing insulin resistance and progression to MetS in young 
adulthood. 
 
1.6.2 Objectives 
The first objective of the study is to assess growth and metabolic parameters of guinea 
pig offspring of an adverse in utero environment independently, and in conjunction with 
a postnatal high-fat/high-sugar diet, in order to investigate the relative contributions of 
the components of the in utero environment and postnatal diet on glucose tolerance and 
body composition as they relate to early markers of the pathogenesis of MetS. 
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The second objective of the study is to investigate the impact of an adverse in utero 
environment upon skeletal muscle lipid metabolism independently, and in conjunction 
with a postnatal high-fat/high-sugar diet, focusing on mitochondrial lipid oxidation, 
acylcarnitine accumulation and mitochondrial dysfunction, as a contributor to the 
pathogenesis of insulin resistance. 
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Chapter 2: 
Growth and Body Composition of Guinea Pig Offspring are Altered in Response to 
Low Birth Weight and Postnatal Exposure to a “Western” Diet 
 
 
 
 
 
 
 
Data presented in this chapter is part of a larger work profiling our entire cohort, which is 
currently in preparation for submission.  
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2.1 Introduction 
 Metabolic syndrome (MetS) is characterized by a cluster of risk factors, including 
hyperglycemia, central obesity, hypertriglyceridemia, dyslipidemia and high blood 
pressure,1,2 which ultimately increases the patient’s risk of developing cardiovascular 
disease, type 2 diabetes, and other age-related metabolic diseases.3 An early marker of 
disease progression is insulin resistance, as it is typically observable before overt 
manifestations become apparent.4  Insulin resistance is a metabolic state in which 
peripheral tissues are no longer sensitive to the anabolic effects of insulin, perpetuating a 
state of hyperglycemia, further validating insulin resistance as a critical precursor to the 
pathophysiological development of MetS.4  
 The prevalence of MetS and its associated morbidities are steadily increasing in 
developed countries, with recent surveys estimating that 1 in 5 Canadians aged 18-79 
display observable manifestations of MetS.5 Classically, the origins of MetS and insulin 
resistance have largely been attributed to lifestyle factors, including consumption of 
energy-dense diets and sedentary behavior.6  The increasing prevalence of the symptoms 
associated with MetS mirrors the increase in obesity rates, which is largely attributable to 
increased consumption of energy-dense, high-fat/high-sugar, “Western” diets and their 
propensity to induce a state of insulin resistance.6  These Western diets, with their high 
percentage of saturated fatty acids and low percentage of poly-unsaturated fatty acids,7 
alter lipid metabolism, induce an inflammatory state, and promote altered insulin 
sensitivity, increasing the patient’s risk for developing cardio-metabolic disease.6,8 The 
Western diet is also characterized by a high percentage of added sugars,9 including 
fructose, which alters carbohydrate and glucose metabolism and impact insulin 
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sensitivity, likely further contributing to the development of a state of insulin 
resistance.10,11  These increases in fats and sugars independently, and in combination, 
alter growth trajectory, favouring fat deposition and accelerating development of obesity 
and metabolic disease, promoting MetS progression. 
 Recently, human epidemiological studies have highlighted that an adverse in 
utero environment that restricts fetal growth, culminating in intrauterine growth 
restriction (IUGR) and low birth weight (LBW), increases the propensity for the 
offspring to develop age-related metabolic and cardiovascular diseases in later life.12  
Indeed, the recent EPOCH study highlighted higher fasting insulin levels and homeostatic 
model assessment of insulin resistance (HOMA-IR) values indicative of impaired insulin 
sensitivity as early as 10 years of age in IUGR-exposed children, independent of both 
childhood body mass index (BMI) and BMI trajectory following a period of “catch-up 
growth” during the first year of life.13 Similarly, reports of a 7-fold increased risk for 
development of insulin resistance by the age of young adulthood have also been 
observed.14 Furthermore, this pattern holds throughout the life-span, with low birth 
weight males at age 64 exhibiting a strong association with impaired glucose tolerance, a 
marker of whole-body insulin resistance and type 2 diabetes.15 Additionally, animal 
models of low birth weight generated through a variety of means, including caloric 
restriction, maternal protein restriction and uterine artery ligation, have confirmed the 
impact of an adverse in utero environment on an increased incidence of cardiovascular 
disease, visceral obesity and hypercholesterolemia in these offspring.4,16-20 Overall, these 
human and animal studies highlight that metabolic adaptations to an adverse in utero 
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environment are associated with a predisposition for development of aspects of MetS in 
later life. 
 The Developmental Origins of Health and Disease (DOHaD) hypothesis has 
developed immensely over the last thirty years to postulate how adaptations to limited 
nutrient and oxygen supply, as a consequence of reduced placental blood flow to the 
fetus, results in an adverse in utero environment which would have the ability to 
permanently program structural and functional alterations to major metabolic organs.4  
These adaptive responses during critical periods of in utero development are thought to 
program a “thrifty phenotype” which aids in immediate survival of the fetus.  One overt 
manifestation of this adaptive growth in utero is a leaner phenotype at birth as a 
consequence of reduced muscle mass,21,22 which has been associated with a programmed 
predisposition to altered insulin sensitivity in later life.4,12,14,20   Since organogenesis 
occurs predominantly in utero and is followed by a period of rapid fetal growth and loss 
of organ plasticity shortly after birth,23,24 environmental insults during this sensitive 
period of development have the potential to result in a fixed functional capacity of vital 
metabolic organs.24   As such, these adaptive responses in response to an adverse in utero 
environment have the potential to induce a propensity for life-long metabolic 
consequences as these offspring interact with their postnatal environment.12,20  
 Additionally, IUGR and LBW are associated with a period of rapid postnatal 
catch-up growth which further modulates later-life disease risk.12  The cessation of 
growth experienced in utero is suggested to slow the genetic growth program of the fetus, 
delaying the loss of proliferative capacity typically experienced following birth, allowing 
for rapid catch-up growth to occur in early life.25 However, this period of rapid growth in 
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early life has been associated with increased childhood adiposity,26 as well as an 
increased strain on vital metabolic organs that contribute to the development of MetS.27 
In comparison to the nutrient deprivation experienced in utero, introduction to a postnatal 
environment characterized by relative nutrient excess also has the potential to induce 
postnatal catch-up growth and alter the metabolic capacity of vital organs, increasing the 
offspring’s risk for developing metabolic disease with age.24   
 Recently, evidence has suggested that in utero influences and secondary insults in 
adult life may have a synergistic effect, further exacerbating an already dysfunctional 
system and promoting earlier onset of MetS.12  While some studies have suggested the 
prevalence of childhood obesity has begun to plateau in the United States,28 it still 
remains a concern worldwide.  Indeed, using the WHO guidelines for classifying obesity 
in children, it was estimated that approximately 33% of children in Canada aged 5 to 11 
years were overweight or obese between 2009 and 2011.29 This increased incidence of 
childhood obesity can largely be attributed to early introduction of energy-dense diets and 
sedentary behavior;28 however genetics and the contribution of the in utero environment 
cannot be negated. Ultimately, altered childhood growth and body composition, namely 
obesity, have the potential to influence later-life disease risk, putting these children at 
increased risk of developing symptoms associated with MetS at an earlier age.30  While 
the increasing prevalence of childhood obesity and poor food choices in our society 
continues to expand, the postnatal effects of consumption of an energy-dense Western 
diet still remain largely unexplored in LBW offspring. As such, we sought to assess body 
composition, growth parameters and glucose tolerance as a marker of the MetS 
phenotype in guinea pig offspring of an adverse in utero environment.  Additionally, we 
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investigated body composition, growth and glucose tolerance in offspring of an adverse 
in utero environment in conjunction with a postnatal high-fat/high-sugar diet in order to 
investigate the relative contributions of the components of the diet on progression of the 
MetS phenotype. 
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2.2 Materials and Methods 
2.2.1 Ethics Statement 
 Animal care, maintenance and surgical procedures were conducted in accordance 
with the guidelines of the Canadian Council on Animal Care.  All procedures were 
approved by The University of Western Ontario Animal Use Subcommittee (Appendix 
II). 
 
2.2.2 Animal Handling 
 Time-mated pregnant Dunkin-Hartley guinea pigs (Charles River Laboratories, 
Wilmington, MA, USA) were housed in a constant temperature (20°C) and humidity 
(30%) controlled environment with 12h light/dark cycle. All animals had ad libitum 
access to standard guinea pig chow (LabDiet diet 5025) and tap water. 
 All pregnant guinea pigs underwent uterine artery ablation, as previously 
described,31 to induce uteroplacental insufficiency and IUGR. At mid-gestation (~32 
days, term ~67 days), sows were anesthetized in an anesthetic chamber (4-5% isoflurane 
with 2L/min O2, followed by 2.5-3% isoflurane with 1L/min O2 for maintenance).  
Immediately following induction of anesthesia, a subcutaneous injection of Rubinol 
(Glycopyrrolate, 0.01mg/kg, Sandoz Can Inc., Montreal, QC) was administered. A 
midline incision was made below the umbilicus, exposing the bicornate uterus.  Arterial 
vessels feeding each horn of the uterus were identified, and every second branch was 
cauterized using an Aaron 2250 electrosurgical generator (Bovie Medical, Clearwater, 
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FL), then the abdominal cavity closed.  Immediately following surgery, a subcutaneous 
injection of Temgesic (Buprenorphine, 0.025mg/kg, Schering-Plough Co., Kenilworth, 
NJ) was administered, and regular post-operative monitoring undertaken.  Sows delivered 
spontaneously at term (approximately 67-69 days),31 at which time pup weight, length, 
abdominal circumference and biparietal distance were measured.  At the end of the 
pupping period, male guinea pigs were allocated to the low birth weight (LBW) group if 
birth weight was below the 25th percentile, and the normal birth weight (NBW) group if 
birth weight was between the 25th and 75th percentile (Figure 2.1).  Based on these 
criteria, LBW pups were below 80g, and NBW pups were above 90g, in accordance with 
previously reported data.19,32 
 Pups remained with their dams during the 15-day lactation period.  Five days 
prior to weaning, all pups were introduced to small amounts of a control diet (Harlan 
Laboratories TD.110240: Table 2.1) and weaned on postnatal day (PND)15 into 
individual cages.  At this time, guinea pig offspring were randomized to either a control 
(CD, Harlan Laboratories TD.110240: Table 2.1) or a Western (WD, Harlan Laboratories 
TD.110239: Table 2.1) diet.  To avoid litter effects, only one male LBW and one male 
NBW animal from a single litter was assigned to each diet.  From the time of weaning, 
feed intake was measured daily, and body weights were measured daily until PND50, 
then twice weekly until PND145, corresponding to young adulthood.16,33   
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Figure 2.1: Birth Weight Distribution. Pregnant sows underwent uterine artery ablation 
at mid-gestation in order to induce placental insufficiency and intrauterine growth 
restriction.  Briefly, in anesthetized sows, a midline incision was made below the 
umbilicus, exposing the bicornate uterus.  Arterial vessels feeding each horn of the uterus 
were identified, and every second branch was cauterized, reducing placental blood flow, 
oxygen and nutrient transfer to the fetus.  Following spontaneous pupping, pups born 
below the 25th percentile (dashed line) were classified as low birth weight (LBW), and 
those above the 25th percentile were classified as normal birth weight (NBW).  Animals 
between 80g and 90g (grey, hatched bar) were excluded from analyses. 
 
 
 
 
 
 
 
 
51 
 
 
Component  Control Diet (CD) Western Diet (WD) 
Total protein (isolated soy 
protein, %kcal) 
22 21 
Total Fat (%kcal) 18 46 
          Saturated Fatty Acids 15 70 
          Poly-unsaturated Fatty 
Acids 
61 4 
Mono-unsaturated Fatty Acids 24 26 
Fatty Acid Composition 
(%weight) 
  
C12:0 1.26 17.90 
Myristic Acid (C14:0) 1.28 9.33 
Palmitic Acid (C16:0) 14.74 21.64 
Stearic Acid (C18:0) 5.93 16.96 
Oleic Acid (C18:1cis9) 25.60 26.72 
Linoleic Acid (C18:2n-6) 46.04 7.45 
Alpha Linoleic Acid (C18:3n-3) 5.15 - 
Total Carbohydrate (%kcal) 60 33 
Sucrose 11 22 
Fructose - 7.6 
Cholesterol (%kcal) - 0.25 
Density (kcal/g) 3.4 4.2 
Table 2.1: Composition of the Postnatal Diets. 
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2.2.3 Analysis of Growth and Feed Intake 
 Absolute growth rate (AGR: g/day), percent increase in body weight, and 
fractional growth rate (FGR: AGR/birth weight)16 were calculated for the 15-day 
lactation period for n=20 NBW and n=18 LBW offspring.  
 The post-weaning period was divided into three intervals: weaning-PND50 
representing the period of maximal growth, PND51-110 representing the period of 
adolescent growth, and PND111-145 representing the plateau period in young adulthood.  
For each interval, the AGR, average food intake (g/day/kg body weight), calorie 
consumption (calories/day) and efficiency (g gained/day/calories consumed/day) were 
calculated for n=11 NBW/CD, n=11 LBW/CD, n=9 NBW/WD and n=7 LBW/WD 
offspring. 
 
2.2.4 Computed Tomography (CT) Measurements 
 At approximately PND110, in vivo computed tomography scans were performed, 
as previously described,19 in order to quantify total adipose tissue, bone and muscle 
volume of the whole body (from proximal tibia to base of skull).34  Briefly, anesthesia 
was induced in an anesthetic chamber using 4-5% isoflurane with 2L/min O2, and 
maintained with 1.5-3% isoflurane.  Images were taken using a Discovery CT750 HD 
scanner (GE Healthcare, Mississauga, ON) at 1.25mm slices, with voltage and current set 
to 80kV and 100mA, respectively.  Using a MATLAB developed program (The 
Mathworks Inc., Natick, MA), bone, muscle and adipose tissue were differentiated by 
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thresholding the CT image slides of the guinea pig.35  Using pixel size and thickness of 
each CT image, volumes (cm3) of bone, muscle and adipose tissue type were calculated 
for each tissue type and expressed as a percentage of total body volume for n=4-5 
animals per group. 
 
2.2.5 Glucose Tolerance Testing 
 At PND60 and PND120, intraperitoneal glucose tolerance tests (IPGTTs) were 
performed on n=12 NBW/CD, n=12 LBW/CD, n=9 NBW/WD and n=7 LBW/WD 
offspring to assess whole body glucose tolerance.   Following an overnight (16h) fast, a 
bolus injection of 0.5% dextrose (1g/kg body weight)16,36 was administered 
intraperitoneally.  Blood was sampled at the peripheral ear vein at times 0, 10, 20, 50, 80, 
110, 140, 170, and 200 minutes following injection.  Blood glucose levels were measured 
using a Bayer Contour hand-held glucometer (Bayer Diabetes, Mississauga, ON).  Area 
under the glucose curve was calculated using GraphPad Prism 6 (GraphPad Software, 
San Diego, CA) for each animal as a measure of glucose clearance.37 
 
2.2.6 Statistical Analyses  
 All data presented are mean ± standard error (SEM).  Statistical significance 
during the lactation period was determined using a two-tailed unpaired t-test.  Two-way 
ANOVA followed by post-hoc Tukey’s test was performed to assess the effects of birth 
weight and postnatal diet. Two-way ANOVA Repeated Measures, followed by post-hoc 
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Tukey’s test, were performed to assess the effects of birth weight and postnatal diet over 
the course of the experimental period.  All statistical analyses were performed using 
GraphPad Prism 6 (GraphPad Software, San Diego, CA).  Values of p<0.05 were 
considered statistically significant. 
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2.3 Results 
2.3.1 Uterine Artery Ablation Results in Growth Restriction of LBW Offspring 
 At the time of birth, LBW offspring displayed indications of growth restriction.  
Birth weight/birth length, a measure of leanness,16 was significantly (p<0.001) reduced in 
LBW offspring, compared to NBW offspring (Table 2.2).  Biparietal diameter was 
significantly (p<0.05) decreased in LBW offspring, compared to their NBW counterparts 
(Table 2.2).  Crown-rump distance was significantly (p<0.01) reduced in LBW offspring 
(Table 2.2).  Abdominal circumference was reduced (p=0.0544) in LBW offspring (Table 
2.2).  
 
 Bi-
parietal 
Distance 
(cm) 
Crown- 
Rump 
Length 
(cm) 
Abdominal 
Circumference 
(cm) 
Ponderal  
Index 
(g/cm3) 
Birth 
Weight/ 
Birth 
Length 
(g/cm) 
Absolute 
Growth 
Rate 
(g/day) 
%Increase 
in Body 
Weight 
Fractional 
Growth 
Rate  
NBW 2.16 ± 
0.035 
15.49 ± 
0.32 
11.56 ± 0.17 0.029 ± 
0.002 
6.7 ± 
0.21 
9.50 ± 
0.26 
115.7 ± 
3.79 
0.092 ± 
0.002 
LBW 2.04 ± 
0.039 
13.97 ± 
0.38 
10.98 ± 0.24 0.029 ± 
0.002 
5.46 ± 
0.22 
8.29 ± 
0.24 
149.6 ± 
6.14 
0.113 ± 
0.004 
 * ** p=0.0544 ns *** ** **** **** 
 
Table 2.2: Birth Characteristics and Lactation Period Growth.  Following 
spontaneous birth, pup weights, length, biparietal distance, and abdominal circumference 
were measured as indicators of growth restriction. Pup weight was measured daily 
throughout the 15-day lactation period.  Data presented are mean ± standard error (SEM) 
for n=20 normal birth weight (NBW) and n=18 low birth weight (LBW) offspring.  
Statistical significance was determined by two-tailed unpaired Student’s t-test. *p<0.05, 
**p<0.01, ***p<0.001, ****p<0.0001, ns = not significant. 
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2.3.2 Growth Performance During the Lactation Period 
 During the lactation period, LBW offspring exhibited an altered growth trajectory, 
including a 13% reduction  (p<0.01) in absolute growth rate (AGR; Table 2.2).  However, 
LBW offspring showed a 149.6% increase in their body weight over the course of the 
lactation period, a 29% (p<0.0001) greater increase than the NBW offspring (Table 2).  
The fractional growth rate was also 23% greater (p<0.0001) in LBW offspring, compared 
to NBW (Table 2.2). 
 
2.3.3 Growth Performance and Energy Intake Post-weaning 
 During the post-weaning period, NBW/CD offspring had an AGR of 7.38 ± 0.323 
g from weaning until PND50, an AGR of 4.62 ± 0.23 g from PND51-110, and an AGR of 
2.87 ± 0.47 g from PND111-145 (Figure 2.2A), ultimately reaching a body weight of 
825.2 ± 28.3 g at the time of putdown.  During the period from weaning until PND50, 
NBW/WD offspring displayed a 27% reduction (p<0.01) in AGR, compared to NBW/CD 
offspring, whereas LBW/WD offspring displayed a 34% reduction in AGR compared to 
NBW/CD offspring (p<0.001; Figure 2.2A).  No significant differences in mean AGR 
were observed for the period from PND51-110.  From PND111 to the time of putdown, 
LBW/CD offspring displayed a 52% reduction (p<0.05) in AGR, compared to NBW/CD 
offspring (Figure 2.2A). An overall reduction (p<0.01) in total mean AGR was also 
observed in our WD-fed groups, independent of time.  Additionally, there was a 
significant (p<0.01) interaction between time and our experimental groups (Figure 2.2A).  
WD-fed offspring remained significantly (p<0.05) lighter than CD-fed offspring at the 
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time of putdown, with body weights of NBW/WD: 732.3 ± 26.8 g; LBW/WD: 708.8 ± 
19.8 g vs NBW/CD: 825.2 ± 28.3 g; LBW/CD: 747.9 ± 38.1 g.  Compared to the 
NBW/CD group, male LBW/WD animals had significantly (p<0.05) lower body weights 
at putdown. 
 No significant differences in average food intake were observed throughout the 
experimental period (Figure 2.2B).  However, calorie consumption was significantly 
(p<0.0001) higher in WD-fed offspring, independent of time  (Figure 2.2C).  From 
weaning-PND50, calorie consumption was 23% higher in NBW/WD (p<0.05) and 36% 
higher in LBW/WD (p<0.001) offspring compared to NBW/CD.  From PND51-110, 
calorie consumption was 26% higher in NBW/WD (p<0.05) compared to NBW/CD, and 
from PND111-PND145, calorie consumption was 34% higher in NBW/WD (p<0.05) and 
55% higher in LBW/WD (p<0.001) when compared to NBW/CD (Figure 2.2C).   
 The feeding efficiency (grams gained/day/calories consumed/day) was 
significantly (p<0.0001) decreased in WD-fed offspring, in addition to a significant 
(p<0.05) interaction with time (Figure 2.2D).  From weaning-PND50, feeding efficiency 
was reduced by 39% in NBW/WD (p<0.0001) and by 52% in LBW/WD (p<0.0001) 
offspring compared to NBW/CD.  From PND51-110, NBW/WD males showed a 35% 
reduction in (p<0.01) feed efficiency compared to NBW/CD, whereas LBW/CD 
offspring showed a 50% reduction in (p<0.01) feed efficiency from 111-PD, when 
compared to NBW/CD (Figure 2.2D).   
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Figure 2.2: Post-weaning Growth and Feeding Behaviour. A) Absolute growth rate 
(AGR) = grams gained per day. B) Average food intake = grams of food 
consumed/kilogram body weight. C) Calorie consumption = calories consumed per day. 
D) Feeding efficiency = grams gained per day/calories consumed per day. Data presented 
are the mean ± standard error (SEM) for n=11 NBW/CD, n=11 LBW/CD, n=9 NBW/WD 
and n=7 LBW/WD offspring.  Statistical significance was determined by Two-Way 
ANOVA repeated measures, followed by post-hoc Tukey’s Test.  Interaction: *p<0.05, 
**p<0.01 significant interaction between experimental group and time; **p<0.01, 
****p<0.0001 significant effect of experimental group, independent of time; ≠p<0.05, 
≠≠p<0.01, ≠≠≠p<0.001, ≠≠≠≠p<0.0001 by post-hoc Tukey’s Test. 
A B 
C D 
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2.3.4 Body Composition and Glucose Tolerance 
 Whole-body adiposity, as measured by computed tomography at PND110, was 
significantly (p<0.01) reduced in WD-fed offspring, independent of birth weight (Figure 
2.3).  At tissue collection, mesenteric fat pad depot weights were significantly (p<0.001) 
reduced in WD-fed offspring at the time of putdown (Table 2.3).  Post-hoc analysis 
demonstrated a significant (p<0.01) reduction of mesenteric fat pad mass in NBW/WD 
and LBW/WD, when compared to NBW/CD offspring (Table 2.3).  
 No significant differences were observed in whole body glucose tolerance 
following a bolus administration of glucose at PND60 (Figure 2.4A) or PND120 (Figure 
2.4C).  The clearance of glucose, as measured by the area under the curve, was also not 
significantly altered by birth weight or postnatal diet at PND60 (Figure 2.4B) or PND120 
(Figure 2.4D).  
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Figure 2.3: Body Composition as Assessed by Computed Tomography Analysis.  
Volumes occupied by muscle, bone and adipose tissue in the area between the proximal 
tibia to base of skull was calculated using a MATLAB-derived application, normalized to 
total body volume and expressed as a percentage.  Data presented are the mean ± 
standard error (SEM) for n=4-5 animals per group.  Statistical significance was 
determined by Two-Way ANOVA, followed by post-hoc Tukey’s Test. **p<0.01 
significant effect of diet, independent of birth weight.  
 
 
 Inguinal  
Fat 
Mass 
Brown  
Fat 
Mass 
Epididymal 
Fat Mass 
Mesenteric 
Fat Mass 
Perirenal 
Fat Mass 
Retroperit-
oneal  
Fat Mass 
Leg  
Fat 
Mass 
Males        
NBW/CD 0.011 ± 
0.0007 
0.010 ± 
0.0010 
0.012 ± 
0.0009 
0.015 ± 
0.0010 
0.007 ± 
0.0009 
0.009 ± 
0.0004 
0.002 ± 
0.00009 
LBW/CD 0.012 ± 
0.0009 
0.007 ± 
0.0007 
0.011 ± 
0.0008 
0.013 ± 
0.0010 
0.006 ± 
0.0008 
0.008 ± 
0.0010 
0.002 ± 
0.00008 
NBW/WD 0.011 ± 
0.0006 
0.009 ± 
0.0010 
0.011 ± 
0.0008 
0.010 ± 
0.0010  ≠≠ 
0.005 ± 
0.0004 
0.008 ± 
0.0005 
0.002 ± 
0.00017 
LBW/WD 0.011 ± 
0.0010 
0.009 ± 
0.0016 
0.009 ± 
0.0009 
0.009 ± 
0.0010  ≠≠ 
0.006 ± 
0.015 
0.008 ± 
0.0010 
0.002 ± 
0.00019 
 ns ns ns Diet: *** ns ns ns 
Table 2.3: Adipose Tissue Depot Weights. Data presented are mean ± standard error 
(SEM) for n=11 NBW/CD, n=11 LBW/CD, n=9 NBW/WD, n=7 LBW/WD offspring. 
Statistical significance was determined by Two-Way ANOVA, followed by post-hoc 
Tukey’s Test. Diet: ***p<0.001, significant effect of diet, independent of birth weight. 
≠≠p<0.01, compared to NBW/CD by post-hoc Tukey’s Test.  ns = not significant.  
 
61 
 
 
 
Figure 2.4: Glucose Tolerance. A) Blood glucose values (mmol l-1) following an 
intraperitoneal injection of 1g/kg of 50% dextrose solution at PND60.  B) The area under 
the glucose curve (AUGC) as a measurement of glucose clearance at PND 60. C) Blood 
glucose values (mmol l-1) at PND120.  D) The area under the glucose curve (AUGC) at 
PND 120. Data presented are the mean ± standard error (SEM) or min. to max. box and 
whisker plots for n=12 NBW/CD, n=12 LBW/CD, n=9 NBW/WD, n=7 LBW/WD.  
Statistical significance was determined by Two-Way ANOVA, followed by post-hoc 
Tukey’s Test. 
 
 
 
A B 
C D 
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2.4 Discussion 
 Early-life growth and development, especially the contribution of the in utero 
environment as a key contributor to later life metabolic outcome, has continued to gain 
recognition and support in the global health and scientific community.38 Human and 
animal studies have highlighted that insults affecting growth trajectory in utero and early 
postnatal life have the potential to alter the programmed metabolic development of the 
offspring, increasing their risk of developing serious metabolic consequences as they 
interact with their postnatal environment.  Therefore, the aim of the current study was to 
assess growth and metabolic parameters of guinea pig offspring subjected to an adverse 
in utero environment, and to assess the impact of the easily accessible Western diet in the 
postnatal period on altered growth and metabolic parameters associated with a 
developing MetS phenotype. 
 We chose to utilize a guinea pig model to investigate developmental 
programming and the importance of the in utero environment on metabolic outcomes of 
the offspring since, similar to humans and sheep, the guinea pig is a precocious species 
that develops predominantly prenatally and is born relatively mature.39 Unlike other 
rodent models, the guinea pig has a relatively long gestation (approximately 67-69 
days),31 allowing for fetal adaptations to an adverse in utero environment.  Invasion and 
endocrine control of the placenta is also similar between human and guinea pig, further 
validating the use of this model to investigate the fetal adaptations to chronic 
perturbations in placental blood flow.40,41 The uterine artery ablation technique employed 
has been shown to decrease delivery of oxygen and nutrients to the fetus via the 
placenta,31 recapitulating the most common type of placental insufficiency characterized 
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by placental hypoxia and abnormal uterine artery Doppler waveforms typically observed 
in obstetrical clinics.42 Also of note, guinea pig lipid metabolism, fat deposition, as well 
as metabolic responses to a high-fat diet, are similar to humans,43-45 further validating our 
guinea pig model for investigating the relative impact of diet on aspects of postnatal 
metabolism. 
 In our cohort, the uterine artery ablation surgery induced IUGR, and LBW 
offspring below the 25th percentile displayed markers of growth restriction.  Specifically, 
LBW offspring exhibited a leaner phenotype as evidenced by the reduced birth 
weight/birth length ratio.  Similar reports of a lean phenotype have been observed in 
other animal models of IUGR.16 Additional markers included a reduced biparietal 
diameter, abdominal circumference, and crown-rump length, in accordance with other 
guinea pig models of IUGR.16,18,31 Therefore, IUGR induces an altered body composition 
as early as the time of birth when LBW offspring are compared to their NBW littermates.  
 During early life, the LBW offspring displayed an altered growth trajectory when 
compared to NBW offspring.  While the absolute growth rate (g/day) was lower in LBW 
offspring, their percent increase in body weight and fractional growth rate throughout the 
lactation period were greater than the NBW offspring.  This accelerated growth trajectory 
is characteristic of the period of rapid postnatal catch-up growth often observed in human 
offspring of adverse in utero environments,12 and has also been observed in animal 
models of IUGR.16,46 Fractional growth rate is commonly used as a marker of the 
interaction between an offspring’s genetic growth potential and the nutritional 
environment experienced. An increased fractional growth rate in early postnatal life has 
been shown to be predictive of increased visceral obesity and impaired glucose tolerance 
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in later life, early markers of MetS pathogenesis.47,48 Therefore, this accelerated growth 
trajectory observed in our LBW offspring during the lactation period may be indicative of 
rapid postnatal catch-up growth that predisposes these offspring to development of age-
related metabolic diseases. 
 Of particular concern to the global health community is the increased incidence of 
worldwide childhood obesity along with the emergence of risk factors associated with 
MetS in children and young adults.49 Independent of weight at birth, a high intake of 
saturated fatty acids and simple sugars in addition to a lack of poly-unsaturated fatty 
acids have been implicated in MetS pathogenesis.7,50 Diets high in saturated fats have the 
propensity to promote ectopic lipid accumulation, disrupting normal metabolic function 
and perpetuating a state of insulin resistance as an early indicator of MetS progression.51  
Additionally, a high intake of simple sugars, namely glucose and fructose, is known to 
disrupt whole body glucose homeostasis, altering insulin action in addition to promoting 
ectopic lipid accumulation, two situations that have to the potential to promote insulin 
resistance and progression of MetS.52  Furthermore, decreased consumption of poly-
unsaturated fatty acids also contributes to insulin resistance and a MetS phenotype by 
altering the composition of skeletal muscle phospholipids and influencing insulin 
action.52 With the goal of recapitulating the adverse metabolic consequences observed in 
children and young adults, the composition of our WD replicates a “classic” WD, as 
defined by a relatively large contribution of saturated fats, and added simple sugars, 
namely fructose.  
 Following weaning, LBW offspring on a CD (LBW/CD) continued to display an 
altered growth trajectory, such that at the time of putdown, there was no significant 
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difference in weight between NBW/CD and LBW/CD offspring.  This highlights that the 
LBW/CD experienced a period of rapid postnatal growth that may be associated with an 
increased development of risk factors associated with MetS.53  It is interesting to note that 
these LBW/CD offspring did display a reduced absolute growth from PND111 to the 
time of putdown, in addition to a reduced weight gain during this period despite 
consuming a similar number of calories per day when compared to NBW/CD offspring. 
This reduced weight gain during this period highlights the possible emergence of 
metabolic deficiencies impairing efficient metabolism of caloric intake.  While this 
reduction in growth during the plateau phase did occur, these offspring still reached 
similar weights as their NBW counterparts, further supporting the notion that these 
offspring experienced an early phase of rapid growth, a phenomena characteristic of 
LBW postnatal growth following development in an adverse in utero environment. 
 In our cohort, WD-fed offspring remained significantly lighter than CD-fed 
offspring throughout the duration of the post-weaning period, even at the time of 
putdown.  During the period of maximal growth, from weaning until PND50, WD-fed 
offspring, irrespective of birth weight, displayed a reduced AGR, despite increased 
calorie consumption.  This discrepancy, in addition to the reduced feed efficiency, 
highlights an inefficiency affecting the ability of these animals to gain weight despite 
consuming a more calorie-dense diet.  Additionally, the LBW/WD offspring remained 
significantly lighter throughout the duration of the experimental period, highlighting that 
the consumption of a postnatal WD stunted the accelerated growth associated with 
adverse growth in utero.  Interestingly, this reduced body weight in the WD-fed offspring 
occurred in conjunction with altered body composition and adiposity.  At the whole body 
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level, WD-fed offspring displayed reduced adiposity when assessed by computed 
tomography.  Additionally, when measured at the time of putdown, mesenteric fat pad 
mass, a measure of visceral adiposity,54 was also reduced in the WD-fed offspring.  This 
reduction in adipose tissue mass, and overall reduction in adiposity, in addition to the 
reduced body weight observed in these offspring, highlight that components of the 
postnatal WD alters the body composition and metabolic profile of these offspring. 
 The diet of modern society is characterized by excess fats and sugars, particularly 
fructose and saturated fats, which have been associated with not only a rise in obesity 
rates, but also higher incidence of insulin resistance and type 2 diabetes.7,9 While fructose 
is typically associated with an increase in adiposity and insulin resistance,54 rodent 
studies that introduce fructose from an early age have observed similar reductions in 
body weight and adiposity.55-57 It has been suggested that early introduction of fructose in 
the diet is associated with development of fructose intolerance and subsequently an 
impairment of weight gain.58,59 Early in life, intestinal levels of GLUT5, the main 
fructose transporter, are reported to be low, impairing fructose transport and contributing 
to the development of fructose intolerance should administration of fructose be in large 
quantities during this period of development.60  
 While recent evidence suggests that the excess fat consumed in energy-dense 
diets may be repartitioned to other tissues, namely liver, negatively impacting metabolic 
health,61 excess consumption of fructose on its own has also been associated with 
alterations in liver metabolism. In non-human primates fed a high-fructose diet for 7 
years, poor hepatic health as assessed by serum biochemistry was associated with 
histological liver damage, without significant increases in body weight.62  The 
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consumption of a fructose-rich diet for greater than the equivalent of one year also 
resulted in development of lipidosis in the liver, promoting development of hepatic 
steatosis and metabolic disease.62 Human subjects consuming fructose have also been 
shown to display significantly higher rates of hepatic de novo lipogenesis in comparison 
to those consuming glucose alone,63 highlighting the liver as an important metabolic 
organ impacted by fructose consumption that may perpetuate the MetS phenotype.  
Consumption of fructose and saturated fatty acids in combination has also been reported 
to alter body composition and endocrine function of adult offspring.  Studies where 
rodents were fed 30% fructose with or without addition of saturated fats displayed 
reduced fat accumulation and impaired insulin sensitivity in male offspring weaned onto 
the fructose plus saturated fat diet for 12 weeks.64 This study highlights that an early 
exposure to a combination of fructose and saturated fat modulates adiposity and 
endocrine function, promoting a MetS phenotype.64   
 Another important hallmark in the pathogenesis of MetS is dysregulation of 
glucose homeostasis, namely the development of hyperglycemia and glucose 
intolerance.6  Typically, studies assessing glucose homeostasis as a component of the 
MetS phenotype focus on the adult period,65,66 with few studies investigating the impact 
of being weaned onto a poor diet on the development of glucose intolerance.  Studies 
have shown that children growing up in families consuming poor diets are exposed 
earlier in life to these energy-dense diets, and continue this consumption pattern 
throughout postnatal life.67,68 Therefore, an important aspect of our study was to 
investigate the impact of being weaned onto a poor diet on glucose tolerance as a 
component of the MetS phenotype. In our cohort, whole-body glucose tolerance as 
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assessed by IPGTT was not affected by birth weight or postnatal diet. However, at this 
age similar results have been observed in other models of young IUGR offspring, namely 
those in sheep and rodents.46,69 The young age of our offspring, approximately equivalent 
to 18-20 years in the adult,33 may explain the maintenance of glucose homeostasis we 
have observed.  In a study examining 20-year-old men who were born low birth weight, 
glucose tolerance was similarly maintained, however reduced insulin sensitivity was also 
observed.70 Maintenance of glucose tolerance has also been observed in young offspring 
of type 2 diabetic mothers; however progression to a state of insulin resistance does occur 
with age.71  Therefore, the young age of our offspring highlights that the progression 
towards a MetS phenotype may be in its early stages.  It is important to note that 
reductions in peripheral insulin-stimulated glucose uptake, namely in liver, heart, adipose 
tissue and skeletal muscle, are typically observed before overt whole-body changes in 
glucose tolerance.72  Young LBW men with normal whole body glucose disposal have 
also been observed to display reduced forearm glucose uptake, and molecular changes in 
insulin signaling, highlighting an early step in disease pathogenesis that may continue to 
fail with age. 21,73,74 Overall, while we do not observe overt features of whole-body 
glucose intolerance at this stage, there may be underlying alterations at the physiological 
level that predispose these offspring to development of later life MetS as they continue to 
interact with their postnatal environment. 
 While our animals remain small and non-obese at this young age, they do show 
evidence of metabolic disruptions.  Previous studies from our laboratory have 
demonstrated increased aortic wall stiffening in LBW offspring,75 which was further 
exacerbated by postnatal consumption of a WD.32  These LBW-induced alterations are an 
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early sign of vascular dysfunction that may be associated with risk factors for the 
development of later life cardiovascular disease.  Additionally, we have observed altered 
adipose tissue lipid metabolism in conjunction with increased visceral adiposity in the 
LBW offspring,19 predisposing these offspring to later life dyslipidemia associated with 
MetS.  Therefore, the presence of these previously characterized metabolic disruptions, in 
addition to the altered growth and metabolic parameters assessed here, support the theory 
that the in utero environment and growth trajectory are important players in determining 
postnatal disease risk. 
 In summary, our data suggest that body composition, growth, and feed efficiency 
are altered following development in an adverse in utero environment.  Additionally, 
interaction with a postnatal nutritional environment characterized by nutrient excess 
impairs growth and further alters the body composition of the offspring.  This altered 
growth and body composition is associated with an increased predisposition for these 
offspring to develop age-related metabolic diseases, supporting the concept of 
developmental programming of postnatal metabolism. 
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Chapter 3: 
Indicators of Skeletal Muscle Mitochondrial Dysfunction and Impaired Insulin 
Signaling Occurs in Low Birth Weight Guinea Pigs, and Following Postnatal 
Exposure to a “Western” Diet 
 
 
 
 
 
Data presented in this chapter is in preparation for submission. 
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3.1 Introduction 
 Epidemiological studies have highlighted that an adverse in utero environment 
that restricts fetal growth, culminating in intrauterine growth restriction (IUGR) and low 
birth weight (LBW), increases the propensity for the offspring to develop age-related 
metabolic and cardiovascular diseases in later life.1-4  Before overt manifestations of 
metabolic syndrome (MetS) are apparent, insulin resistance is typically observed, 
highlighting that the development of insulin resistance is a critical precursor to the 
pathophysiological development of MetS and establishing its use as an early marker of 
metabolic disease development and progression.5 Insulin resistance is classically 
characterized as a metabolic state in which peripheral tissues, particularly skeletal 
muscle, are no longer responsive to insulin, preventing insulin-stimulated glucose uptake 
and perpetuating a state of hyperglycemia.6 Insulin sensitivity is primarily assessed in 
skeletal muscle, since this is the location for the majority of insulin-stimulated glucose 
uptake, accounting for up to 70% of whole body glucose clearance.7  
 Typically, insulin resistance development is associated with poor diet choices and 
sedentary lifestyles;8,9 however, the in utero environment is now recognized as a key 
player in insulin resistance pathogenesis.3,5,10  Indeed, LBW offspring have been shown 
to display a 7-fold increased risk of being insulin resistant by young adulthood.11  More 
recently, the EPOCH study highlighted higher fasting insulin levels and homeostatic 
model assessment of insulin resistance (HOMA-IR) values indicative of impaired insulin 
sensitivity as early as 10 years of age in IUGR-exposed children.12  These studies 
highlight that metabolic adaptations initiated in utero can have life-long metabolic 
consequences. 
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 The origins of skeletal muscle insulin resistance in the adult population are 
complex and multifactorial, however energy-dense, high-fat/high-sugar “Western” diets 
have been implicated as contributing factors in the pathophysiological progression to 
insulin resistance.9 Consumption of this diet generates a surplus of circulating fatty acids, 
ultimately leading to ectopic lipid accumulation in non-adipose tissues, such as skeletal 
muscle, and impaired mitochondrial function.13  Skeletal muscle lipid accumulation in 
animal models has been associated with impairments in insulin signaling, with long-chain 
acyl-CoAs, triglycerides (TG) and diacylglycerol (DAG) highlighted as key mediators of 
this phenomenon.  The saturation of the lipids making up the TG pool is also a critical 
factor contributing to skeletal muscle insulin resistance.  A higher proportion of saturated 
fatty acids in the TG pool reduces lipid oxidation, allowing accumulation of DAG and 
ceramide.14  Accumulation of these lipotoxic intermediates has been associated with 
classical markers of insulin resistance.15  These markers include reductions in the 
phosphorylation of the insulin receptor and decreased activation of phosphoinositide-3 
(PI-3) kinase, which is responsible for phosphorylating and activating Protein Kinase B 
(Akt). Activation of Akt requires phosphorylation at both Thr308 and Ser473; therefore a 
reduction in phosphorylation at either site may be indicative of impaired signaling.16  
Active Akt is responsible for phosphorylating and activating the Akt substrate of 160 kDa 
(AS160) at Thr642, allowing insertion of glucose transporters (GLUT4) into the plasma 
membrane.15,17 Decreases in the phosphorylation and activation of the above 
intermediates occur in conjunction with an increase in the inhibitory phosphorylation of 
Insulin Receptor Substrate-1 (IRS-1) at Ser307, ultimately resulting in a decrease in 
insulin-stimulated glucose uptake through GLUT4 transporters.15 Insulin resistance can 
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occur at any level of the insulin signaling cascade, from the initial binding of insulin to its 
receptor to alterations in the phosphorylation cascade responsible for initiating glucose 
uptake.18 When these molecular alterations associated with insulin resistance occur in 
conjunction with hyperinsulinemia and/or maintenance of whole body glucose tolerance, 
it is associated with a pre-diabetic state characteristic of an early stage of disease 
pathogenesis.19,20 
 An alternate theory for development of impaired insulin sensitivity implicates 
alterations in skeletal muscle mitochondrial metabolism.  It has been recently 
demonstrated that adults with high intakes of high-fat food and reduced physical activity 
display impaired mitochondrial function.21   Mitochondrial dysfunction is defined as a 
decrease in mitochondrial substrate oxidation resulting from a general decrease in 
oxidative phosphorylation.22  In order to initiate the oxidation process, long-chain acyl-
CoAs in the skeletal muscle must enter the mitochondria as acylcarnitines.  
Acylcarnitines are formed when long-chain acyl-CoAs have their CoA exchanged for 
carnitine, catalyzed by subcellular carnitine palmitoyltransferase 1 (CPT1), which is rate 
limiting step of oxidation, and classically used as a surrogate marker of oxidative 
capacity.13,21,23,24  Once the acylcarnitines have crossed into the mitochondria via 
carnitine acetyltransferase, they are converted back to acyl-CoAs by carnitine 
palmitoyltransferase 2 (CPT2) so the long-chain acyl-CoAs can undergo β-oxidation.24 
The process of β-oxidation successively reduces the length of the acyl-CoA carbon chain 
by 2 carbons through the actions of a series of enzymatic reactions catalyzed by very 
long-chain acyl-CoA dehydrogenase (VLCAD), medium-chain acyl-CoA dehydrogenase 
(MCAD), and 3-ketoacyl-CoA thiolase (KT) among others.21,25 Acetyl-CoA, the products 
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of β-oxidation, are then fed through the TCA cycle, generating carbon dioxide and 
electron carriers such as NADH and FADH2.  These electron carriers then enter the 
electron transport chain in order to generate ATP as an energy source through oxidative 
phosphorylation.26  Accumulation of acylcarnitines in tissue is reported to be indicative 
of impairment in the utilization of the substrates generated through β-oxidation, and the 
presence of fatty acids that are incompletely oxidized.23 It has also been suggested that 
these acylcarnitines, when present in excessive amounts, have the ability to promote 
alterations in the phosphorylation status of key insulin signaling intermediates through 
the actions of stress-induced kinases,27 highlighting acylcarnitine accumulation secondary 
to mitochondrial dysfunction as key mediators of the pathogenesis of insulin resistance. 
 Recently, evidence has suggested that in utero influences and secondary insults in 
adult life may have a synergistic effect, further exacerbating an already dysfunctional 
system and promoting earlier onset of MetS.10  Of late, an increased incidence of 
childhood obesity has largely been attributed to early introduction of energy-dense diets 
and sedentary behavior.28 However, genetics and the contribution of the in utero 
environment to epigenetic alterations to metabolic function cannot be negated when 
assessing whether these children are at increased risk of developing symptoms associated 
with MetS at an earlier age.29  Therefore, the present study is aimed to identify alterations 
in skeletal muscle mitochondrial lipid metabolism following IUGR independently, and in 
conjunction with early postnatal exposure to a Western diet. 
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3.2 Materials and Methods 
3.2.1 Ethics Statement 
 Animal care, maintenance and surgical procedures were conducted in accordance 
with the guidelines of the Canadian Council on Animal Care.  All procedures were 
approved by The University of Western Ontario Animal Use Subcommittee (Appendix 
II). 
 
3.2.2 Animal Handling  
 Time-mated pregnant Dunkin-Hartley guinea pigs (Charles River Laboratories, 
Wilmington, MA, USA) where housed in a constant temperature (20°C) and humidity 
(30%) controlled environment with 12h light/dark cycle. All animals had ad libitum 
access to standard guinea pig chow (LabDiet diet 5025) and tap water. 
 All pregnant guinea pigs underwent uterine artery ablation, as previously 
described,30 to induce uteroplacental insufficiency and intrauterine growth restriction 
(IUGR). At mid-gestation (~32 days, term ~67 days), sows were anesthetized in an 
anesthetic chamber (4-5% isoflurane with 2L/min O2, followed by 2.5-3% isoflurane with 
1L/min O2 for maintenance).  Immediately following induction of anesthesia, a 
subcutaneous injection of Rubinol (Glycopyrrolate, 0.01mg/kg, Sandoz Can Inc., 
Montreal, QC) was administered. A midline incision was made below the umbilicus, 
exposing the bicornate uterus.  Arterial vessels feeding each horn of the uterus were 
identified, and every second branch was cauterized using an Aaron 2250 electrosurgical 
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generator (Bovie Medical, Clearwater, FL).  Immediately after surgery, a subcutaneous 
injection of Temgesic (Buprenorphine, 0.025mg/kg, Schering-Plough Co., Kenilworth, 
NJ) was administered, and monitoring continued following surgery.  Sows delivered 
spontaneously at term, at which time pup weight, length, abdominal circumference and 
biparietal distance were measured. Following the pupping period, all birth weights were 
collated and if birth weight was below the 25th percentile these guinea pigs were allocated 
to the low birth weight (LBW) group, and if birth weight was between the 25th and 75th 
percentile these pups were allocated to the normal birth weight (NBW) group (Figure 
2.1).  Based on these criteria, LBW pups were below 80g, and NBW pups were above 
90g, in accordance with previously reported data.31,32 Low body weight is often 
recognized as a crude measure of an adverse in utero growth environment.  An additional 
measure of adverse growth in utero, and potentially more reflective of the growth 
conditions experienced in utero is birth weight/birth length,33 which was also measured 
(Chapter 2). 
 Pups remained with their dams during the 15-day lactation period.  Five days 
prior to weaning, all pups were introduced to a synthetic control diet (Harlan Laboratories 
TD.110240: Table 2.1) and weaned on PND15 into individual cages.  At this time, guinea 
pig offspring were randomized to either a control (CD, Harlan Laboratories TD.110240: 
Table 2.1) or a Western (WD, Harlan Laboratories TD.110239: Table 2.1).  To avoid 
litter effects, only one LBW and one NBW animal from a single litter was assigned to 
each diet.  Only male pups were examined for this study in order to prevent confounding 
factors related to estrous cycle and hormone profile of female offspring. 
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3.2.3 Assessment of Whole-Body Glucose Tolerance 
 At PND60 and PND120, intraperitoneal glucose tolerance tests (IPGTTs) were 
performed to assess whole body glucose tolerance as previously described in section 
2.2.5. 
 
3.2.4 Assessment of Skeletal Muscle Glucose Uptake 
 At PND50 and PND110, pups underwent positron-emission tomography (PET) 
scans in order to assess in vivo glucose uptake at the level of the skeletal muscle.  Prior to 
scanning, body weights and blood glucose measurements were taken.  Throughout the 
duration of the scans, physiological parameters including heart rate, respiration rate and 
oxygen saturation were monitored to ensure well-being of the animal.  Pups were 
anesthetized in an anesthetic chamber (4-5% isoflurane with 2L/min O2) then transferred 
to a tight fitting nose cone (2.5-3% isoflurane with 1L/min O2 for maintenance).  While 
anesthetized, pups were injected with ~25kBq/kg (0.2-0.3mL) of 18F-fluoro-deoxy-
glucose (FDG) via the pedal vein.  Following injection, pups were allowed to recover for 
40 minutes, before being anesthetized again (4-5% isoflurane with 2L/min O2) and placed 
on a micro-PET scanner (GE eXplore Vista, GE Healthcare) fitted with a nose cone (2.5-
3% isoflurane with 1L/min O2 for maintenance).  Emission scans for the leg regions were 
conduced for 20 minutes, then reconstructed in 3D mode.  Resulting images were 
analyzed with a custom MATLAB-designed program (MATLAB; MathWorks Inc., MA, 
USA), where regions of interest were drawn around the muscles of the hind-limb.  
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Measurements of Standard Uptake Value (SUV) were obtained by applying FDG dosage 
and body weight of the pup to the following equation:34,35  
𝑆𝑈𝑉 =    𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦  𝑖𝑛  𝑇𝑖𝑠𝑠𝑢𝑒(𝐼𝑛𝑡𝑟𝑖𝑛𝑠𝑖𝑐  𝐴𝑐𝑡𝑖𝑣𝑖𝑡𝑦 𝐵𝑜𝑑𝑦𝑊𝑒𝑖𝑔ℎ𝑡) 
 
3.2.5 Tissue Collection  
 At PND145, pups were sacrificed by CO2 inhalation36 following an overnight fast.  
Gastrocnemius muscle, a representative muscle with mixed composition of oxidative and 
glycolytic fibers,37 was removed and trimmed of excess fat and connective tissue, then 
flash frozen in liquid nitrogen for subsequent analysis. 
 
3.2.6 Protein Extraction and Immunoblotting 
 Gastrocnemius samples (~50mg each) were homogenized in 0.5mL ice-cold lysis 
buffer (pH 7.4, 50mM Tris-HCl, 1% NP-40, 0.5% Sodium-deoxycholate, 150mM NaCl, 
0.1% sodium dodecyl sulfate) containing protease inhibitor cocktail (Cocktail set 1, 
Calbiochem, Bilerica, MA) and phosphatase inhibitors (1 M NaF, 0.2 M Na2VO4, 0.2 M 
NaPP and 1 M Na2Gly).  Homogenates were incubated on ice for 15 minutes, then 
subjected to sonication with 3-5 bursts at 30% output (MISONIX: Ultrasonic liquid 
processor), followed by centrifugation at 15,000g for 30 min at 4°C.  The supernatant 
was collected and Pierce BCA Protein Assay (Thermo Scientific, Waltham MA) was 
employed for protein quantification. 
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 Protein samples were separated using 7.5%, 10% or 12% Bis-Tris gels, and 
transferred onto Immobilon transfer membranes (EMD Millipore, Billerica, MA) via wet 
transfer. Consistent protein loading and sufficient transfer of proteins was confirmed 
using 1× Amido Black stain and images were captured using a Versadoc System (Bio-
Rad, Mississauga, Ontario). Membranes were blocked overnight at 4°C with Tris-
buffered saline (TBS)/0.1% Tween 20 (Thermo Fisher Scientific, Waltham, MA) 
containing 5% skim milk, 5% bovine serum albumin (BSA; AMRESCO, Solon, Ohio) or 
10% BSA as indicated in Table 3.1.  Following blocking, primary antibodies were 
applied for 1h at room temperature at dilutions specified in Table 3.1.  The blots were 
then washed in TBS/0.1% Tween 20 and incubated at 1h room temperature with the 
appropriate secondary conjugated antibody (Santa Cruz Biotechnology, Santa Cruz, CA) 
in TBS/0.1% Tween 20 containing 5% skim milk or BSA. The blots were then washed in 
TBS/0.1% Tween 20 and protein bands were revealed by Luminata Forte Western Blot 
HRP Substrate (EMD Millipore, Billerca, MA) and captured using a Versadoc System 
(Bio-Rad, Mississauga, Ontario).  All images were visualized using Quantity One 
software (Bio-Rad, Mississauga, Ontario), and densitometry values (arbitrary units) were 
determined using Image Lab 4.0 software (Bio-Rad, Mississauga, Ontario).  The 
abundance of target proteins was expressed relative to Amido Black densitometry values 
for proteins of the same molecular weight.38 
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3.2.7 RNA Extraction and Quantitative Real-Time PCR (qRT-PCR) 
 Total RNA was extracted from gastrocnemius tissue by homogenizing ~20mg in 
1mL Trizol (Invitrogen, Carlsbad, CA) and following the manufacturers protocol.  Total 
RNA was subsequently treated with deoxyribonuclease for 30 minutes to eliminate 
genomic DNA.  Quantification of RNA was performed with the ND-1000 NanoDrop 
spectrophotometer (Thermo Fisher Scientific, Rochester, NY).  Each sample was also 
assessed for RNA integrity using 1.2% agarose electrophoresis with RedSafe™ (iNtRON 
Biotechnology, Sangdaewon-Dong, Joongwon-Ku, Sungnam, Kyungki-Do, 462-120, 
KOREA).  Complementary DNA was synthesized from 2µg of purified RNA, reverse-
transcribed using M-MLV Reverse Transcriptase (Life Technologies, Burlington, ON) 
and a C1000 Thermal Cycler (Bio-Rad, Mississauga, ON).  All primers were designed 
from guinea pig (cavia porcellus) sequences using NCBI/Primer-BLAST tool (Table 
3.2).  Standard curves for each primer pair (three pairs for each gene) were generated 
from serial dilutions of cDNA for determination of primer efficiencies. PCR efficiencies 
for each primer set were 90-105% (Table 3.2).  Melting curve analysis and presence of a 
single amplicon at the expected size in a 1.8% agarose gel were used to confirm 
amplification of a single product.  cDNA products were used as templates for qRT-PCR 
assessment of gene expression using the SYBR green system (SensiFast™ Sybr No-Rox 
Mix; Bioline, London, United Kingdom) on a Bio-Rad CFX384 Real-Time system 
instrument (Bio-Rad, Mississauga, ON).  Each sample was run in triplicate.  Forty cycles 
of amplification were performed, with each cycle consisting of: denaturation at 95°C for 
15s, annealing at the pre-determined temperature for each primer set denoted in Table 3.2 
for 20s, and extension at 72°C for 20s.  Control samples containing no cDNA were used 
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to confirm absence of DNA contamination. The transcript level of target genes was 
normalized to β-actin; there were no differences in the expression of β-actin between 
experimental groups.  The fold expression of each individual target gene was determined 
by the 2-ΔCt method.39 
 
3.2.8 Thin Liquid Chromatography and Gas Chromatography  
 Total lipids were extracted from gastrocnemius muscle (~160mg), using a 
protocol adapted from Klaiman et al.40  Briefly, tissue samples were homogenized in 
850µl 1:1 chloroform:methanol (v/v) containing 0.1% butylated hydroxytoluene (BHT).41  
Following homogenization, 8.5mL of 2:1 chloroform:methanol (v/v)+0.1% BHT was 
added to each sample.  1.7mL of 0.25% KCl was added to separate the aqueous solutes, 
then incubated at 70°C for 10 minutes.  Once the samples were cooled, they were 
centrifuged at 2000rpm for 5 minutes, and the aqueous layer was removed.  The 
remaining solution, containing lipids, was dried under a gentle stream of N2, and 
resuspended in 1mL chloroform.  20µL of total lipids were removed for subsequent 
analyses and diluted to a concentration of 2µg/µL.  The remaining sample was dried 
again under a gentle stream of N2.   
 Separation and analysis of lipid classes was accomplished by thin layer 
chromatography-flame ionization detection (TLC-FID) using the Iatroscan MK-6 
TLC/FID Analyzer System (Shell-USA, Federicksburg, VA).  The system is composed of 
10 quartz rods that are 15cm in length and 0.9mm in diameter, coated with a 75µm layer 
of porous silica-gel particulates that are 5µm in diameter42 (Shell-USA, Federicksburg, 
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VA).  Prior to application of samples, chromarods were repeatedly blank scanned in order 
to burn off any impurities and activate the rods. 1µl of the 2µg/µL lipid sample or the 
reference standard was spotted onto the rods.  Rods were developed in a TLC chamber 
with benzene:chloroform:formic acid (70:30:0.5 v/v/v) to separate the neutral lipids until 
the solvent front reached the 100 mark on the rod holder.  Rods were subsequently 
removed and dried at 60°C in a rod dryer (TK8, Iatron Inc, Tokyo, Japan) for 5 minutes.  
Rods were analyzed using the following settings: 2L/min atmospheric air, 160mL/min 
hydrogen, scanning speed of 3s/cm.  Area under the curve for the peaks of interest were 
integrated using PeakSimple 3.29 Software (SRI Instruments, CA) and expressed as a 
percentage of the total area under the curve for all peaks analyzed.  
 In preparation for gas chromatography, the total lipids were fractioned using 
Supelco Supelclear LC-NH2 sPE columns (Supelco, Bellefonte, PA).  Total lipid samples 
were resuspended in chloroform to a concentration of 10mg/mL.  Once the columns were 
conditioned, 300µL of suspended sample was added and allowed to flow through the 
column, then centrifuged at 1000rpm for 1min.  Neutral lipids were eluted with 1.8mL of 
2:1 chloroform:isopropanol (v/v), followed by centrifugation at 1000rpm for 1min.  Non-
esterified fatty acids were eluted with 1.6mL 98:2 isopropyl ether:acetic acid (v/v), 
followed by centrifugation at 1000rpm.  Phospholipids were eluted with 3mL of 
methanol, followed by centrifugation at 1000rpm for 1min.  Each sample was 
subsequently dried under a gentle flow of N2.  300µg of each sample was then methylated 
by adding 200µL of Meth-HCl to the dried sample and incubated at 90°C for 45min.  
800µL of water, followed by 500µL of hexane was added to each sample, with the 
hexane layer extracted and put in a fresh tube.  Following hexane extraction, samples 
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were dried under a gentle flow of N2, and resuspended in dichloromethane for injection 
into a 6890N gas chromatograph (Hewlett Packard, Palo Alto, CA, USA) with a J&W 
Scientific High Resolution Gas Chromatography Column (DB-23, Agilent Technologies) 
and a flame ionization detector. Fatty acids were identified by comparison of the relative 
retention time with known standards (Supelco 37 component FAME mix, and Supelco 
PUFA No.3, from Menhaden Oil). 
 
3.2.9 Extraction and LC-MS/MS Method for the Analysis of Amino Acids and 
Acylcarnitines 
 Acylcarnitine and amino acid analysis was performed by the Analytical Facility 
for Bioactive Molecules, The Hospital for Sick Children, Toronto, Canada.  
 Ground tissue was weighed out and a solution of 1:1 water:methanol was added to 
yield 25mg/mL. Samples were then homogenized and kept on ice.  An equivalent of 5mg 
of homogenized tissue was added to an Eppendorf tube with an acylcarnitine internal 
standard (IS) mixture (NSK-B, Cambridge Isotopes) and an amino acid IS mixture 
(Arginine-13C6, ADMA-d7, citrilline-d7, glutamic acid-d2, ornithine-d7, and leucine-d10, 
Cambridge Isotopes and CDN Isotopes).  Samples and standard mixtures were then 
acidified with 60µL of 0.1% formic acid and then protein was precipitated using 1mL of 
0.3% formic acid in acetonitrile.  Tubes were then vortexed and centrifuged at 10,000g 
for 10 minutes at 4°C. Supernatants were transferred to conical glass tubes and the 
remaining pellet in the Eppendorf was re-suspended in an additional 1mL 0.3% formic 
acid in acetonitrile and vortexed and centrifuged again.  The combined supernatants were 
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dried under a gentle flow nitrogen gas.  Samples and standards were derivatized with 
100µL butanolic-HCL 3N for 20 minutes at 65°C.  Solvent was then removed under a 
gentle flow nitrogen gas and samples were reconstituted in 200µL MPB (see below) and 
transferred to auto sampler vials. 10µL of the reconstituted sample was diluted 50x in the 
same solution for amino acid analysis. 
 Extracted samples were injected onto a Kinetex HILIC 50 x 4.6 mm 2.6 µm 
column (Phenomenex) connected to an Agilent 1290 HPLC system attached to a Q-Trap 
5500 mass spectrometer (AB Sciex, Framingham, MA).  Injected samples were eluted 
with a gradient of mobile phases MPA: 90/10 5 mM ammonium formate pH 
3.2/acetonitrile and MPB: 10/90 5mM ammonium formate pH 3.2/acetonitrile. For 
Acylcarnitines, the gradient started at 4% MPA for 1 minute, increasing to 45% for 0.65 
min, holding for 0.05 min and then returning to 4% MPA for the remaining 3 minutes.  
For amino acids, the 50 x diluted samples were eluted with a gradient of MPA starting at 
4% for 2.5 minutes and increasing to 75% MPA until 6 minutes, holding at 75% MPA for 
1 minute, and then returning to 4% over the final 2.5 minutes.  Mass transitions were 
monitored for each sample and compared against known standard mass transitions for 
species analyzed.43 Data was collected and analyzed using Analyst v1.6 (AB Sciex, 
Framingham, MA). Qualitative area ratios were determined for each species examined.43 
 
3.2.10 Statistical Analyses 
 Data presented are mean ± standard error (SEM) or min. to max. box and whisker 
plots.  Statistical significance was determined by two-way ANOVA followed by post-hoc 
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Tukey’s test to assess the effects of birth weight and postnatal diet, using GraphPad 
Prism 6 (GraphPad Software, San Diego, CA).  Tests of correlation were performed with 
the Spearman rank-order test. Values of p<0.05 were considered statistically significant. 
 A principle component (PC) analysis (PCA) of the acylcarnitine and amino acid 
measurements was performed (SPSS Statistics, version 21.0; IBM SPSS, Armonk, NY) 
to reduce the dimensionality of the data set while retaining as much of the variance as 
possible.  The metabolic PCs, defined as linear, orthogonal (uncorrelated) combinations 
of the original metabolites, were ordered according to their decreasing ability to explain 
variance in the original data set.  Only principle components with eigenvalues greater 
than 1 were retained.  The cumulative variance explained by the 9 PCs included in the 
resultant analysis was 87.6%.  The data set was then rotated using an orthogonal varimax 
procedure.  To facilitate biological interpretation of the PCs, the associated weight 
loading factors for each metabolite were examined and metabolites with a loading score 
greater than 0.5 are reported for each factor.  Tests of main effects of birth weight, diet, 
and birth weight by diet interactions were performed using two-way ANOVA.  
Associations between factor scores and immunoblot measurements are reported as 
Spearman rank correlation coefficients. 
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Protein Species Dilution Blocking 
Solution 
Company Catalogue 
No. 
IRβ Rabbit 
Monoclonal 
1:1000 5% BSA Cell Signaling 
Technology 
3025 
pIRβ (Tyr 
1150/1151) 
Rabbit 
Monoclonal 
1:1000 5% BSA Cell Signaling 
Technology 
3024 
IRS1 Rabbit 
Monoclonal 
1:1000 5% BSA Cell Signaling 
Technology 
2382 
pIRS1 (Ser 
307) 
Rabbit 
Monoclonal 
1:1000 5% BSA Cell Signaling 
Technology 
2381 
p85 Rabbit 
Monoclonal 
1:1000 5% BSA Cell Signaling 
Technology 
4257 
p110 Rabbit 
Monoclonal 
1:500 5% BSA Cell Signaling 
Technology 
3011 
Pan AKT Rabbit 
Monoclonal 
1:1000 5% BSA Cell Signaling 
Technology 
4691 
pAKT (Ser 
473) 
Rabbit 
Monoclonal 
1:1000 5% BSA Cell Signaling 
Technology 
4060 
pAKT (Thr 
308) 
Rabbit 
Monoclonal 
1:1000 5% BSA Cell Signaling 
Technology 
2965 
AS160 Rabbit 
Monoclonal 
1:1000 5% BSA Cell Signaling 
Technology 
2670 
pAS160 
(Thr 642) 
Rabbit 
Polyclonal 
1:1000 5% BSA Cell Signaling 
Technology 
4288 
GLUT4 Mouse 
Monoclonal 
1:1000 5% Skim 
Milk 
ABCAM ab166704 
GLUT2 Rabbit 
Monoclonal 
1:1000 5% Skim 
Milk 
Santa Cruz 
Biotechnology 
sc-9117 
GLUT5 Mouse 
Monoclonal 
1:4000 5% Skim 
Milk 
Pierce 
Biotechnologies 
MA1-036 
JNK Mouse 
Monoclonal 
1:1000 5% BSA Santa Cruz 
Biotechnology 
sc-7345 
pJNK (Thr 
183/Tyr 
185) 
Mouse 
Monoclonal 
1:1000 10% BSA Santa Cruz 
Biotechnology 
sc-6254 
IKKβ Rabbit 
Polyclonal 
1:1000 5% BSA Cell Signaling 
Technology 
2678 
pIKKβ (Ser 
176/180) 
Rabbit 
Polyclonal 
1:1000 5% BSA Cell Signaling 
Technology 
2694 
PKC-θ Rabbit 
Polyclonal 
1:1000 5% BSA Cell Signaling 
Technology 
2059 
CD36 Rabbit 
Polyclonal 
1:500 5% Skim 
Milk 
Santa Cruz 
Biotechnology 
sc-9154 
FATP1 
(ACSVL5) 
Rabbit 
Polyclonal 
1:1000 5% Skim 
Milk 
Santa Cruz 
Biotechnology 
sc-25541 
FATP4 Rabbit 1:1000 5% Skim Santa Cruz sc-25670 
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(ACSVL4) Polyclonal Milk Biotechnology 
CPT1 Mouse 
Monoclonal 
1:500  5% Skim 
Milk 
Santa Cruz 
Biotechnology 
sc-393070 
PPARα Mouse 
Monoclonal 
1:500 5% Skim 
Milk 
ABCAM ab2779 
PGC1α Rabbit 
Polyclonal 
1:500 5% Skim 
Milk 
Santa Cruz 
Biotechnology 
sc-13067 
SIRT1 Mouse 
Monoclonal 
1:2000 5% Skim 
Milk 
Santa Cruz 
Biotechnology 
sc-74465 
SIRT3 Rabbit 
Polyclonal 
1:1000 5% Skim 
Milk 
ABCAM ab86671 
FOXO1 Rabbit 
Polyclonal 
1:1000 5% BSA Cell Signaling 
Technology 
9454 
pFOXO1 
(Ser256) 
Rabbit 
Polyclonal 
1:1000 5% BSA Cell Signaling 
Technology 
9461 
Anti-Rabbit 
Secondary 
Donkey 1:10,000 - Santa Cruz 
Biotechnology 
sc-2077 
Anti-Mouse 
Secondary 
Donkey 1:10,000 - Santa Cruz 
Biotechnology 
sc-2314 
Anti-Goat 
Secondary 
Donkey 1:20,000 - Santa Cruz 
Biotechnology 
sc-2020 
Table 3.1: Specifications and Catalog Numbers of Antibodies Used for 
Immunoblotting. 
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Gene Accession No. 
Anneal 
Temp 
(°C) 
Forward 
Sequence 
(5’è3’) 
Reverse Sequence 
(3’è5’) Efficiency 
VLCAD XM_003466
183.2 
59 CAAACTGGCAGTG
ACGGCT 
TTGGTGGGGGTCAGA
CTGTA 
91.2% 
MCAD XM_003479
087.2 
59 CGAGTTGACCGAA
CAGCAGA 
CAACAGGCATTTGCC
CCAAG 
94.4% 
KT XM_003464
099.2 
59 TAAGGTCCTACGC
AGTGGTTG 
CTCCATAAGCCCTCT
TCCCAC 
90.8% 
PDK4 XM_003475
111.2 
59 GCAGTGGTCCAAG
ATGCCTT 
TGGTGTTCAACTGTT
GCCCT 
94.2% 
CPT1b XM_003461
559.1 
59 AGCTCCCCATTCC
TAGCAGA 
CGCTGAGCATTCGTC
TCTGA 
96.7% 
PGC1α XM_003467
408.2 
56 CAAGACCAGTGAA
TTGAGGG 
CATCCTTTGGGGTCTT
TGAG 
92.5% 
PPARα NM_001173
004.1 
56 AGATCCAGAAAAA
GAACCGC 
TTTTGCTTTCTCAGAC
CTCG 
91.8% 
SIRT1 XM_005005
505.1 
58 TTGCAACTGCATC
TTGCCTG 
TCATGGGGTATGGAA
CTTGGAA 
103.8% 
SIRT3 XM_004999
541.1 
58 CATGGCGGATCTG
CTACTCA 
AGGCTGCATGTTGTG
GTTTG 
93.8% 
β-actin NM_001172
909.1 
59 AAGAGATGTGGCC
TCAAAGC 
CAGGAACAGGCCGTA
GAGTG 
100.6% 
Table 3.2: Primers Used for Analysis of Gene Expression by qRT-PCR. 
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3.3 Results 
3.3.1 Glucose Homeostasis is Maintained at 4 Months of Age 
 Intraperitoneal glucose tolerance challenges were performed to assess whole body 
glucose tolerance.  No significant differences were observed in whole body glucose 
handling following a glucose load at either PND 60 (Figure 3.1A) or PND120 (Figure 
3.1C).  The whole body clearance of glucose, as measured by the area under the curve, 
was also not significantly altered by birth weight or postnatal diet at either PND60 
(Figure 3.1B) or PND120 (Figure 3.1D).   
 Glucose uptake at the level of the skeletal muscle was assessed using 18F-FDG 
PET and measuring the standard uptake value of radioactivity observed during the scans.  
No significant differences in skeletal muscle glucose uptake were observed due to birth 
weight or postnatal diet at either PND50 (Figure 3.2A) or PND110 (Figure 3.2B). 
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Figure 3.1: Whole-Body Glucose Tolerance. A) Blood glucose values (mmol l-1) 
following an intraperitoneal injection of 1g/kg of 50% dextrose solution at PND60.  B) 
The area under the glucose curve (AUGC) as a measurement of glucose clearance at PND 
60. C) Blood glucose values (mmol l-1) at PND120.  D) The area under the glucose curve 
(AUGC) at PND 120. Data presented are the mean ± standard error (SEM) or min. to 
max. box and whisker plots for n=6 NBW/CD, n=6 LBW/CD, n=6 NBW/WD, n=5 
LBW/WD.  Statistical significance was determined by Two-Way ANOVA, followed by 
post-hoc Tukey’s Test. 
 
 
 
A B 
C D 
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Figure 3.2: Skeletal Muscle Glucose Uptake at A) Postnatal Day 50 and B) Postnatal 
Day 110.  Standard Uptake Value (SUV) = image derived radioactivity / (injected 
activity/body weight). Data presented are min. to max. box and whisker plots for n=6 
NBW/CD, n=6 LBW/CD, n=6 NBW/WD, n=5 LBW/WD.  Statistical significance was 
determined by Two-Way ANOVA, followed by post-hoc Tukey’s Test. 
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3.3.2 Skeletal Muscle Lipid Profile 
 Using thin layer chromatography-flame ionization detection (TLC-FID), 
separation and analysis and lipid classes in gastrocnemius muscle was accomplished.  
There were no significant differences in the accumulation of triglycerides (TG), 
cholesterol (Chol), or diacylglycerol (DAG) due to birth weight or postnatal diet (Figure 
3.3). 
 The intermuscular fatty acid pool was profiled using gas chromatography.  In the 
neutral lipid fraction, there was a significant (p<0.001) increase in C14:0 in WD-fed 
animals, a significant  (p<0.001) decrease in C18:2n6c in WD-fed animals, and a 
significant (p<0.01) decrease in C18:3n3 in WD-fed animals (Figure 3.4A).  In the 
phospholipid fraction there was a significant (p<0.001) decrease in C16:0 and a 
significant (p<0.01) increase in C18:1n7 in WD-fed animals (Figure 3.4B).  No 
alterations in the fatty acid composition were influenced by birth weight alone. 
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Figure 3.3: Relative Abundance of Lipid Species in Gastrocnemius Muscle. 
Measured by thin liquid chromatography-flame ionization detection. Data presented are 
mean ± standard error (SEM) for n=6 NBW/CD, n=6 LBW/CD, n=6 NBW/WD, n=5 
LBW/WD. Statistical significance was determined by Two-Way ANOVA, followed by 
post-hoc Tukey’s Test. 
 
 
Figure 3.4: Fatty Acid Profile of Lipids in Gastrocnemius Muscle. A) Neutral lipid 
fraction and B) Phospholipid fraction, measured by gas chromatography. Data presented 
are mean ± standard error (SEM) for n=6 NBW/CD, n=6 LBW/CD, n=6 NBW/WD, n=5 
LBW/WD. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 by Two-Way ANOVA 
followed by post-hoc Tukey’s Test. 
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3.3.3 Skeletal Muscle Insulin Signaling is Disrupted in WD-fed and LBW offspring 
 The phosphorylation of the β-subunit of the insulin receptor (IRβ) is required for 
its activation and propagation of downstream signaling events.44  Skeletal muscle of WD-
fed, and LBW offspring displayed a 46% (p=0.1729) and 67% (p=0.1460) reduction of 
phosphorylation of IRβ, respectively (Figure 3.5B).  
 In contrast to tyrosine phosphorylation, which activates IRS-1, serine 
phosphorylation is inhibitory, preventing activation of PI3-kinase and downstream 
signaling events.44  In WD-fed offspring, there was a significant (p<0.01) increase in 
inhibitory serine phosphorylation of IRS-1 (Figure 3.5C). 
 Full activation of PI3-kinase requires coordination between the p85 regulatory 
subunit and the p110 catalytic subunit,45 in order to phosphorylate downstream 
components of the insulin signaling pathway.  Total protein levels of the p85 regulatory 
subunit were significantly (p<0.01) reduced in LBW-offspring, irrespective of postnatal 
diet (Figure 3.5D).  Total protein levels of the p110 catalytic subunit were reduced by 
37% (p=0.0977) in LBW-offspring, irrespective of postnatal diet (Figure 3.5E). 
 Protein Kinase B/Akt is phosphorylated by PI3-kinase at two resides, Ser473 and 
Thr308, that are both required for full activation of this protein.46  At the Ser473 residue, 
phosphorylation was significantly (p<0.05) reduced in WD-fed offspring, and reduced 
(p=0.059) in LBW-offspring, irrespective of postnatal diet (Figure 3.5F).  Additionally, a 
potential interaction between birth weight and postnatal diet (p=0.0803) was observed.  
At the Thr308 residue, there was a significant (p<0.001) increase in phosphorylation in 
WD-fed offspring (Figure 3.5G) 
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 One of the final steps required for GLUT4 translocation is activation of Akt 
Substrate of 160 kDa (AS160), which is accomplished by Akt-mediated phosphorylation 
at Thr642.47  Phosphorylation of AS160 at Thr642 was significantly (p<0.05) reduced in 
LBW/CD offspring when compared to NBW/CD offspring (Figure 3.5H).  Additionally, 
a significant (p<0.01) interaction between birth weight and postnatal diet was observed. 
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pAKT-308 60 kDa 
AKT 60 kDa 
Amido Black 
F E 
pAKT-473 60 kDa 
AKT 60 kDa 
Amido Black 
pIRβ 95 kDa 
IRβ 95 kDa 
Amido Black 
pIRS-1 180 kDa 
IRS-1 180 kDa 
Amido Black 
p110 110 kDa 
Amido Black 
p85 85 kDa 
Amido Black 
A B 
C D 
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Figure 3.5: Expression and Phosphorylation of Key Proteins Involved in Insulin 
Signaling.  A) Insulin Receptor phosphorylation, B) Insulin Receptor Substrate-1 (IRS-1) 
phosphorylation, C) p85 subunit of PI3-Kinase, D) p110 subunit of PI3-Kinase, E) 
Protein Kinase B/Akt phosphorylation at Ser-473, F) Protein Kinase B/Akt 
phosphorylation at Thr-308, G) Akt Substrate of 160 kDa (AS160) phosphorylation, H) 
Working schematic for molecular manifestations of insulin resistance.  Data presented are 
min. to max. box and whisker plots for n=6 NBW/CD, n=6 LBW/CD, n=6 NBW/WD, 
n=5 LBW/WD.  Representative blots of the respective proteins are below each group. 
Statistical significance was determined by Two-Way ANOVA, followed by post-hoc 
Tukey’s Test. *p<0.05, **p<0.01, ***p<0.001 significant main effect of birth weight, 
diet or interaction; ≠p<0.05 by post-hoc Tukey’s Test.  
pAS160 160 kDa 
AS160 160 kDa 
Amido Black 
G 
H 
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3.3.4 Glucose Transporter Profiles are Altered in WD-fed and LBW Offspring 
 While there were no significant differences observed in total skeletal muscle 
GLUT4 expression (Figure 3.6A), total GLUT2 expression was significantly (p<0.001) 
reduced in WD-fed offspring.  However, birth weight significantly (p<0.01) increased 
expression of GLUT2 (Figure 3.6B).  When compared to NBW/CD offspring, LBW/CD 
offspring showed a significant (p<0.05) increase in GLUT 2 expression.  Alternatively, 
total GLUT5 expression was significantly increased in WD-fed offspring (p<0.01), as 
well as LBW offspring (p<0.05; Figure 3.6C).  Similar to GLUT2 expression levels, 
GLUT5 was significantly (p<0.05) increased in LBW/CD offspring when compared to 
NBW/CD offspring. 
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Figure 3.6: Expression of Glucose Transporters.  A) GLUT4, B) GLUT2, C) GLUT5. 
Data presented are min. to max. box and whisker plots for n=6 NBW/CD, n=6 LBW/CD, 
n=6 NBW/WD, n=5 LBW/WD.  Representative blots of the respective proteins are below 
each group. Statistical significance was determined by Two-Way ANOVA, followed by 
post-hoc Tukey’s Test. *p<0.05, **p<0.01, ***p<0.001 significant main effect of birth 
weight, diet or interaction; ≠p<0.05 by post-hoc Tukey’s Test. 
 
GLUT4 54 kDa 
Amido Black 
GLUT2 60 kDa 
Amido Black 
GLUT5 55 kDa 
Amido Black 
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3.3.5 Disruption of FOXO1 Signaling Occurs in WD-fed Offspring 
 In skeletal muscle of WD-fed offspring, there were significantly (p<0.001) 
reduced total protein levels of the transcription factor FOXO1 (Figure 3.7A).  
Additionally, there was significantly (p<0.05) increased phosphorylation of FOXO1 at 
Ser256, promoting nuclear export and preventing activation of its target genes48 (Figure 
3.7B), a pattern not observed in LBW offspring. 
 
 
 
 
Figure 3.7: Expression of A) Total Levels and B) Phosphorylation of FOXO1 
Protein.  Data presented are min. to max. box and whisker plots for n=6 NBW/CD, n=6 
LBW/CD, n=6 NBW/WD, n=5 LBW/WD.  Representative blots of the respective 
proteins are below each group. Statistical significance was determined by Two-Way 
ANOVA, followed by post-hoc Tukey’s Test. *p<0.05, ***p<0.001, significant main 
effect of diet. 
 
FOXO1 82 kDa 
Amido Black 
pFOXO1 82 kDa 
FOXO1 82 kDa 
Amido Black 
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3.3.6 Stress-Induced Kinases are Activated in WD-fed and LBW Offspring 
 Stress-induced kinases, including JNK, IKKβ and PKC-θ, are known to be 
activated in situations of oxidative stress or lipid accumulation.24,49 A differential pattern 
of stress-induced kinase activation was present in WD-fed vs LBW offspring.  Activation 
of JNK through phosphorylation at Thr183/Tyr185 was significantly (p<0.0001) increased 
only in WD-fed offspring (Figure 3.8A), whereas phosphorylation levels were minimal in 
LBW/CD offspring.  Activation of JNK has been documented to promote inhibitory 
serine phosphorylation of IRS-1.50  In our study, an increased JNK phosphorylation ratio 
correlated with an increased IRS-1 serine phosphorylation ratio (r=0.554, p=0.006, 
Figure 3.14C). 
 Furthermore, the activation of IKKβ through phosphorylation at Ser176/180 was 
significantly (p<0.0001) increased in WD-fed and LBW offspring (Figure 3.8B).  A 
significant (p<0.0001) interactive effect between birth weight and postnatal diet was also 
observed. 
 Lastly, total protein levels of PKC-θ were significantly (p<0.01) higher in LBW-
offspring, irrespective of postnatal diet.  When compared to NBW/CD offspring, 
LBW/CD offspring showed a robust (p<0.05) increase in total PKC-θ protein levels.  
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Figure 3.8: Expression and Phosphorylation of Key Stress-Induced Kinases.  A) JNK 
phosphorylation, B) IKKβ phosphorylation, C) Total PKC-θ levels.  Data presented are 
min. to max. box and whisker plots for n=6 NBW/CD, n=6 LBW/CD, n=6 NBW/WD, 
n=5 LBW/WD.  Representative blots of the respective proteins are below each group. 
Statistical significance was determined by Two-Way ANOVA, followed by post-hoc 
Tukey’s Test. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001 significant main effect of 
birth weight, diet or interaction; ≠p<0.05, ≠≠≠≠p<0.0001 by post-hoc Tukey’s Test. 
 
 
pJNK 54 kDa 
JNK 54 kDa 
Amido Black 
pIKKβ 87 kDa 
IKKβ 87 kDa 
Amido Black 
PKC-θ 85 kDa 
Amido Black 
A B 
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3.3.7 Fatty Acid Transporters are Differentially Altered in WD-fed and LBW 
Offspring  
 CD36, one transporter by which fatty acids can enter skeletal muscle, exhibited 
significantly (p<0.0001) reduced total protein levels in WD-fed offspring (Figure 3.9A).  
However, birth weight significantly (p<0.05) increased protein levels of CD36, such that 
LBW/CD offspring showed significantly (p<0.05) increased expression when compared 
to NBW/CD offspring (Figure 3.9A).   
 In contrast, FATP1 was significantly (p<0.01) increased in WD-fed offspring 
(Figure 3.9B).  Additionally, a significant (p<0.01) interactive effect between birth 
weight and postnatal diet was observed, such that LBW/WD offspring displayed 
significantly (p<0.001) increased FATP1 expression when compared to LBW/CD 
offspring (Figure 3.9B).  Expression levels of FATP4 were not altered by birth weight or 
postnatal diet (Figure 3.9C). 
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Figure 3.9: Fatty Acid Transporters.  A) CD36, B) FATP1, C) FATP4.  Data presented 
are min. to max. box and whisker plots for n=6 NBW/CD, n=6 LBW/CD, n=6 
NBW/WD, n=5 LBW/WD.  Representative blots are below each group. Statistical 
significance was determined by Two-Way ANOVA, followed by post-hoc Tukey’s Test. 
*p<0.05, **p<0.01, ****p<0.0001 significant main effect of birth weight, diet or 
interaction; ≠p<0.05, ≠≠≠p<0.001 by post-hoc Tukey’s Test. 
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3.3.8 Mitochondrial β-oxidation is Disrupted in LBW Offspring 
 The rate limiting step of mitochondrial β-oxidation, CPT1-catalyzed transport of 
acylcarnitines into the mitochondria, is often used as a marker of mitochondrial oxidative 
capacity.51  We observed a significant (p<0.05) decrease in CPT1b mRNA transcript 
abundance in LBW offspring, irrespective of postnatal diet (Figure 3.10A).  A significant 
(p<0.05) decrease was also observed at the protein level in LBW offspring (Figure 
3.10B). 
 Up-regulation of PDK4 inactivates the pyruvate dehydrogenase complex, 
initiating a switch from glucose catabolism to lipid oxidation.52 However, PDK4 mRNA 
expression levels were not altered by birth weight or postnatal diet (Figure 3.10C).  To 
initiate lipid oxidation and the cycle of β-oxidation, acyl-CoA must be dehydrogenated, 
which is accomplished by enzymes specific to the length of the chain being oxidized.25  
Both VLCAD, which dehydrogenates the very-long acyl-CoA chains, and MCAD, which 
dehydrogenates the medium acyl-CoA chains, mRNA levels were not altered by birth 
weight or postnatal diet (Figures 3.10D and 3.10E, respectively).  The final enzyme in the 
β-oxidation cycle is KT, which catalyzes the removal of the 2-carbon acetyl-CoA that is 
fed into downstream TCA cycle.25  KT mRNA levels were significantly (p<0.05) 
decreased in skeletal muscle of LBW offspring, irrespective of postnatal diet (Figure 
3.10F). 
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Figure 3.10: Expression of Key Enzymes Involved in Mitochondrial β-Oxidation.  A) 
CPT1b mRNA expression, B) CPT1 protein expression, C) PDK4 mRNA expression, D) 
VLCAD mRNA expression, E) MCAD mRNA expression, F) KT mRNA expression.  
Data presented are min. to max. box and whisker plots for n=6 NBW/CD, n=6 LBW/CD, 
CPT1 90 kDa 
Amido Black 
B 
D 
E F 
A 
C 
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n=6 NBW/WD, n=5 LBW/WD.  Representative blots of the respective proteins are below 
each group. Statistical significance was determined by Two-Way ANOVA, followed by 
post-hoc Tukey’s Test. *p<0.05, significant main effect of birth weight. 
 
3.3.9 Transcription Factors Regulating Mitochondrial β-oxidation are Reduced in 
WD-fed and LBW Offspring 
 PGC-1α and PPARα are well-known transcription factors that regulate aspects of 
mitochondrial lipid oxidation.53  While skeletal muscle PGC-1α mRNA expression was 
similar among groups (Figure 3.11A), protein levels were significantly (p<0.001) reduced 
in WD-fed offspring, and reduced by 15% (p=0.0797) in LBW offspring (Figure 3.11B). 
 A similar pattern was observed for PPARα, where mRNA expression was not 
different among groups (Figure 3.11C).  However, protein levels were similarly 
significantly (p<0.001) reduced in WD-fed offspring, and reduced by 26% (p=0.0845) in 
LBW offspring (Figure 3.11D).  
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Figure 3.11: Expression of Transcription Factors Regulating Mitochondrial β-
Oxidation.  A) PGC-1α mRNA expression, B) PGC-1α protein expression, C) PPARα 
mRNA expression, D) PPARα protein expression.  Data presented are min. to max. box 
and whisker plots for n=6 NBW/CD, n=6 LBW/CD, n=6 NBW/WD, n=5 LBW/WD.  
Representative blots of the respective proteins are below each group. Statistical 
significance was determined by Two-Way ANOVA, followed by post-hoc Tukey’s Test. 
***p<0.001, significant main effect of diet. 
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3.3.10 Sirtuins Regulating Mitochondrial Biogenesis are Reduced in WD-fed 
Offspring  
 Skeletal muscle sirtuins are a family of transcription factors regulating 
mitochondrial biogenesis and function.54  SIRT1, which is predominantly found in the 
cytosol, is a key player involved in regulation of lipid oxidation.55  While mRNA 
expression levels of SIRT1 were not different between experimental groups (Figure 
3.12A), SIRT1 protein levels were significantly (p<0.001) reduced in WD-fed offspring 
(Figure 3.12B).  Additionally, LBW/CD offspring displayed a significant (p<0.05) 
increase in SIRT1 protein levels when compared to NBW/CD offspring, and a significant 
(p<0.05) interactive effect between birth weight and postnatal diet was also observed 
(Figure 3.12B). 
 SIRT3, which is exclusively located in the mitochondria, is a key player in 
regulating mitochondrial oxidation at the level of β-oxidation and the electron transport 
chain.56  Similar to SIRT1, SIRT3 mRNA expression was not affected by birth weight or 
postnatal diet (Figure 3.12C).  However, protein levels of SIRT3 were significantly 
(p<0.05) reduced in WD-fed offspring (Figure 3.12D). 
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Figure 3.12: Expression of Skeletal Muscle Sirtuins.  A) SIRT1 mRNA expression, B) 
SIRT1 protein expression, C) SIRT3 mRNA expression, D) SIRT3 protein expression.  
Data presented are min. to max. box and whisker plots for n=6 NBW/CD, n=6 LBW/CD, 
n=6 NBW/WD, n=5 LBW/WD.  Representative blots of the respective proteins are below 
each group. Statistical significance was determined by Two-Way ANOVA, followed by 
post-hoc Tukey’s Test. *p<0.05, ***p<0.001, significant main effect of diet or 
interaction. ≠p<0.05, by post-hoc Tukey’s Test. 
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3.3.11 Markers of Mitochondrial Dysfunction are Present in WD-fed and LBW 
Offspring 
 Recently, acylcarnitine metabolites have emerged as strong markers of 
mitochondrial stress and dysfunction.21,23,57,58 Accumulation of even-chain acylcarnitines 
represents partially oxidized intermediates of β-oxidation, whereas accumulation of odd-
chain acylcarnitines represents catabolism of amino acids.21   
 In gastrocnemius muscle, medium-chain acylcarnitines (C6-C12) were 
significantly (p<0.05) increased following consumption of a postnatal WD (Figure 
3.13A).  Additionally, a significant (p<0.05) effect of birth weight upon accumulation of 
C8 and C10 was also observed (Figure 3.13A).  While not reaching statistical 
significance, a potential interactive effect between birth weight and postnatal diet was 
observed in C8-C12 species, with LBW/WD offspring tending to exhibit increased 
accumulation of C8 and C12 (p=0.0622 and p=0.0554, respectively) when compared to 
NBW/WD offspring (Figure 3.13A).  Levels of C2 acylcarnitine, the end product of 
complete β-oxidation,25 were significantly (p<0.05) reduced in WD-fed offspring. 
 Similarly, long-chain acylcarnitines (C14-C18:1) were significantly (p<0.0001) 
increased following consumption of a postnatal WD (Figure 3.13B).  Significant (p<0.05) 
effects of birth weight were observed in C14:1, C16, C18 species, whereas birth weight 
alone tended to induce accumulation of C18:1 and C18:3 species (p=0.0763 and 
p=0.0906, respectively; Figure 3.13B).  A significant (p<0.05) interactive effect between 
birth weight and postnatal diet was observed for C14:1 acylcarnitine.  In LBW/WD 
offspring, significant (p<0.05) accumulation of C14:1 and C16 was noted, while C18 
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tended (p=0.0592) to accumulate, when compared to NBW/WD offspring (Figure 3.13B).  
A significant (p<0.01) reduction of C20:4 acylcarnitine levels was also observed in WD-
fed offspring (Figure 3.13B) 
 Inhibition of NADH-linked β-hydroxy fatty acyl-CoA oxidation is known to 
promote accumulation of hydroxyacylcarnitines.59  We observed significant (p<0.05) 
accumulation of the 3-β-hydroxylated forms of C12, C14, C16, C18 and C18:1 in 
response to WD-feeding (Figure 3.13C).  Birth weight also induced a significant (p<0.05) 
accumulation of C16-OH (Figure 3.13C).  A potential interactive effect between birth 
weight and postnatal diet (p=0.0615) was observed in C12-OH species (Figure 3.13C). 
 A cluster of amino acids has recently been identified that strongly predict risk of 
developing diabetes and impaired insulin action, including the branched-chain amino 
acids (leucine, isoleucine, valine), as well as tyrosine and phenylalanine.58  In our model, 
we observed increased (p=0.0572) levels of leucine in LBW offspring, irrespective of 
postnatal diet (Figure 3.13D).  We also observed reduced (p=0.0734) levels of isoleucine 
in gastrocnemius muscle of WD-fed offspring (Figure 3.13D).  Lastly, we observed a 
significant (p<0.05) accumulation of phenylalanine in WD-fed offspring, and a trend 
(p=0.0878) towards accumulation in LBW offspring (Figure 3.13D). 
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Figure 3.13: Acylcarnitine and Amino Acid Levels in Gastrocnemius Muscle. A) C2 
& medium-chain acylcarnitines, B) long-chain acylcarnitines, C) hydroxylated 
acylcarntines, D) gluconeogenic amino acids as measured by LC-MS/MS.  Data 
presented are mean ± standard error (SEM) for n=5-8 animals per group.  Statistical 
significance was determined by Two-Way ANOVA, followed by post-hoc Tukey’s Test. 
*p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, significant main effect of birth weight, 
diet, or interaction.  ≠p<0.05, by post-hoc Tukey’s Test. Common names for the 
acylcarnitine short hands can be found in Appendix I. 
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3.3.12 Principle Components Analysis (PCA) of Acylcarntine and Amino Acid 
Levels 
 We employed PCA as an unbiased data reduction strategy to determine a model 
of how acylcarnitine and amino acid metabolism relates to the observed alterations in 
insulin signaling described above.  Nine factors were identified, explaining 87.6% of the 
total variance in the model.  Features of the top 4 PCs are described in Table 3.3. 
 The first PC (PC1; medium- and long-chain acylcarnitines) was composed of 
even-chain acylcarnitines ranging from C8 through C18, in addition to the unsaturated 
acylcarnitines C14:1, C16:1 and C18:1.  Additionally, C2 (acetylcarnitine) was also a 
part of this component, however the negative loading factor suggests that levels of C2 
would decrease as levels of the other components of this cluster increase, similar to the 
accumulation profile we observed in Figure 3.13. A significant (p<0.0001) main effect of 
diet was observed for the components of this factor, highlighting postnatal diet as a major 
contributor to the acylcarnitine species associated with this component.   PC2 
(hydroxylated acylcarnitines) was composed predominantly of the hydroxylated 
acylcarnitines derived from C4, C12-C18 and C18:1, with contributions from C4 as well 
as C6. A potential contribution (p=0.076) of postnatal diet was observed for this factor. 
PC3 (poly-unsaturated long-chain acylcarnitines) was composed of C18:2, C18:3, C20:4 
and C22:5 acylcarnitine species, with a significant (p=0.022) contribution of postnatal 
diet to this cluster.  PC4 (gluconeogenic amino acids) was composed of the amino acids 
leucine, isoleucine, valine, tyrosine and phenylalanine. Birth weight was a potential 
(p=0.075) contributor to the species observed in this factor. 
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 Since accumulation of medium- and long-chain acylcarnitines is a well-
documented marker of mitochondrial dysfunction,21,22 we decided to focus further 
analysis on PC1. PC1 scores were moderately correlated with increased JNK 
phosphorylation as a measure of its activation (r=0.658, p=0.001; Figure 3.14A).  
Additionally, PC1 scores were modestly correlated with increased inhibitory serine IRS-1 
phosphorylation (r=0.466, p=0.025; Figure 3.14B). 
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  P-values for Main Effect 
Factor Metabolite 
Description 
Birth Weight Diet Birth Weight 
and Diet 
PC1, medium- & 
long-chain 
acylcarnitines; 
eigenvalue 12.6 
(43.40%) 
 
C2 (-0.715) 
C8 (0.556) 
C10 (0.797) 
C12 (0.886) 
C14 (0.801) 
C16 (0.929) 
C18 (0.836) 
C14:1 (0.766) 
C16:1 (0.877) 
C18:1 (0.921) 
p=0.273 p<0.0001 p=0.469 
PC2, 
hydroxylated 
acylcarnitines; 
eigenvalue 3.9 
(13.71%) 
 
C4 (0.865) 
C6 (0.784) 
C4-OH (0.721) 
C12-OH (0.723) 
C14-OH (0.783) 
C16-OH (0.741) 
C18-OH (0.814) 
C18:1-OH 
(0.764) 
 
p=0.415 p=0.076 p=0.569 
PC3, poly-
unsaturated 
long-chain 
acylcarnitines; 
eigenvalue 3.3 
(11.36%) 
 
C18:2 (0.807) 
C18:3 (0.813) 
C20:4 (0.716) 
C22:5 (0.925) 
 
p=0.775 p=0.022 p=0.996 
PC4, 
gluconeogenic 
amino acids; 
eigenvalue 2.2 
(7.53%) 
 
Leu (0.723) 
Ile (0.603) 
Val (0.801) 
Tyr (0.554) 
Phe (0.673) 
 
 
p=0.075 p=0.587 p=0.459 
Table 3.3: Results of the Exploratory PCA on Acylcarnitine Levels. Eigenvalues and 
percent contribution to total sample variance is presented for the first 4 principle 
components of the model.  Individual features of each component are displayed, along 
with rotated loading coefficients when greater than 0.5. Values in parentheses next to 
each metabolite are the loading coefficient from the PCA model, which is a measure of 
the importance of each metabolite to the factor.  Parenthetical values next to the 
eigenvalue represent the percentage of the total sample variation for each factor. 
Common names for the acylcarnitine short hands can be found in Appendix I. 
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Figure 3.14: Correlation Analyses. A) Correlation of JNK phosphorylation and Factor 1 
score, B) Correlation of IRS-1 phosphorylation and Factor 1 score, C) Correlation of 
IRS-1 phosphorylation and JNK phosphorylation. Regression lines with 95% confidence 
intervals of the mean are shown. 
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3.4 Discussion 
 With the recent surge of research investigating the developmental origins of 
health and disease, the contribution of the in utero environment and its ability to 
modulate growth is a well-established determinant of later life disease risk.  However, the 
mechanisms by which adverse growth in utero may induce later life insulin resistance 
and the progression to MetS remain elusive.  In this study, we sought to determine the 
relative contribution of the in utero environment upon disrupted skeletal muscle lipid 
metabolism as a component of the pathophysiological progression of insulin resistance.  
Additionally, with the increasing availability of high-fat/high-sugar diets and their early 
introduction during the postnatal period, we sought to determine whether early 
consumption of these diets would have a synergistic effect following a LBW outcome, 
promoting early markers of insulin resistance. 
 
3.4.1 Skeletal Muscle Insulin Signaling and Glucose Homeostasis in LBW offspring 
 While we did not see alterations in whole-body glucose tolerance or skeletal 
muscle glucose uptake in our cohort, we did observe molecular disruptions to the skeletal 
muscle insulin signaling cascade, a documented component of pre-diabetes.9,20 LBW was 
associated with a reduction in the phosphorylation of the insulin receptor, as well as 
decrease in total protein content of the p85 and p110 subunits of PI3-kinase, highlighting 
impaired activation, in addition to reductions in phosphorylation of Akt at Ser473, and 
AS160 at Thr642.  Similar to our observations, reduced levels of p85 and p110 have been 
observed in both animal models of IUGR, as well as young adult men born LBW.60-62  
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This impairment of PI3-kinase actions in these other models of IUGR occurred in 
conjunction with impaired phosphorylation of Akt and AS160 in response to insulin 
stimulation.63 In young adulthood, the molecular alterations observed in human offspring 
also occurred with maintenance of whole-body glucose tolerance, similar to what we 
have observed in our cohort.60,61 It has been postulated that changes in expression and 
phosphorylation of the insulin signaling intermediates precedes the development of overt 
insulin resistance and glucose intolerance,61 providing a molecular signature associated 
with early stages of disease progression.64  Therefore, the persistent changes in the insulin 
signaling pathway, in conjunction with maintenance of glucose homeostasis highlight 
that at this young age, our guinea pigs are in an early-stage of insulin resistance 
pathogenesis resembling a pre-diabetic state;20 however, we speculate that with time 
insulin sensitivity will decrease and disrupt glucose homeostasis, similar to human 
reports4,61 and animal models of older LBW offspring.65 
 While whole-body glucose tolerance is maintained in young adolescent men born 
LBW, reduced glucose uptake in the muscles of the forearm have been observed.60  This 
reduced glucose uptake is typically associated with reductions in skeletal muscle GLUT4 
content,60,61,63 reducing insulin-stimulated glucose uptake into the muscle. Interestingly, 
we did not observe any significant differences in total GLUT4 protein content in our 
cohort, nor did we observe deficiencies in skeletal muscle glucose uptake as measured by 
18F-FDG PET scans.  However, we observed significant increases of GLUT2 and GLUT5 
total protein content in LBW offspring. Additionally, we observed significant decreases 
in GLUT2 content in WD-fed animals, in conjunction with significant increases in 
GLUT5 content, which may be able to provide an avenue for compensation in order to 
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maintain skeletal muscle glucose uptake following consumption of a postnatal WD.  In 
the skeletal muscle the more significantly expressed GLUTs include GLUT4, GLUT5 
and GLUT12;66  however, GLUT2 is a low-affinity glucose transporter, known to 
facilitate minimal glucose uptake into skeletal muscle in order to maintain glucose 
homeostasis.67 Additionally, GLUT5, while typically considered to be the main fructose 
transporter in skeletal muscle,68 also has the ability to facilitate glucose uptake.66  It is 
even responsive to the actions of insulin, activating the GLUT5 promoter region to 
induce its expression in response to the hormonal milieu.66 Therefore, the observed 
increases in total GLUT5 protein content of LBW and WD-exposed offspring highlight a 
potential compensatory mechanism at play in our model, similar to that observed in the 
muscle of type 2 diabetic patients, aimed at maintaining glucose homeostasis at this 
age.69 
 
3.4.2 Mechanisms Underlying Molecular Alterations in Insulin Signaling 
 We next sought to assess the mechanisms by which the alterations in skeletal 
muscle insulin signaling may occur.  Literature investigating the mechanisms underlying 
insulin resistance pathogenesis secondary to high-fat feeding highlighted three candidate 
stress-induced kinases that may be activated in situations of oxidative stress or lipid 
overload.24  Following chronic exposure to high-fat diets, activation of JNK through 
phosphorylation at Thr183/Tyr185 has been associated with increased inhibitory serine 
phosphorylation of IRS-1 at Ser307.50  Similarly, in our offspring exposed to postnatal 
WD diets, we saw a robust activation of JNK, which was modestly correlated with the 
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observed inhibitory serine phosphorylation of IRS-1.  However, phosphorylation of JNK 
was not detectable in our LBW/CD offspring, prompting further investigation into other 
stress-kinases that may be activated in LBW situations.  In addition to significant 
activation of IKKβ in our WD-fed offspring, we also observed significant activation in 
our LBW/CD offspring, in addition to a LBW-specific increase in total levels of PKC-θ.  
Each of these stress-kinases have been well documented to have the ability to promote 
inhibitory serine phosphorylation of IRS-1 in situations of oxidative stress,49 disrupting 
downstream insulin signaling events.  Overall, we observed differential activation of 
stress-induced kinases in LBW and WD-fed offspring, highlighting that activation of 
stress-induced kinases may be environment specific depending on the mechanism by 
which the stress occurs. Additionally, in LBW/WD offspring, where activation of stress-
kinases due to a LBW outcome and postnatal consumption of a WD may occur, an 
interactive effect is possible, promoting further disruption to skeletal muscle insulin 
signaling. 
 Activation of stress-kinases is also known to occur secondary to lipid overload 
and accumulation of toxic lipid intermediates, including triglycerides, DAG and 
ceramides.15,49  Therefore, we sought to determine the relative contribution of lipotoxic 
intermediates to the alterations in insulin signaling and the activation of stress-kinases 
observed above. We did not observe any significant accumulation of triglycerides or 
DAG in the skeletal muscle of WD-fed offspring, contrary to other high-fat diet-induced 
insulin resistance models.14,15 Interestingly, altered insulin sensitivity in the absence of 
DAG accumulation has been observed in pre-diabetic men,70 highlighting alternative 
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mechanisms may be at play early in disease progression, namely accumulation of other 
lipotoxic intermediates such as ceramides or acylcarnitines.49  
 We also profiled the composition of the fatty acids present in the skeletal muscle 
by gas chromatography.  A higher percentage of saturated fatty acids in the neutral lipid 
fraction has been associated with reduced insulin sensitivity,14 similar to the 
accumulation of C14:0 we observed in our WD-fed offspring. We also observed 
reductions in the omega-6 and omega-3 poly-unsaturated fatty acids in the neutral lipid 
fraction, which have also been implicated in reduced insulin sensitivity.14,71 Unsaturated 
fatty acids have the ability to protect against lipotoxicity by promoting uptake into an 
inert triglyceride pool that is not esterified into intermediates, namely ceramide.14  
Additionally, a higher proportion of saturated fatty acids in this lipid pool have been 
associated with higher ceramide content due to de novo ceramide synthesis.72  These 
alterations in fatty acid composition favouring ceramide accumulation have the potential 
to reduce insulin sensitivity by reducing Akt activation.49 Overall, the alterations we 
observed in the skeletal muscle of WD-fed offspring mirrored the composition of the 
dietary fats present in the WD (Chapter 2, Table 2.1).  Additionally, we did not observe 
any alterations in the fatty acid profile due to birth weight alone, prompting further 
investigation into mitochondrial metabolism as an alternative theory to explain the 
observed defects in insulin signaling.  
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3.4.3 Mitochondrial Oxidation in Response to LBW and Postnatal WD 
 The first step in the mitochondrial oxidation of lipids is entry of fatty acids into 
the skeletal muscle through the coordinated actions of the fatty acid transporters 
FAT/CD36, FATP1 and FATP4.73  In our model, total protein levels of CD36 were 
significantly reduced in offspring consuming a postnatal WD; however FATP1 was 
significantly increased in these same offspring.  Conversely, in LBW/CD offspring, 
CD36 levels were significantly increased, but FATP1 levels were significantly decreased.  
Not only does this data suggest differential expression of fatty acid transport proteins in 
response to birth weight and postnatal diet, but also highlights a mechanism by which 
fatty acid transport into the skeletal muscle can continue without impediment.  
Additionally, recent evidence suggests both CD36 and FATP1 are localized to the 
mitochondria in addition to the plasma membrane,74,75 providing a concentrated supply of 
long-chain fatty acids for entry into mitochondria and subsequent oxidation.  Therefore, 
the differential expression of FATP1 and CD36 also support the notion that entry of fatty 
acids into the cell for oxidation is not compromised at this stage of disease progression, 
preventing accumulation of fatty acids as triglycerides or toxic lipid intermediates.  
 However, we did observe accumulation of acylcarnitine intermediates in skeletal 
muscle of WD-fed offspring, as well as LBW offspring. These intermediates are known 
to accumulate in situations of mitochondrial dysfunction and incomplete fatty acid 
oxidation, where they are indicative of impairment of substrate flux through the TCA 
cycle and oxidative phosphorylation.21,57,58 Therefore, we investigated the enzymatic 
reactions involved in β-oxidation and the regulation of the oxidative process in order to 
shed light on possible mechanisms underlying the observed accumulation of 
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acylcarnitines. At both the mRNA and protein level, CPT1, the rate-limiting step of the 
oxidation process,25 was reduced in LBW offspring, irrespective of postnatal diet.  
Additionally, mRNA levels of KT, the enzyme responsible for catalyzing the removal of 
acetyl-CoA from the fatty acid chain,25 was reduced in LBW offspring. These defects in 
the oxidative process would slow down the rate of β-oxidation and impair substrate 
utilization through the remaining steps of the oxidative process, preventing complete 
oxidation of the fatty acid chains. However, the reduced levels of these oxidative 
enzymes were LBW-specific, highlighting that the accumulation of acylcarnitines in the 
WD-fed offspring is likely due to alternate defects in other components along the 
oxidative pathway. 
 
3.4.4 Regulation of Mitochondrial Biogenesis and Oxidative Function 
 In order for fatty acids to be completely oxidized, the tight coordination of a 
number of transcription factors regulating mitochondrial biogenesis and oxidative 
function is required. PPARα is one such transcription factor that is highly expressed in 
oxidative tissues, including skeletal muscle, which is known to induce activation of genes 
involved in β-oxidation.24,76 However, in order for full activation of PPARα target genes, 
coordination with PGC-1α is required.53,77  PGC-1α also has the ability to independently 
activate genes involved in the TCA cycle and oxidative phosphorylation, promoting 
complete oxidation of lipid substrates.55  Consumption of high-fat diets is known to 
reduce protein levels of PGC-1α21,57 reducing lipid oxidation and promoting 
accumulation of acylcarnitine intermediates indicative of mitochondrial dysfunction.  We 
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observed similar reductions in total protein levels in our WD-exposed offspring.  Recent 
studies have also reported reduced PGC-1α protein levels in gastrocnemius muscle of 
adolescent low birth weight offspring.78  While the reductions we observed in our model 
did not reach statistical significance in the LBW/CD offspring, we did see a 15% 
reduction in total protein levels, which we postulate would still have the ability to impair 
complete lipid oxidation in these offspring.  Reduced PGC-1α has also been observed in 
C2C12 muscle cells exposed to hypoxia in culture, a key characteristic of adverse in utero 
environments.79 The ability of hypoxia alone to modulate the regulation of mitochondrial 
lipid metabolism highlights a potential role for hypoxia and potentially its association 
with oxidative stress in an adverse in utero environment80,81 in promoting later life 
persistent mitochondrial dysfunction.   
 The sirtuins (SIRTs) are another important family of transcription factors 
involved in regulating mitochondrial biogenesis and oxidative function.  SIRT1, which is 
predominantly localized to the nucleus or cytosol, promotes deacetylation of target 
proteins involved in lipid metabolism and energy balance, including PGC-1α and 
PPARα.54,82 Reduced levels of SIRT1 protein have been observed in skeletal muscle of 
type 2 diabetic patients,83 as well as rats consuming high fat diets.84  This reduction in 
SIRT1 has also been associated with hyperacetylation of PGC-1α and PPARα, preventing 
their ability to complex with one another to induce lipid oxidation.55  We have observed 
similar reductions in SIRT1 protein levels in our WD-exposed offspring, highlighting 
impaired regulation of lipid oxidation through the SIRT1-PGC-1α pathway.  
Additionally, SIRT3 which is exclusively located in the mitochondria, catalyzes the 
deacetylation of proteins involved in β-oxidation as well as the electron transport 
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chain.56,85,86 In rodents exposed to high fat diets, muscle levels of SIRT3 protein are 
significantly reduced,87 similar to the reduced SIRT3 total protein level we observed in 
gastrocnemius of WD-fed offspring.  Since SIRT3 knockouts have been associated with 
hyperacetylation of SIRT3 target proteins,88 preventing their activation and promoting 
mitochondrial dysfunction in addition to insulin resistance,89 we speculate that the 
reduced SIRT3 levels observed in our model would be associated with reduced activation 
of SIRT3 target proteins, preventing complete lipid oxidation.  
 While FOXO1 protein levels were decreased following postnatal consumption of 
a WD, FOXO1 phosphorylation at Ser256 mediated by Akt 90 was significantly increased.  
As such, while there are reduced levels of FOXO1, the increased phosphorylation could 
suggest an increased level of exclusion of the available protein from the nucleus, thus 
negatively impacting transcription of gluconeogenic and lipid metabolism gene targets.91 
Additionally, the increased phosphorylation, possibly mediated by Akt, suggests that Akt 
retains its ability to phosphorylate these sites on FOXO1 despite an observed reduction in 
Ser473 phosphorylation level, suggesting a potential compensatory activation of 
alternative phosphorylation sites on Akt aimed at maintaining its kinase activity. 
 In terms of the regulation of mitochondrial biogenesis and function, the main 
effects on the protein expression of these transcription factors were largely attributable to 
consumption of a postnatal WD, with a trend towards decreasing levels of PPARα and 
PGC-1α in response to a LBW outcome.  However, the alterations observed in the 
enzymes involved in β-oxidation were exclusively observed in LBW offspring, 
irrespective of postnatal diet.  As such, it is possible that the defects inducing 
acylcarnitine accumulation in LBW offspring versus WD-exposed offspring occur at 
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different levels of the oxidative process, namely β-oxidation in LBW offspring, and 
downstream TCA cycle or oxidative phosphorylation in the WD-exposed offspring.  
These differential mechanisms, when superimposed on one another in the LBW/WD 
offspring would have the potential to impair the oxidative process to a greater extent, 
promoting increased acylcarnitine accumulation, similar to the interactive effect we 
observed in numerous acylcarnitine species.  As such, postnatal consumption of a WD 
following a LBW outcome may exacerbate mitochondrial dysfunction, promoting 
increased accumulation of acylcarnitine intermediates.   
  
3.4.5 A Model Linking Mitochondrial Dysfunction and Defective Insulin Signaling 
 Acylcarnitine accumulation secondary to mitochondrial dysfunction has been 
shown to activate pro-inflammatory signaling pathways and induce a state of oxidative 
stress,27 promoting insulin resistance. Therefore, we sought to use PCA in order to 
identify a cluster of metabolites that may be implicated in skeletal muscle insulin 
resistance pathogenesis.  The first cluster, composed of medium- and long-chain 
acylcarnitine species, accounted for more than 40% of the variation of the model, 
highlighting this cluster of metabolites as important players in the pathogenesis of 
mitochondrial dysfunction.  Medium- and long-chain acylcarnitines are known to 
accumulate secondary to incomplete lipid oxidation, therefore representing a key 
manifestation of mitochondrial dysfunction.21,57,58 The exact mechanisms associated with 
acylcarnitine accumulation remain poorly defined, however the observed reductions in 
CPT1, KT, PPARα, PGC-1α, SIRT1 or SIRT3 in our model are likely candidates 
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modulating mitochondrial lipid metabolism, mitochondrial dysfunction and acylcarnitine 
accumulation.  Additionally, a significant main effect of diet was observed for PC1, 
highlighting postnatal diet as a key contributor to the accumulation of these metabolites.  
The metabolites of PC1 were also significantly correlated with activation of JNK, as well 
as with inhibitory serine phosphorylation of IRS-1.  Recent evidence suggests 
accumulation of C-14 carnitine in particular is able to induce phosphorylation and 
activation of JNK,27 highlighting a potential mechanism by which mitochondrial 
dysfunction and altered insulin signaling may be linked.  In our model generated by PCA, 
accumulation of medium- and long-chain acylcarnitines is also associated with increased 
activation of JNK, promoting inhibitory serine phosphorylation of IRS-1 and disrupted 
insulin signaling.  Interestingly, acylcarnitine accumulation has been observed in 
individuals with pre-diabetes who do not display overt reductions in insulin sensitivity,92 
highlighting that our offspring may also be at a pre-diabetic stage since we are seeing 
molecular disruptions in mitochondrial function and insulin signaling without whole body 
alterations in insulin sensitivity. 
 With the knowledge that hypoxia associated with IUGR induces a state of 
oxidative stress in the fetus,93-95 we speculate that it is this exposure to oxidative stress 
that initiates the persistent molecular alterations in insulin signaling and mitochondrial 
metabolism.  Limited nutrient supply in utero has been associated with an alteration in 
the redox state of metabolic tissues of the fetus, altering their metabolic function.96 
Additionally, low oxygen availability has been associated with decreased function of the 
electron transport chain in fetal mitochondria, generating reactive oxygen species (ROS) 
that leads to persistent oxidative damage to the mitochondria.97-99 Mitochondrial 
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dysfunction itself has also been associated with ROS production,96 perpetuating a state of 
oxidative stress that has the potential to activate stress-induced kinases or induce post-
translational modifications to important mitochondrial transcription factors. 
 In summary, IUGR culminating in LBW predisposes the offspring to disrupted 
insulin signaling and mitochondrial lipid metabolism in skeletal muscle. Additionally, 
early exposure to a postnatal WD independently induces alterations in mitochondrial lipid 
metabolism and insulin signaling; however, consumption of this diet following a LBW 
outcome likely unmasks a LBW-induced metabolic dysfunction, increasing the 
offspring’s risk of developing insulin resistance.  Lastly, alterations in mitochondrial 
function, as observed by acylcarnitine accumulation, occur early in disease progression, 
without overt disruption of whole-body glucose tolerance, highlighting a pre-diabetic 
situation in these offspring. Characterization of other modulators, such as the epigenetic 
drivers, of disrupted mitochondrial metabolism that may underlie the persistent molecular 
changes observed when exposed to an adverse in utero environment will be the subject of 
future studies. 
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4.1 Summary 
 The importance of the in utero environment in modulating growth trajectory and 
influencing the propensity for development of age-related metabolic diseases is rapidly 
gaining recognition among healthcare professionals and government agencies.  Evidence 
strongly suggests that infants displaying IUGR, culminating in a LBW, are at greater risk 
for developing type 2 diabetes, cardiovascular disease and obesity.1-8 The Developmental 
Origins of Health and Disease (DOHaD) hypothesis first put forth by Forsdahl, Barker, 
and expanded upon by others, postulated that development of these chronic, non-
communicable, metabolic diseases are the result of a programming mechanism initiated 
during critical periods of in utero development in order to promote fetal survival in poor 
intrauterine conditions.5,9-12 Recent evidence has also suggested that secondary insults in 
postnatal life, including the increasingly accessible “Western” diet, have the potential to 
exacerbate an already dysfunctional system, further increasing the risk of developing age-
related metabolic diseases.1,13,14 Given the increasing prevalence of non-communicable 
metabolic diseases, understanding the mechanisms underlying fetal programming of adult 
disease along with the contribution of postnatal diet on the development of metabolic 
disorders is of critical importance.  While some mechanisms have been postulated, 
including epigenetic modifications, oxidative stress, and nuclear receptor signaling,15-17 
further delineation of the persistent molecular alterations initiated in utero remain to be 
elucidated. 
 We chose to focus on the developmental programming of skeletal muscle insulin 
resistance as it relates to development of later life progression to type 2 diabetes and 
MetS, since skeletal muscle is the primary location for insulin-stimulated glucose 
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uptake18 and a major regulator of whole body energy homeostasis.19  Overall, the present 
studies provide strong evidence for the role of the in utero environment in modulating 
skeletal muscle lipid metabolism and insulin signaling as a precursor to the development 
of insulin resistance.  Additionally, the work presented in this thesis, as well as 
others,13,14,20,21 provide further support that a postnatal diet characterized by relative 
nutrient excess has the potential to exacerbate an already dysfunctional system and alter 
growth trajectory (Chapter 2) and metabolism (Chapter 3) of the offspring. 
 In the first study (Chapter 2), we sought to characterize the growth and metabolic 
parameters of offspring born following an adverse in utero environment, characterized by 
reduced oxygen and nutrient supply, as they grew into young adulthood.  Furthermore, 
we also sought to investigate the relative contribution of a consistent, early exposure to a 
postnatal Western diet on the potential for an increased risk of developing features of 
age-related metabolic diseases.  The study presented evidence that the immediate post-
birth growth trajectory of LBW offspring is altered following IUGR, displaying rapid 
postnatal catch-up growth from weaning through to PND50.  This pattern of growth is 
classically replicated in animal and human IUGR studies, and is traditionally associated 
with augmenting the offspring’s risk for developing age-related metabolic 
diseases.4,15,22,23 Few, if any, studies are available that examine this growth pattern when 
LBW offspring are exposed to a true WD early in life consisting of high fat and high 
processed sugars.  Early exposure to a postnatal Western diet appeared to have a 
differential effect on growth trajectory, stunting the accelerated catch-up growth post-
weaning that is traditionally associated with LBW.  Additionally, these WD-fed offspring 
exhibited a non-obese phenotype and in fact displayed a significantly reduced overall 
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adiposity.  While our offspring displayed maintenance of whole-body glucose tolerance 
and a non-obese phenotype at this young age, previously published studies in our lab,24-26 
as well as investigation of skeletal muscle lipid metabolism (Chapter 3) highlight that 
metabolic disturbances are indeed present in these offspring and may be associated with a 
pre-diabetic phenotype. 
 The second study (Chapter 3) postulated that adverse in utero conditions would 
impair skeletal muscle mitochondrial function and lipid metabolism, promoting a state of 
mitochondrial dysfunction, which negatively alters insulin signaling.  While whole-body 
glucose tolerance, as well as skeletal muscle glucose uptake, was maintained, we 
observed skeletal muscle-specific molecular alterations in insulin signaling and lipid 
metabolism.  Additionally, we observed hallmarks of mitochondrial dysfunction, 
including an increased level of acylcarnitine intermediates, in WD-fed, as well as in 
LBW/CD offspring.  Furthermore, early consumption of a postnatal WD by LBW 
offspring from weaning appeared to unmask LBW-induced metabolic disruptions by 
early adulthood by inducing further accumulation of acylcarnitines.  Molecular 
alterations in skeletal muscle lipid metabolism and insulin signaling are frequently 
observed early in the pathogenesis of insulin resistance.8,27 Changes in these two 
molecular pathways, in conjunction with maintenance of glucose uptake and glucose 
tolerance, highlights a pre-diabetic phenotype, an early step in disease progression, as 
previously reported in humans.7,8,27,28 
 Taken together, these two studies provide strong evidence for the role of the in 
utero environment in modulating growth and future disease risk.  In both studies, early 
introduction of a postnatal WD altered growth trajectory and metabolism, potentially 
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unmasking and exacerbating LBW-induced metabolic dysfunctions.  While our offspring 
outwardly appear healthy due to their non-obese, glucose tolerant phenotype, our studies 
highlight disruptions in skeletal muscle lipid metabolism and insulin signaling associated 
with a developing metabolically unhealthy phenotype (Table 4.1) 
 
4.2 Speculations 
 An adverse in utero environment typically observed in situations of IUGR has 
been associated with hypoxia, reducing the amount of oxygen reaching the developing 
fetus.29,30 Fetal hypoxia has been observed to correlate with the incidence of later life 
cardiovascular disease in high altitude Bolivian populations,31 and has been replicated in 
rodent studies as well.32,33 Skeletal muscle levels of key intermediates of insulin 
signaling, including Akt and GLUT4, are significantly reduced in adults exposed to 
prenatal hypoxia,34,35 further highlighting hypoxia as a key modulator of later life disease 
risk, possibly by promoting a state of oxidative stress.36 IUGR has been associated with 
increased indices of oxidative stress in the fetus,37-39 while oxidative stress has been 
postulated to underlie the programming of later life hypertension.  Therefore, oxidative 
stress in utero has recently been highlighted as a potential mechanism promoting later life 
metabolic disease. One mechanism by which this may occur is an altered redox state in 
fetal tissues in response to limited oxygen and nutrient availability.  These low oxygen 
levels have the potential to decrease activity of the electron transport chain, reducing 
oxidative phosphorylation, and generating ROS that promote persistent oxidative damage 
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and mitochondrial dysfunction.27,40,41 Additionally, mitochondrial dysfunction itself leads 
to production of ROS, further perpetuating a state of oxidative stress.17 
 Of note, progression of insulin resistance following consumption of a WD is also 
strongly associated with a state of oxidative stress.42-44 Mitochondrial dysfunction is also 
known to occur secondary to high-fat feeding,43,45,46 increasing mitochondrial stress and 
decreasing mitochondrial oxidative phosphorylation.47 This impairment in mitochondrial 
function promotes ROS generation, as well as acylcarnitine accumulation, both of which 
have the potential to activate stress-induced kinases that mediate alterations in insulin 
signaling.48-51  Of note, the molecular disruptions occurring in skeletal muscle of 
LBW/CD offspring and NBW/WD offspring, and their associated phenotype, are similar 
among these two groups.  This suggests that a similar trigger may be responsible for 
inducing the metabolic dysfunctions in both these groups, namely oxidative stress. 
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 Birth Weight Diet Birth Weight/Diet 
Interaction 
Growth & Feeding Behaviour    
AGR ê  ê   
Food Intake    
Calorie Consumption  é   
Feed Efficiency ê  ê   
Body Composition    
Whole-body Adiposity  ê   
Mesenteric Fat Pad Mass  ê   
Glucose Homeostasis    
Whole-body Glucose Tolerance    
Skeletal Muscle Glucose Uptake    
GLUT4    
GLUT2 é  ê   
GLUT5 é  é   
Fatty Acid Uptake    
CD36 é  ê   
FATP1 ê  é  éé  
FATP4    
Mitochondrial Oxidation    
CPT1 (mRNA & protein) ê    
VLCAD    
MCAD    
PDK4    
KT ê    
PGC-1α (protein) ê  p=0.0797 ê   
PPARα (protein) êp=0.0845 ê   
Mitochondrial Biogenesis    
SIRT1 é  ê   
SIRT3  ê   
FOXO1  ê   
pFOXO1  é   
Mitochondrial Dysfunction    
Acylcarnitines é  é  éé  
Stress-Induced Kinases    
pJNK  é   
pIKKβ é  é  é  
PKC-θ é    
Insulin Signaling    
pIRβ    
pIRS-1  é   
p85 ê    
p110 êp=0.0977   
pAkt (Ser473) êp=0.0590 ê  êêp=0.0803 
pAkt (Thr308)  é   
pAS160 ê   é  
Skeletal Muscle Lipid Profile    
Triglycerides    
Diacylglycerol    
Cholesterol    
Saturated Fatty Acids  é   
Omega 6/Omega 3 Poly-unsaturated 
Fatty Acids 
 ê   
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Table 4.1: Summary Table of Birth Weight and Diet Effects and Their Interaction 
on Postnatal Growth, Skeletal Muscle Lipid Metabolism and Insulin Signaling.  
 
4.3 Potential Limitations 
 Unfortunately, no study is perfect and there are limitations that must be addressed.  
Firstly, in both studies presented, we chose to examine only male offspring in order to 
reduce confounding variables associated with estrus cycle and differences in hormonal 
profiles between females and males.  Previous studies have highlighted an increased 
susceptibility of males to the programming effects of an adverse in utero 
environment,52,53 further prompting us to limit the current studies to male offspring at this 
time.  However, studies that have examined both males and females have highlighted 
differential responses between the sexes to the influence of the in utero environment on 
later life insulin sensitivity.54,55  For example, IUGR offspring in animal models are 
known to display improved insulin sensitivity in very early postnatal life; however, a shift 
towards impaired glucose clearance and decreased insulin sensitivity was observed as 
these offspring aged.52,56,57  Interestingly, the timing of this shift in insulin sensitivity 
appears to be sex-specific, with insulin action being impaired earlier in males in 
comparison to females.52,55  Therefore, investigation of our female cohort would have 
provided insight into the mechanisms associated with fetal programming of insulin 
resistance and how each sex responds to the initial in utero insult. 
 Secondly, our assessment of insulin resistance may have been improved overall.  
While we were able to extensively profile the expression and phosphorylation of the 
insulin signaling cascade in the skeletal muscle, we were unable to assess insulin 
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sensitivity at the whole-body level or skeletal muscle level directly. Unfortunately, due to 
the low sequence homology between human and guinea pig insulin,58 assessing insulin 
levels in vivo in the guinea pig is challenging.  We have currently been unable to generate 
confident results for plasma levels of insulin with commercially available ELISAs, 
despite numerous attempts, therefore limiting our ability to report in vivo insulin levels 
and to generate indices of whole-body insulin resistance.  We have attempted to perform 
whole-body insulin tolerance tests (ITT) using an intraperitoneal injection of 1IU/kg of 
human insulin, as determined by a dose-response study.  To assess insulin sensitivity we 
measured the percent drop in blood glucose values over the course of the 22-minute ITT, 
as a reflection of the ability of insulin to reduce blood glucose levels.59  However, due to 
a small sample size and inconsistent results, we do not feel confident reporting on the 
whole-body insulin sensitivity of our cohort at this time.  Going forward, further refining 
our insulin tolerance test protocol and continuing to optimize the measurement of plasma 
insulin levels in the guinea pig would be important in order to confidently speak to the 
overall insulin sensitivity of our cohort. 
 Additionally, all in vivo measurements were performed in the basal, fasted state, 
as were the final tissue collections.  While we were able to observe significant alterations 
in skeletal muscle lipid metabolism and insulin signaling in the basal state in agreement 
with other studies,8,60 observations in the insulin-stimulated state would have 
strengthened our conclusions.  It would have been beneficial to observe if the skeletal 
muscle was able to mount a response to exogenous insulin since insulin resistance is 
typically characterized by a reduction in glucose uptake in response to insulin 
stimulation.61 To address this, performing the 18F-FDG PET scans following insulin 
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administration would allow us to determine if skeletal muscle was able to take up glucose 
in response to insulin.  As reported by Reichkendler et al, exercise training was observed 
to increase insulin-stimulated glucose uptake in skeletal muscle, highlighting FDG-PET 
scans as a useful technique to assess in vivo skeletal glucose uptake in response to insulin 
administration.62  Also, performing our tissue collections immediately following insulin 
injection would have allowed us to compare the phosphorylation state of key insulin 
signaling intermediates in the basal and insulin-stimulated state in order to investigate 
their activation in response to insulin, and whether insulin-stimulated phosphorylation of 
key signaling intermediates was blunted.   
 The fasted-to-fed transition is also important in highlighting metabolic 
disruptions.63,64 Studies have shown that during the metabolic transition from a fasted to 
fed state, diabetic individuals fail to shift from fatty acid to glucose oxidation, depleting 
TCA cycle intermediates and highlighting a metabolic inflexibility.65 Therefore, 
examining some animals in the fed state would allow for a metabolic comparison that 
may highlight the development of metabolic inflexibility associated with MetS disease 
progression.  Additionally, mitochondria in skeletal muscle are thought to be particularly 
vulnerable to the nutritional milieu, with the mitochondria of obese animals displaying 
inabilities to adjust fatty acid influx in response to nutritional status, which is particularly 
evident in the fed state.63  It has also been suggested that metabolic inflexibility in 
response to nutrient status occurs early in disease progression,63,64 highlighting early 
detectable markers that may be used to monitor disease progression.  Although the fasted 
state allowed us to assess basal metabolic parameters, it would be beneficial to observe 
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how these metabolic parameters are altered in the non-fasted state and whether the fasted-
to-fed transition highlighted any further impairment in skeletal muscle lipid metabolism.  
 Finally, considerations must be made when analyzing our protein expression data 
of the transcription factors involved in regulating mitochondrial β-oxidation, as 
reductions in protein levels do not always imply reductions in activity.  Activity of these 
transcription factors is tightly regulated by post-translational modifications that facilitate 
or inhibit the ability of these proteins to activate their target genes. For example, the 
acetylation status of both PPARα and PGC-1α are known to impact their ability to 
complex with one another to induce their gene targets.  SIRT1 is an important component 
of this regulation, responsible for deacetylating PGC-1α, allowing it to complex with 
PPARα to promote lipid oxidation.66  However, when SIRT1 is not active, PGC-1α 
remains hyperacetylated, preventing upregulation of lipid oxidation.67 Therefore, 
investigation into the activity and post-translational modification of these transcription 
factors involved in mitochondrial biogenesis and oxidative function may provide insight 
into the mechanisms by which mitochondrial lipid metabolism is regulated and how an 
adverse in utero environment may induce persistent alterations to these transcription 
factors. 
 
4.4 Future Directions 
 As mentioned above, the current studies were limited to male offspring; therefore, 
further investigation of the programming events underlying insulin resistance in female 
offspring would be of great value.  Preliminary evidence suggests that females are, 
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similar to the males, glucose tolerant at this young age; however, molecular investigation 
of skeletal muscle insulin signaling and mitochondrial lipid metabolism remains to be 
completed.  Investigation of the same markers in the females would allow for 
determination of sexually dimorphic effects of the in utero environment on the 
development of insulin resistance. 
 Furthermore, it would be worthwhile to conduct another longitudinal study to 
examine later time points in order to determine if the glucose intolerant phenotype would 
emerge in the cohort as they aged.  Our current time point for sacrifice, approximately 
PND145, is still within the young adult period for the guinea pig.68,69 Many non-
communicable, metabolic diseases do not present until the effects of aging and insults in 
later life are compounded with insults that occurred in early life.1,9  Therefore, due to the 
young age of our animals, it is possible that overt symptoms of MetS have not yet had 
time to manifest.  Guinea pigs subjected to a high fat diet for 7 months are known to 
display mild glucose intolerance,70 highlighting that with continued exposure to a 
postnatal WD, overt manifestations of MetS are likely to occur. Given the proper funding 
and resources, a longitudinal study that follows the cohort through to 7-8 months of age, 
or until observable manifestations of MetS are present, would be of great interest. 
 Additionally, it would be of interest to determine which component, excess fat or 
excess sugar, of the postnatal WD had the largest contribution to the diet effects we 
observed.  This could be accomplished by designing diets isocaloric to our WD, with one 
diet containing excess fats alone and one diet containing excess sugars alone.  By 
introducing these diets to a subset of our cohort from weaning, performing the in vivo 
measurements and molecular analysis, in comparison to a control diet and a Western diet, 
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we would be able to determine whether it is the excess fat or the excess sugar present in 
the WD that is generating the effects we observed in these studies. We speculate that the 
excess fats present in a high fat diet would promote defects in skeletal muscle lipid 
metabolism,63,71 whereas excess sugars would have the potential to alter body 
composition and glucose tolerance.72-74  
 As previously mentioned, the reduced protein expression of the transcription 
factors regulating mitochondrial biogenesis and oxidative function needs to be explored 
further.  Investigation of post-translational modifications, including phosphorylation and 
acetylation, that are known to modulate the transcriptional activity of these transcription 
factors is required in order to associate these changes in protein expression with 
alterations in function. PGC-1α phosphorylation can be mediated by 5’ adenosine 
monophosphate-activated protein kinase (AMPK) at Thr177 and Ser538,75 and is known to 
promote PGC-1α stability, allowing activation of gene targets;66 whereas Akt-mediated 
phosphorylation of PGC-1α at Ser570 inhibits transcriptional activity.76 Therefore, 
investigation of PGC-1α phosphorylation may provide insight into the activation of this 
transcription factor.  Acetylation of lysine residues of the transcription factors regulating 
mitochondrial metabolism has also recently been highlighted as an important control 
mechanism regulating the ability of these transcription factors to form the complexes 
required to initiate transcription of their gene targets.77 The acetylation status of PGC-1α 
and PPARα are tightly regulated by SIRT1, a deacetylase activated in response to 
nutrient availability.66 Upon activation, SIRT1 catalyzes the reversible deacetylation of 
PGC-1α and PPARα, allowing them to complex together in order to induce transcription 
of their gene targets.78,79 Therefore, assessing the acetylation status of PGC-1α and 
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PPARα may provide insight into the activity of SIRT1 as well as the regulation of 
oxidative gene targets.  Additionally, chromatin immunoprecipitation could be employed 
to investigate the binding of these transcription factors to their target promoters, 
providing further information regarding how these transcription factors may be inducing 
the observed reductions in mitochondrial β-oxidation. 
 While the phosphorylation of FOXO1 was maintained, in conjunction with a 
reduced Akt phosphorylation level, investigation regarding mechanisms by which this 
phenomenon may occur would be of value given Akt does play a major role in regulating 
FOXO1phosphorylation status. In situations of insulin resistance, phosphorylation of 
FOXO1 is often reduced, resulting in hyperactivation of FOXO1 and disruption of 
glucose homeostasis.45 Since we observed enhanced phosphorylation of FOXO1 at Ser256 
following postnatal WD-consumption, investigation of alternative sites of 
phosphorylation, namely Thr24 and Ser319, which is mediated by other kinases such as 
serine/threonine kinase SGK 80 would allow for a better understanding of FOXO1 
transcriptional regulation of glucose and lipid homeostasis in states of altered insulin 
sensitivity.  
 Additionally, it would be of value to assess the regulation of PI3-kinase and its 
ability to activate Akt.  The PI3-kinase signaling pathway is incredibly important in 
regulating not only glucose homeostasis, but also protein synthesis, proliferation, 
differentiation and cell survival depending on which downstream targets of Akt are 
activated.81  One critical phosphatase that catalyzes the dephosphorylation and 
deactivation of PI3-kinase is phosphatase and tensin homologue deleted on chromosome 
10 (PTEN).81  An increase in the gene expression and protein levels of PTEN have been 
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observed in rodent models of type 2 diabetes,82 suggesting PTEN as an important player 
in insulin resistance pathogenesis.  Dephosphorylation of PTEN at Ser380, Thr382, and 
Thr383 promotes PTEN activity,83 and PTEN activity has been observed to increase in 
response to excess free fatty acid availability.84  Therefore, assessing the phosphorylation 
and activation of PTEN may provide insight into the regulation of PI3-kinase in response 
to insulin stimulation, and its ability to facilitate glucose uptake through the Akt/AS160 
branch of this signaling pathway. 
 Lastly, other post-translational and epigenetic mechanisms need to be further 
explored in order to explain the long-lasting effect of adverse in utero growth on later life 
skeletal muscle function and metabolism.  Epigenetic alterations initiated in utero are 
hypothesized to occur in response to adverse environments, which may ultimately 
promote survival in the short term but may have long-term detrimental effects on 
metabolic pathways.15,85,86 Research aimed at determining a molecular mechanism 
linking environmental cues to altered persistent gene expression and later life disease 
progression has highlighted DNA methylation as a likely candidate.66  Hypermethylation 
of the PGC-1α promoter region has been associated with reduced gene expression in 
LBW offspring,87,88 as well as diabetic subjects,89 preventing PGC-1α expression and 
impairing mitochondrial oxidative function.  Additionally, hypermethylation has been 
observed in response to hypoxia,90 highlighting another mechanism by which adverse in 
utero environments may induce permanent epigenetic alterations to metabolic function. 
Small non-coding RNAs known as microRNAs (miRNA) have also been gaining 
recognition for their role in disease pathogenesis.85 Given mRNA was not changed for the 
transcription factors we investigated but protein levels were decreased, miRNAs are 
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potential candidates mediating this phenomenon as they initiate post-transcriptional 
regulation of protein expression.91  miRNA-34a has recently been observed to be 
associated with a decrease in SIRT1 translation in vitro,79 whereas miRNA-15b and 
miRNA-16 have been associated with alterations in insulin signaling proteins in response 
to diabetes and LBW.92 Oxidative stress has also been observed to be an integral 
component in not only aging, but also age-related metabolic disease progression, by 
promoting epigenetic alterations in metabolism through miRNAs.93 As such, future work 
investigating the epigenetic mechanisms underlying the persistent molecular alterations 
in skeletal muscle metabolism observed following an adverse in utero environment and 
the interaction with the postnatal environment is required.  
 
4.5 Conclusions 
 The results of the present study provide further evidence for the importance of the 
in utero environment in modulating later-life disease risk. We also highlight that while 
young LBW offspring may outwardly appear healthy due to a non-obese, glucose tolerant 
phenotype, subtle changes at the level of the skeletal muscle represent a developing 
metabolically unhealthy phenotype.  These persistent molecular alterations to the insulin 
signaling pathway and mitochondrial lipid metabolism following consumption of a 
postnatal WD or an adverse in utero environment are early markers of insulin resistance 
pathogenesis, increasing the risk of these offspring for developing insulin resistance and 
the components of MetS.  Additionally, consumption of a postnatal WD following a 
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LBW outcome appears to exacerbate the metabolic disturbances initiated in utero, putting 
these offspring at greater risk for developing insulin resistance and other aspects of MetS. 
 Studies from other groups, as well as colleagues in our laboratory, have 
highlighted that other physiological parameters, including vascular and adipose 
development, of LBW offspring is unique in comparison to NBW offspring.13,14,24-26 The 
mechanisms underlying metabolic disease in the LBW offspring in comparison to that 
induced by poor diet in adulthood may be different. In this study, an adverse in utero 
environment modulated a different set of enzymes and transcription factors regulating 
mitochondrial lipid oxidation than consumption of a postnatal WD.  However, the 
divergent pathways converge upon similar stress-induced kinases and each induced 
alterations in the insulin signaling pathway, leading to a similar overall phenotype.  
Activation of these multiple pathways, when superimposed upon each other due to 
consumption of a poor postnatal diet following IUGR, may have the potential to further 
increase disease risk. 
 Of particular concern are recent studies highlighting that LBW offspring are 
unable to lose weight as efficiently as normal birth weight offspring when they are placed 
on a calorie restricted diet,94 and that IUGR-induced deficiencies in PGC-1α appear 
resistant to exercise interventions targeted to improve symptoms associated with MetS.95  
These LBW offspring with a unique metabolic profile, while being at higher risk of 
developing components of MetS, may be resistant, or lack the plasticity to respond to 
current intervention practices, highlighting the need for LBW-specific therapeutic 
options.  Additionally, current intervention strategies to combat metabolic disease are 
mostly targeted to overweight or obese individuals.96,97 However, as observed in these 
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studies, as well as others,72,74,98 these young LBW offspring are non-obese, highlighting 
the need for further investigation into therapeutic options that are not centered around 
obesity and its contribution to MetS pathogenesis.  Therefore, it is imperative that further 
investigation into not only the molecular mechanisms underlying the developmental 
programming of metabolic disease be conducted, but also investigation into how we can 
translate this knowledge into LBW-specific therapeutic options designed for the unique 
metabolic profile associated with adverse growth in utero. 
 
 
 
 
 
 
 
 
 
 
 
163 
 
4.6 References 
1 Osmond, C. & Barker, D. J. Fetal, infant and childhood growth are predictors of 
coronary heart disease, diabetes, and hypertension in adult men and women. 
Environ Health Perspect. 108, 545-553 (2000). 
2 Barker, D. J. et al. Fetal nutrition and cardiovascular disease in adult life. Lancet 
341, 938-941 (1993). 
3 Barker, D. J., Winter, P. D., Osmond, C., Margetts, B. & Simmonds, S. J. Weight 
in infancy and death from ischaemic heart disease. Lancet 2, 577-580 (1989). 
4 Crume, T. L. et al. The long-term impact of intrauterine growth restriction in a 
diverse U.S. cohort of children: the EPOCH study. Obesity 22, 608-615, 
doi:10.1002/oby.20565 (2014). 
5 Hales, C. N. et al. Fetal and infant growth and impaired glucose tolerance at age 
64. BMJ 303, 1019-1022 (1991). 
6 Jaquet, D., Gaboriau, A., Czernichow, P. & Levy-Marchal, C. Insulin resistance 
early in adulthood in subjects born with intrauterine growth retardation. The 
Journal of clinical endocrinology and metabolism 85, 1401-1406, 
doi:10.1210/jcem.85.4.6544 (2000). 
7 Jensen, C. B. et al. Altered PI3-kinase/Akt signalling in skeletal muscle of young 
men with low birth weight. PLoS One 3, e3738, 
doi:10.1371/journal.pone.0003738 (2008). 
8 Ozanne, S. E. et al. Low birthweight is associated with specific changes in muscle 
insulin-signalling protein expression. Diabetologia 48, 547-552, 
doi:10.1007/s00125-005-1669-7 (2005). 
9 Barker, D. J. The developmental origins of insulin resistance. Hormone research 
64 Suppl 3, 2-7, doi:10.1159/000089311 (2005). 
10 Barker, D. J. et al. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension 
and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 
36, 62-67 (1993). 
11 Forsdahl, A. Observations throwing light on the high mortality in the county of 
Finnmark. Is the high mortality today a late effect of very poor living conditions 
in childhood and adolescence? 1973. International journal of epidemiology 31, 
302-308 (2002). 
12 Forsdahl, A. Living conditions in childhood and subsequent development of risk 
factors for arteriosclerotic heart disease. The cardiovascular survey in Finnmark 
1974-75. Journal of epidemiology and community health 32, 34-37 (1978). 
164 
 
13 Rueda-Clausen, C. F. et al. Hypoxia-induced intrauterine growth restriction 
increases the susceptibility of rats to high-fat diet-induced metabolic syndrome. 
Diabetes 60, 507-516, doi:10.2337/db10-1239 (2011). 
14 Rueda-Clausen, C. F., Morton, J. S., Dolinsky, V. W., Dyck, J. R. & Davidge, S. 
T. Synergistic effects of prenatal hypoxia and postnatal high-fat diet in the 
development of cardiovascular pathology in young rats. American journal of 
physiology. Regulatory, integrative and comparative physiology 303, R418-426, 
doi:10.1152/ajpregu.00148.2012 (2012). 
15 Galjaard, S., Devlieger, R. & Van Assche, F. A. Fetal growth and developmental 
programming. Journal of perinatal medicine 41, 101-105, doi:10.1515/jpm-2012-
0020 (2013). 
16 Rees, W. D., McNeil, C. J. & Maloney, C. A. The Roles of PPARs in the Fetal 
Origins of Metabolic Health and Disease. PPAR research 2008, 459030, 
doi:10.1155/2008/459030 (2008). 
17 Simmons, R. A. Developmental origins of diabetes: The role of oxidative stress. 
Best practice & research. Clinical endocrinology & metabolism 26, 701-708, 
doi:10.1016/j.beem.2012.03.012 (2012). 
18 DeFronzo, R. A. et al. The Effect of Insulin on the Disposal of Intravenous 
Glucose: Results from Indirect Calorimetry and Hepatic and Femoral Venous 
Catheterization. Diabetes 30, 1000-1007, doi:10.2337/diab.30.12.1000 (1981). 
19 Zurlo, F., Nemeth, P. M., Choksi, R. M., Sesodia, S. & Ravussin, E. Whole-body 
energy metabolism and skeletal muscle biochemical characteristics. Metabolism: 
clinical and experimental 43, 481-486 (1994). 
20 Brons, C. et al. Effects of high-fat overfeeding on mitochondrial function, glucose 
and fat metabolism, and adipokine levels in low-birth-weight subjects. Am J 
Encodrinol Metab 302, E43-E51, doi:10.1152/ajpendo.00095.2011.-Low (2011). 
21 Liu, J. et al. Intrauterine growth retardation increases the susceptibility of pigs to 
high-fat diet-induced mitochondrial dysfunction in skeletal muscle. PLoS One 7, 
e34835, doi:10.1371/journal.pone.0034835 (2012). 
22 Khandelwal, P., Jain, V., Gupta, A. K., Kalaivani, M. & Paul, V. K. Association 
of early postnatal growth trajectory with body composition in term low birth 
weight infants. Journal of developmental origins of health and disease 5, 189-
196, doi:10.1017/S2040174414000178 (2014). 
23 Morrison, J. L., Duffield, J. A., Muhlhausler, B. S., Gentili, S. & McMillen, I. C. 
Fetal growth restriction, catch-up growth and the early origins of insulin 
resistance and visceral obesity. Pediatric nephrology 25, 669-677, 
doi:10.1007/s00467-009-1407-3 (2010). 
165 
 
24 Sarr, O., Thompson, J. A., Zhao, L., Lee, T. Y. & Regnault, T. R. Low birth 
weight male guinea pig offspring display increased visceral adiposity in early 
adulthood. PLoS One 9, e98433, doi:10.1371/journal.pone.0098433 (2014). 
25 Thompson, J. A., Gros, R., Richardson, B. S., Piorkowska, K. & Regnault, T. R. 
Central stiffening in adulthood linked to aberrant aortic remodeling under 
suboptimal intrauterine conditions. American journal of physiology. Regulatory, 
integrative and comparative physiology 301, R1731-1737, 
doi:10.1152/ajpregu.00274.2011 (2011). 
26 Thompson, J. A., Sarr, O., Piorkowska, K., Gros, R. & Regnault, T. R. Low birth 
weight followed by postnatal over-nutrition in the guinea pig exposes a 
predominant player in the development of vascular dysfunction. The Journal of 
physiology 592, 5429-5443, doi:10.1113/jphysiol.2014.275016 (2014). 
27 Selak, M. A., Storey, B. T., Peterside, I. & Simmons, R. A. Impaired oxidative 
phosphorylation in skeletal muscle of intrauterine growth-retarded rats. American 
journal of physiology. Endocrinology and metabolism 285, E130-137, 
doi:10.1152/ajpendo.00322.2002 (2003). 
28 Mai, M. et al. Serum levels of acylcarnitines are altered in prediabetic conditions. 
PLoS One 8, e82459, doi:10.1371/journal.pone.0082459 (2013). 
29 Fernandez-Twinn, D. S. & Ozanne, S. E. Mechanisms by which poor early 
growth programs type-2 diabetes, obesity and the metabolic syndrome. 
Physiology & behavior 88, 234-243, doi:10.1016/j.physbeh.2006.05.039 (2006). 
30 Giussani, D. A., Salinas, C. E., Villena, M. & Blanco, C. E. The role of oxygen in 
prenatal growth: studies in the chick embryo. The Journal of physiology 585, 911-
917, doi:10.1113/jphysiol.2007.141572 (2007). 
31 Giussani, D. A., Phillips, P. S., Anstee, S. & Barker, D. J. Effects of altitude 
versus economic status on birth weight and body shape at birth. Pediatr Res 49, 
490-494, doi:10.1203/00006450-200104000-00009 (2001). 
32 Li, G. et al. Effect of fetal hypoxia on heart susceptibility to ischemia and 
reperfusion injury in the adult rat. J Soc Gynecol Investig 10, 265-274 (2003). 
33 Peyronnet, J. et al. Long-lasting adverse effects of prenatal hypoxia on developing 
autonomic nervous system and cardiovascular parameters in rats. Pflugers Archiv 
: European journal of physiology 443, 858-865, doi:10.1007/s00424-001-0766-9 
(2002). 
34 Camm, E. J. et al. Prenatal hypoxia independent of undernutrition promotes 
molecular markers of insulin resistance in adult offspring. FASEB journal : 
official publication of the Federation of American Societies for Experimental 
Biology 25, 420-427, doi:10.1096/fj.10-158188 (2011). 
166 
 
35 Thorn, S. R. et al. Intrauterine growth restriction increases fetal hepatic 
gluconeogenic capacity and reduces messenger ribonucleic acid translation 
initiation and nutrient sensing in fetal liver and skeletal muscle. Endocrinology 
150, 3021-3030, doi:10.1210/en.2008-1789 (2009). 
36 Netzer, N. et al. Hypoxia, Oxidative Stress and Fat. Biomolecules 5, 1143-1150, 
doi:10.3390/biom5021143 (2015). 
37 Myatt, L. et al. Differential localization of superoxide dismutase isoforms in 
placental villous tissue of normotensive, pre-eclamptic, and intrauterine growth-
restricted pregnancies. The journal of histochemistry and cytochemistry : official 
journal of the Histochemistry Society 45, 1433-1438 (1997). 
38 Karowicz-Bilinska, A., Suzin, J. & Sieroszewski, P. Evaluation of oxidative stress 
indices during treatment in pregnant women with intrauterine growth retardation. 
Medical science monitor : international medical journal of experimental and 
clinical research 8, CR211-216 (2002). 
39 Bowen, R. S., Moodley, J., Dutton, M. F. & Theron, A. J. Oxidative stress in pre-
eclampsia. Acta obstetricia et gynecologica Scandinavica 80, 719-725 (2001). 
40 Peterside, I. E., Selak, M. A. & Simmons, R. A. Impaired oxidative 
phosphorylation in hepatic mitochondria in growth-retarded rats. American 
journal of physiology. Endocrinology and metabolism 285, E1258-1266, 
doi:10.1152/ajpendo.00437.2002 (2003). 
41 Chandel, N. S., Budinger, G. R. & Schumacker, P. T. Molecular oxygen 
modulates cytochrome c oxidase function. The Journal of biological chemistry 
271, 18672-18677 (1996). 
42 Abdul-Ghani, M. A. & DeFronzo, R. A. Pathogenesis of insulin resistance in 
skeletal muscle. Journal of biomedicine & biotechnology 2010, 476279, 
doi:10.1155/2010/476279 (2010). 
43 Kelley, D. E., He, J., Menshikova, E. V. & Ritov, V. B. Dysfunction of 
mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 51, 2944-
2950 (2002). 
44 McCullough, A. J. Epidemiology of the metabolic syndrome in the USA. Journal 
of digestive diseases 12, 333-340, doi:10.1111/j.1751-2980.2010.00469.x (2011). 
45 Cheng, Z., Tseng, Y. & White, M. F. Insulin signaling meets mitochondria in 
metabolism. Trends in endocrinology and metabolism: TEM 21, 589-598, 
doi:10.1016/j.tem.2010.06.005 (2010). 
46 Montgomery, M. K. & Turner, N. Mitochondrial dysfunction and insulin 
resistance: an update. Endocrine connections 4, R1-R15, doi:10.1530/EC-14-0092 
(2015). 
167 
 
47 Magalhaes, J. et al. Acute and severe hypobaric hypoxia increases oxidative stress 
and impairs mitochondrial function in mouse skeletal muscle. Journal of applied 
physiology 99, 1247-1253, doi:10.1152/japplphysiol.01324.2004 (2005). 
48 Jing, E. et al. Sirtuin-3 (Sirt3) regulates skeletal muscle metabolism and insulin 
signaling via altered mitochondrial oxidation and reactive oxygen species 
production. Proceedings of the National Academy of Sciences of the United States 
of America 108, 14608-14613, doi:10.1073/pnas.1111308108 (2011). 
49 Kewalramani, G., Bilan, P. J. & Klip, A. Muscle insulin resistance: assault by 
lipids, cytokines and local macrophages. Current opinion in clinical nutrition and 
metabolic care 13, 382-390, doi:10.1097/MCO.0b013e32833aabd9 (2010). 
50 Aguer, C. et al. Acylcarnitines: potential implications for skeletal muscle insulin 
resistance. FASEB journal : official publication of the Federation of American 
Societies for Experimental Biology 29, 336-345, doi:10.1096/fj.14-255901 (2015). 
51 Rutkowsky, J. M. et al. Acylcarnitines activate proinflammatory signaling 
pathways. American Journal of Physiology - Endocrinology and Metabolism 306, 
E1378-E1387, doi:10.1152/ajpendo.00656.2013.-Incomplete (2014). 
52 Owens, J. A. et al. Sex-specific effects of placental restriction on components of 
the metabolic syndrome in young adult sheep. American journal of physiology. 
Endocrinology and metabolism 292, E1879-1889, 
doi:10.1152/ajpendo.00706.2006 (2007). 
53 Sugden, M. C. & Holness, M. J. Gender-specific programming of insulin 
secretion and action. J Endocrinol 175, 757-767 (2002). 
54 Oak, S. A., Tran, C., Pan, G., Thamotharan, M. & Devaskar, S. U. Perturbed 
skeletal muscle insulin signaling in the adult female intrauterine growth-restricted 
rat. American journal of physiology. Endocrinology and metabolism 290, E1321-
E1330, doi:10.1152/ajpendo.00437.2005.-To (2006). 
55 Holemans, K., Verhaeghe, J., Dequeker, J. & Van Assche, F. A. Insulin 
sensitivity in adult female rats subjected to malnutrition during the perinatal 
period. J Soc Gynecol Investig 3, 71-77 (1996). 
56 De Blasio, M. J., Gatford, K. L., Harland, M. L., Robinson, J. S. & Owens, J. A. 
Placental restriction reduces insulin sensitivity and expression of insulin signaling 
and glucose transporter genes in skeletal muscle, but not liver, in young sheep. 
Endocrinology 153, 2142-2151, doi:10.1210/en.2011-1955 (2012). 
57 De Blasio, M. J., Gatford, K. L., McMillen, I. C., Robinson, J. S. & Owens, J. A. 
Placental restriction of fetal growth increases insulin action, growth, and adiposity 
in the young lamb. Endocrinology 148, 1350-1358, doi:10.1210/en.2006-0653 
(2007). 
168 
 
58 Chan, S. J. et al. Guinea pig preproinsulin gene: An evolutionary compromise? 
Proc. Nat. Acad. Sci. USA 81, 5046-5050 (1984). 
59 Bonora, E. et al. Estimates of In Vivo Insulin Action in Man: Comparison of 
Insulin Tolerance Tests with Euglycemic and Hyperclycemic Glucose Clamp 
Studies. Journal of Clinical Endocrinology and Metabolism 68, 374-378 (1989). 
60 Muhlhausler, B. S. et al. The transition from fetal growth restriction to accelerated 
postnatal growth: a potential role for insulin signalling in skeletal muscle. The 
Journal of physiology 587, 4199-4211, doi:10.1113/jphysiol.2009.173161 (2009). 
61 Lebovitz, H. E. Insulin resistance: definition and consequences. Experimental and 
clinical endocrinology & diabetes : official journal, German Society of 
Endocrinology [and] German Diabetes Association 109 Suppl 2, S135-148, 
doi:10.1055/s-2001-18576 (2001). 
62 Reichkendler, M. H. et al. Exercise training favors increased insulin-stimulated 
glucose uptake in skeletal muscle in contrast to adipose tissue: a randomized 
study using FDG PET imaging. American journal of physiology. Endocrinology 
and metabolism 305, E496-506, doi:10.1152/ajpendo.00128.2013 (2013). 
63 Koves, T. R. et al. Mitochondrial overload and incomplete fatty acid oxidation 
contribute to skeletal muscle insulin resistance. Cell metabolism 7, 45-56, 
doi:10.1016/j.cmet.2007.10.013 (2008). 
64 Muoio, D. M. et al. Muscle-specific deletion of carnitine acetyltransferase 
compromises glucose tolerance and metabolic flexibility. Cell metabolism 15, 
764-777, doi:10.1016/j.cmet.2012.04.005 (2012). 
65 Kelley, D. E. & Mandarino, L. J. Fuel selection in human skeletal muscle in 
insulin resistance: a reexamination. Diabetes 49, 677-683 (2000). 
66 Sugden, M. C., Caton, P. W. & Holness, M. J. PPAR control: it's SIRTainly as 
easy as PGC. J Endocrinol 204, 93-104, doi:10.1677/JOE-09-0359 (2010). 
67 Brenmoehl, J. & Hoeflich, A. Dual control of mitochondrial biogenesis by sirtuin 
1 and sirtuin 3. Mitochondrion 13, 755-761, doi:10.1016/j.mito.2013.04.002 
(2013). 
68 Gomez-Pinilla, P. J. et al. Effect of melatonin on age associated changes in 
Guinea pig bladder function. The Journal of urology 177, 1558-1561, 
doi:10.1016/j.juro.2006.11.071 (2007). 
69 Kind, K. L. et al. Effect of maternal feed restriction during pregnancy on glucose 
tolerance in the adult guinea pig. American journal of physiology. Regulatory, 
integrative and comparative physiology 284, R140-152, 
doi:10.1152/ajpregu.00587.2001 (2003). 
169 
 
70 Greulich, S. et al. Secretory products of guinea pig epicardial fat induce insulin 
resistance and impair primary adult rat cardiomyocyte function. Journal of 
cellular and molecular medicine 15, 2399-2410, doi:10.1111/j.1582-
4934.2010.01232.x (2011). 
71 Yu, C. et al. Mechanism by which fatty acids inhibit insulin activation of insulin 
receptor substrate-1 (IRS-1)-associated phosphatidylinositol 3-kinase activity in 
muscle. The Journal of biological chemistry 277, 50230-50236, 
doi:10.1074/jbc.M200958200 (2002). 
72 Cambri, L. T., Ghezzi, A. C., Ribeiro, C., Dalia, R. A. & de Mello, M. A. 
Recovery of rat growth and lipid profiles in adult rats subjected to fetal protein 
malnutrition with a fructose-rich diet. Nutrition research 30, 156-162, 
doi:10.1016/j.nutres.2010.01.001 (2010). 
73 de Moura, R. F., Ribeiro, C., de Oliveira, J. A., Stevanato, E. & de Mello, M. A. 
Metabolic syndrome signs in Wistar rats submitted to different high-fructose 
ingestion protocols. The British journal of nutrition 101, 1178-1184, 
doi:10.1017/S0007114508066774 (2009). 
74 Ghezzi, A. C., Cambri, L. T., Ribeiro, C., Botezelli, J. D. & Mello, M. A. Impact 
of early fructose intake on metabolic profile and aerobic capacity of rats. Lipids in 
health and disease 10, 3, doi:10.1186/1476-511X-10-3 (2011). 
75 Jager, S., Handschin, C., St-Pierre, J. & Spiegelman, B. M. AMP-activated 
protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of 
PGC-1alpha. Proceedings of the National Academy of Sciences of the United 
States of America 104, 12017-12022, doi:10.1073/pnas.0705070104 (2007). 
76 Fernandez-Marcos, P. J. & Auwerx, J. Regulation of PGC-1alpha, a nodal 
regulator of mitochondrial biogenesis. The American journal of clinical nutrition 
93, 884S-890, doi:10.3945/ajcn.110.001917 (2011). 
77 Anderson, K. A. & Hirschey, M. D. Mitochondrial protein acetylation regulates 
metabolism. Essays in biochemistry 52, 23-35, doi:10.1042/bse0520023 (2012). 
78 Huang, J. Y., Hirschey, M. D., Shimazu, T., Ho, L. & Verdin, E. Mitochondrial 
sirtuins. Biochimica et biophysica acta 1804, 1645-1651, 
doi:10.1016/j.bbapap.2009.12.021 (2010). 
79 Nogueiras, R. et al. Sirtuin 1 and sirtuin 3: physiological modulators of 
metabolism. Physiological reviews 92, 1479-1514, 
doi:10.1152/physrev.00022.2011 (2012). 
80 Lee, J. W., Chen, H., Pullikotil, P. & Quon, M. J. Protein kinase A-alpha directly 
phosphorylates FoxO1 in vascular endothelial cells to regulate expression of 
vascular cellular adhesion molecule-1 mRNA. The Journal of biological 
chemistry 286, 6423-6432, doi:10.1074/jbc.M110.180661 (2011). 
170 
 
81 Yao, H., Han, X. & Han, X. The cardioprotection of the insulin-mediated 
PI3K/Akt/mTOR signaling pathway. American journal of cardiovascular drugs : 
drugs, devices, and other interventions 14, 433-442, doi:10.1007/s40256-014-
0089-9 (2014). 
82 Lo, Y. T., Tsao, C. J., Liu, I. M., Liou, S. S. & Cheng, J. T. Increase of PTEN 
gene expression in insulin resistance. Hormone and metabolic research = 
Hormon- und Stoffwechselforschung = Hormones et metabolisme 36, 662-666, 
doi:10.1055/s-2004-826016 (2004). 
83 Vazquez, F. et al. Phosphorylation of the PTEN tail acts as an inhibitory switch 
by preventing its recruitment into a protein complex. The Journal of biological 
chemistry 276, 48627-48630, doi:10.1074/jbc.C100556200 (2001). 
84 Wang, X. L. et al. Free fatty acids inhibit insulin signaling-stimulated endothelial 
nitric oxide synthase activation through upregulating PTEN or inhibiting Akt 
kinase. Diabetes 55, 2301-2310, doi:10.2337/db05-1574 (2006). 
85 Kanaka-Gantenbein, C. Fetal origins of adult diabetes. Annals of the New York 
Academy of Sciences 1205, 99-105, doi:10.1111/j.1749-6632.2010.05683.x 
(2010). 
86 Wadhwa, P. D., Buss, C., Entringer, S. & Swanson, J. M. Developmental origins 
of health and disease: brief history of the approach and current focus on 
epigenetic mechanisms. Seminars in reproductive medicine 27, 358-368, 
doi:10.1055/s-0029-1237424 (2009). 
87 Zeng, Y., Gu, P., Liu, K. & Huang, P. Maternal protein restriction in rats leads to 
reduced PGC-1alpha expression via altered DNA methylation in skeletal muscle. 
Molecular medicine reports 7, 306-312, doi:10.3892/mmr.2012.1134 (2013). 
88 Brons, C. et al. Deoxyribonucleic acid methylation and gene expression of 
PPARGC1A in human muscle is influenced by high-fat overfeeding in a birth-
weight-dependent manner. The Journal of clinical endocrinology and metabolism 
95, 3048-3056, doi:10.1210/jc.2009-2413 (2010). 
89 Barres, R. et al. Non-CpG methylation of the PGC-1alpha promoter through 
DNMT3B controls mitochondrial density. Cell metabolism 10, 189-198, 
doi:10.1016/j.cmet.2009.07.011 (2009). 
90 Watson, C. J. et al. Hypoxia-induced epigenetic modifications are associated with 
cardiac tissue fibrosis and the development of a myofibroblast-like phenotype. 
Human molecular genetics 23, 2176-2188, doi:10.1093/hmg/ddt614 (2014). 
91 Eisenberg, I., Alexander, M. S. & Kunkel, L. M. miRNAS in normal and diseased 
skeletal muscle. Journal of cellular and molecular medicine 13, 2-11, 
doi:10.1111/j.1582-4934.2008.00524.x (2009). 
171 
 
92 Bork-Jensen, J. et al. Glucose tolerance is associated with differential expression 
of microRNAs in skeletal muscle: results from studies of twins with and without 
type 2 diabetes. Diabetologia, doi:10.1007/s00125-014-3434-2 (2014). 
93 Cencioni, C. et al. Oxidative stress and epigenetic regulation in ageing and age-
related diseases. International journal of molecular sciences 14, 17643-17663, 
doi:10.3390/ijms140917643 (2013). 
94 Beauchamp, B. et al. Low birth weight is associated with adiposity, impaired 
skeletal muscle energetics and weight loss resistance in mice. International 
journal of obesity, doi:10.1038/ijo.2014.120 (2014). 
95 Laker, R. C. et al. Exercise early in life in rats born small does not normalize 
reductions in skeletal muscle PGC-1alpha in adulthood. American journal of 
physiology. Endocrinology and metabolism 302, E1221-1230, 
doi:10.1152/ajpendo.00583.2011 (2012). 
96 Bassi, N. et al. Lifestyle modification for metabolic syndrome: a systematic 
review. The American journal of medicine 127, 1242 e1241-1210, 
doi:10.1016/j.amjmed.2014.06.035 (2014). 
97 Keane, D. et al. Diet and metabolic syndrome: an overview. Current vascular 
pharmacology 11, 842-857 (2013). 
98 Malo, E. et al. Plasma lipid levels and body weight altered by intrauterine growth 
restriction and postnatal fructose diet in adult rats. Pediatr Res 73, 155-162, 
doi:10.1038/pr.2012.173 (2013). 
 
 
 
 
 
 
 
 
 
172 
 
 
 
 
 
 
 
 
 
 
APPENDIX I: Acylcarnitine Profile Short Hands 
 
 
 
 
 
 
 
 
 
 
173 
 
 
Acylcarnitine Short Hand Common Name 
C2 Acetyl Carnitine 
C3 Propionyl Carnitine 
C4 Isobutyryl Caritine 
C5 Isovaleryl Carnitine 
C6 Hexanoyl Carnitine 
C8 Octanoyl Carnitine 
C10 Decanoyl Carnitine 
C12 Lauroyl Carnitine 
C14 Myristoyl Carnitine 
C16 Palmitoyl Carnitine 
C18 Stearoyl Carnitine 
C14:1 Tetradecenoyl Carnitine 
C16:1 Palmitoleoyl Carnitine 
C18:1 Oleyl Carnitine 
C18:2 Linoleoyl Carnitine 
C18:3 Octadecatrienoyl Carnitine 
C20:4 Arachiodonoyl Carnitine 
C22:5 Docosapentaenoyl Carnitine 
C4-OH 3-Hydroxy-Butyryl Carnitine 
C12-OH 3-Hydroxy-Dodecanoyl Carnitine 
C14-OH 3-Hydroxy-Tetradecanoyl Carnitine 
C16-OH 3-Hydroxy-Hexadecanoyl Carnitine 
C18-OH 3-Hydroxy-Octadecanoyl Carnitine 
C18:1-OH 3-Hydroxy-Octadecenoyl Carnitine 
 
Appendix Table 1.1: Acylcarnitine Profile Short Hands. 
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AUP Number: 2010-229  
PI Name: Regnault, Timothy  
AUP Title: In Utero Origins Of Adult Insulin Resistance  
Approval Date: 09/08/2014 
Official Notice of Animal Use Subcommittee (AUS) Approval: Your new 
Animal Use Protocol (AUP) entitled "In Utero Origins Of Adult Insulin 
Resistance" has been APPROVED by the Animal Use Subcommittee of the 
University Council on Animal Care. This approval, although valid for four years, 
and is subject to annual Protocol Renewal.2010-229::5 
 
1 This AUP number must be indicated when ordering animals for this project. 
2 Animals for other projects may not be ordered under this AUP number. 
3 Purchases of animals other than through this system must be cleared through the ACVS 
office. Health certificates will be required. 
 
The holder of this Animal Use Protocol is responsible to ensure that all associated 
safety components (biosafety, radiation safety, general laboratory safety) comply 
with institutional safety standards and have received all necessary approvals. 
Please consult directly with your institutional safety officers. 
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